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Abstract 
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric 
disorders in school-age children and is the cause of multiple burdens related to healthcare costs, 
academic performance, and later employment. As such, its etiology represents a major public 
health concern. While genetics play a large role in the etiology of ADHD, multiple 
environmental exposures may contribute to risk. Here, we investigate the role of one toxicant, 
methylmercury (MeHg), measured in hair and blood, and its possible interactions with both other 
toxicants (lead, Pb) and a series of candidate genes. Additionally, we examined possible 
associations of MeHg exposure with the acoustic startle reflex (ASR) and the sensorimotor 
gating process, prepulse inhibition (PPI), in which deficits have been observed in individuals 
with attention deficits. Participants were recruited from the Early Life Exposure in Mexico to 
Environmental Toxicants (ELEMENT) study, a longitudinal birth cohort that began in the 1990s. 
ADHD symptoms were screened using the Conners’ Continuous Performance Test II (CPTII) 
and the Conners’ Rating Scales-Revised (CRS-R). We found no significant associations between 
prenatal and postnatal MeHg exposures and ADHD screening scores. No interaction was seen for 
concurrent exposures to MeHg and Pb. For prenatal exposure, generally, interactions between 
the two metals corresponded to increasing attention deficits scores in trimester 1, while 
interactions between the two corresponded to decreasing attention deficits scores in trimester 2, 
and no pattern was seen in trimester 3. Additionally, we found that associations between hair Hg 
concentration and attention measures differed by dopamine receptor D4 (DRD4) and catechol-O-
methyltransferase (COMT) genotype. ASR without a prepulse was non-linearly associated with
xiii 
 
MeHg exposure. For ASR response magnitudes with prepulses, higher MeHg generally 
corresponded to higher ASR magnitudes, especially in the right tail of their respective 
distributions. No significant associations were seen between MeHg and PPI. This research adds 
to our understanding of how environmental influences like MeHg can play a role in the 
development of attention deficits in children and adolescents.  
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Introduction 
Attention-deficit/ hyperactivity disorder (ADHD), affects approximately 8-10% of school 
aged-children worldwide (Escobar et al. 2005; Rowland et al. 2002). It is the most common 
psychological disorder in that age group (Escobar et al. 2005; Rowland et al. 2002). Although 
commonly assumed by the public to be a disorder of childhood, it can persist into adulthood with 
an estimated prevalence of in adults of 4.4% (Kessler et al. 2006). It is responsible for an 
estimated $31.6 billion in excess healthcare costs (Birnbaum et al. 2005). A diagnosis of ADHD 
is also associated with multiple deficits in academic performance (DeShazo Barry et al. 2002; 
Merrel and Tymms 2001; Henker and Whalen 1989) and increases in number of work absences, 
short-term disability, and worker compensation claims during later employment (Secnik et al. 
2005). The costs and quality of life deficits associated with this and other mental health disorders 
present a pressing public health concern. 
While multiple possible environmental risk factors for ADHD have been identified, these 
are not always well understood (Norman et al. 2013). Environmental exposures are complex and 
interact with each other, as well as individual characteristics. An exposure may only have an 
effect in a specific window of susceptibility, which could contribute to a condition that may not 
manifest clinically until much later in life (Landrigan and Etzel 2013). Understanding how 
environmental exposures, especially those that are widespread and present chronically at low 
doses, contribute to ADHD risk is imperative. 
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Overview of ADHD 
 ADHD is defined in the Diagnostic and Statistical Manual as a “persistent pattern of 
inattention and/or hyperactivity-impulsivity that interferes with functioning or development.” 
(American Psychiatric Association 2013) It is classed as a neurodevelopmental disorder, with 
symptom onset occurring before 12 years of age. A diagnosis in children and adolescents 
requires an individual to exhibit at least six inattention symptoms and/or at least six 
hyperactivity/impulsivity symptoms in two or more settings and must be shown to interfere with 
the individual’s functioning (American Psychiatric Association 2013).  
Inattention is characterized by distraction, outside of an obvious source, and an inability 
to focus. Inattention symptoms would include inability to listen in class, making careless 
mistakes on assignments, and poor time management, among many others (American Psychiatric 
Association 2013). Hyperactivity is defined as “excessive motor activity,” while impulsivity is 
defined as “hasty actions which occur in the moment without forethought and that have a high 
potential for harm to the individual.” Hyperactivity and impulsivity symptoms would include, 
among others fidgeting, feeling restless, talking excessively and interrupting (American 
Psychiatric Association 2013). Based on which type of symptom predominates, an individual 
case can be specified as inattentive presentation, hyperactive/impulsive presentation, or 
combined presentation (American Psychiatric Association 2013).  
While ADHD is most commonly identified after a child begins schooling, some 
symptoms are identifiable in early life. It is developmentally appropriate for preschoolers to 
exhibit behaviors associated with ADHD, but cases can present with hyperactivity and 
impulsivity beyond developmental norms (Cherkasova et al. 2013). However, compared to 
studies of ADHD in older children, there are relatively few studies in this age group (Egger et al. 
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2006). While ADHD was initially thought to present exclusively in children and adolescents, it is 
now know that symptoms can persist into adulthood (Haavik et al. 2010).  
ADHD symptoms indicate deficits in behavioral control, motor control, and executive 
functions. Imaging studies suggest abnormalities in the fronto-striato-thalamic circuitry of 
individuals with ADHD, which could provide a basis for these deficits (Cherkasova and 
Hechtman 2013). Individuals with ADHD have volumetric reductions, especially in the right 
hemisphere (Cherkasova and Hechtman 2013). These are specifically volume reductions in the 
dorsolateral prefrontal cortex (PFC), caudate, pallidum, corpus callosum, and cerebellum 
(Seidman et al. 2005). Interestingly, as the brain matures, the brains of children with ADHD 
follow the same developmental patterns as controls, but are delayed. Studies in adults show 
similar, but less pronounced structural changes (Cherkasova and Hechtman 2013). Additionally, 
studies of executive function find reduced activity in the anterior cingulate cortex (ACC), 
multiple areas of the PFC, thalamus, basal ganglia, and the parietal cortex, as well as increased 
activity in several other areas (Cherkasova and Hechtman 2013). 
Limitations of Environmental Epidemiology Studies of ADHD 
 There are limitations when studying environmental exposures and ADHD. While ADHD 
is common, it is difficult to find a large enough number of cases in a population cohort to yield 
meaningful results. Thus, rather than identifying participants with clinically diagnosable ADHD, 
many assess behavioral outcomes on a continuous scale, such as the Conner’s Rating Scales-
Revised (CRS-R) and the Behavior Assessment System for Children (BASC), which produce 
quantitative results based on a profile of clinically relevant symptoms (Symeonides et al. 2013). 
Treating ADHD as a continuous set of behaviors rather than a discrete outcome can improve the 
statistical power of a study and can allow for examination of subclinical symptoms. However, 
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this method does assume that the same factors will be relevant across the continuum of 
symptoms (Symeonides et al. 2013).  
 Additionally, studies can examine executive function deficits related to ADHD. 
However, these deficits can be heterogeneous between individuals in a sample, observed trends 
might be more easily confounded. Furthermore, because ADHD diagnosed is based on 
behavioral criteria, executive function deficits may not be sufficiently predictive (Symeonides et 
al. 2013). 
 There are also concerns about the effects of reporter differences. A study from the early 
1980s found that adults with ADHD symptoms often under-report their symptom severity 
(Wender et al. 1981). A more recent study found marked differences between self-report data 
from adolescents and parent-report data (Rohde et al. 2001). Evidence indicates that school age 
children should be able to reliably report on their own health and that using a proxy reporter may 
introduce bias. These factors could create inconsistencies between studies that use different 
report methodologies (Riley 2004). 
Role of Other Assessment Methods in Addressing Limitations 
 Because of these issues, efforts have been made to identify potential sets of biomarkers of 
ADHD to help support diagnostic methods. Potential biomarkers have included genetic markers, 
biochemical features, and physical changes in the brain (Faraone et al. 2014). While some of the 
suggested biomarkers, including those related to endophenotypes, may be less practical for use in 
diagnostic practices (Faraone et al. 2014), they could be useful in the context of environmental 
epidemiology studies to support findings observed using more traditional screening methods. 
 One physiological measure of interest is prepulse inhibition (PPI). PPI is a measure of 
sensorimotor gating and can be observed in the acoustic startle reflex (ASR). In PPI, exposure to 
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a brief pre-stimulus (or pre-pulse) ahead of a startling stimulus results in a dampened response 
(Li et al. 2009). Alterations in this process have been observed in a number of psychiatric and 
neurological conditions, including ADHD (Pålsson et al. 2011; Schulz-Juergensen et al. 2014), 
although it is not always observed in ADHD (Feifel et al. 2009; Kohl et al. 2013). In the case of 
attention deficits, deficits in this process are particularly pronounced during tasks which require 
selective attention (Hawk et al. 2003; Scholes and Martin-Iverson 2010). Further, deficits in PPI 
in ADHD cases have been observed to be remediated with methylphenidate treatment (Schulz-
Juergensen et al. 2014; Hawk et al. 2003) and it has been suggested that PPI might be useful as a 
measure of dopaminergic function (Swerdlow et al. 2003).  
Etiology of ADHD 
 Multiple factors are thought to be related to the development of ADHD. Among these, 
genetic factors feature most prominently. Heritability of ADHD is estimated to be 71-90%, based 
on twin studies. Adoption studies also suggest a strong genetic component, although they do not 
completely rule out interactions with the environment (Thapar et al. 2013). Candidate genes for 
ADHD risk are primarily dopaminergic and serotonergic. While the risk associated with these 
genes is generally small and cannot individually explain the entirety of a person’s risk, these 
findings, especially related to the dopaminergic genes, have been consistent (Thapar et al. 2013; 
Swanson et al. 2007).  
 Deficits in dopaminergic signaling are a particularly promising mechanism. 
Methylphenidate (MPH, Ritalin), which is frequently used to treat ADHD, appears to act by 
stimulating the release of stored presynaptic dopamine and blocking reuptake. (Scahill et al. 
2004; Chadchankar et al. 2012) The candidate genes associated with risk include dopamine (DA) 
transporter (DAT1). Imaging studies have shown variable levels of DAT1 expression in the 
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striatum and mesencephalon. Initial studies showed a dramatic increase in DAT1 expression in 
ADHD cases compared to controls, while later studies showed no differences or lower levels. A 
recent review of these imaging studies suggested that these variable findings might be a result of 
DAT1 expression regulation by DA levels. That is, that lower DA levels may result in lower 
DAT1 density. MPH treatment increases DA levels, and DAT1 expression would thus be higher 
as well (Swanson et al. 2007) 
Exposures Associated with ADHD 
 Although genetic factors likely play a large role in ADHD risk, environmental factors and 
gene-environment interactions may also play in the role in the development of ADHD. Most 
likely, if an exposure contributes to ADHD, it could occur during specific windows of 
susceptibility. In many of the existing studies, pre- and peri-natal exposures are of particular 
interest. However, associations with exposures in childhood have also been found. Nevertheless, 
it is still unclear whether any of these possible risk factors are causally related to ADHD.  
 For example, maternal smoking during pregnancy has been repeatedly associated with 
increased rates of ADHD. This has been consistent through methodological differences- using 
diagnosed ADHD versus symptoms and self-reported cigarette use versus the biomarker 
cotinine- and a dose-response relationship which had been previously observed (Thapar et al. 
2013). It is possible, however, that this association is confounded by genetic factors (Thapar et 
al. 2013). Additionally, a study of gene-environment interactions found interactions between 
maternal smoking during pregnancy and DA gene polymorphisms among a group of children 
with ADHD- combined type (Neuman et al. 2007).  
 Lead exposure has also been associated with ADHD in multiple studies. Young children 
are often exposed to lead contaminated dust and soil during hand-to-mouth behaviors (Thornton 
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et al. 1990; Lanphear et al. 1998). Additionally, resorption of the maternal skeleton during 
pregnancy can mobilize lead and expose the developing fetus (Rothenberg et al. 2000). Low-
level lead exposure in childhood has most notably been associated with reductions in measured 
intelligence (Koller et al. 2004; Lanphear et al. 2005), as has prenatal exposure (Schnaas et al. 
2006; Gomaa et al. 2002). Similarly, a number of studies have found associations between 
deficits in attention measures and exposure to lead during childhood (Nigg et al. 2008; Calderon 
et al. 2001; Nigg et al. 2010; Braun et al. 2006). Fewer studies have associated exposure during 
prenatal development and attention deficits (Plusquellec et al. 2007). Multiple studies noted that 
lead exposure was associated with hyperactivity and impulsivity symptoms, but not inattention 
(Nigg et al. 2008; Boucher et al. 2012; Sioen et al. 2013), which could indicate that the 
associations between lead and attention might be mediated by lead’s cognitive effects. That is, 
that cognitive deficits lead to poorer behavioral control (Nigg et al. 2008). In vivo studies 
suggest that lead exposure during synaptogenesis decreases levels of the proteins synaptophysin 
and synaptobrevin, resulting in impaired vesicular release (Neal et al. 2010). 
 Multiple other environmental risk factors for ADHD have been proposed. These include 
maternal medication use during gestation, maternal obesity, essential nutrient deficiency, a 
number of psychosocial conditions, and additional metals, such as mercury. (Thapar et al. 2013; 
Froehlich et al. 2011). There are still many gaps in the available literature regarding how these 
factors might interact with each other, how they interact with genetic susceptibilities, and the role 
of epigenetic processes (Froehlich et al. 2011; Mill and Petronis 2008).  
A Focus on Organic Mercury 
 Methylmercury (MeHg) is an organic form of mercury (Hg) and a known neurotoxicant, 
included in top three of the Agency for Toxic Substances and Disease Registry’s priority list of 
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hazardous substances (ATSDR 2011). Gaseous elemental Hg generally enters the atmosphere via 
emissions from coal combustion (Sherman et al. 2012). Elemental Hg then deposits in aquatic 
environments during precipitation events (Sherman et al. 2012). Bacteria in river sediments can 
then add a methyl group to the elemental Hg to form MeHg (Yu et al. 2012; Gilmour et al. 
2013). 
Once MeHg is produced, it is prone to bioaccumulation and biomagnification. 
Bioaccumulation is defined as the uptake of pollutants by organisms from a media, including 
dietary sources. The result of this process are tissue concentrations of the pollutant higher than 
what was found in the original media (IUPAC 1993). Biomagnification refers to the increasing 
tissue concentration of a pollutant associated with increasing trophic level. That is, an organism 
higher on the food chain would have a higher tissue concentration of a pollutant than its prey 
(IUPAC 1996). Human exposure to MeHg is frequently via consumption of fish. The level of 
exposure is dependent on the trophic level of the fish, the level of contamination where the fish 
was caught or raised, and the amount consumed (Clarkson and Magos 2006). As of 2010, 81% of 
fish advisories in the United States were due at least in to part MeHg levels (U.S. EPA 2011). In 
the U.S., low-level exposure is widespread and roughly 3% of women of child-bearing age have 
exposure levels above the CDC’s level of concern (5.8µg/L) (U.S. EPA 2013). This is of note 
because MeHg has been shown to cross the placental barrier to expose the developing fetus 
(Mergler et al. 2007). 
 A number of epidemiological studies have examined the relationship between MeHg 
exposures and later behavioral and cognitive effects. Studies examining concurrent MeHg 
exposure generally do not find an association with attention deficits (Ha et al. 2009; Nicolescu et 
al. 2010). More studies have found associations with prenatal exposure. A 1997 study in the 
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Faroe Islands found attention deficits related to high cord blood levels of MeHg (Grandjean et al. 
1997). A more recent study by Grandjean et al. and a study by Oken et al. found similar results 
(Grandjean et al. 2012; Oken et al. 2005). However, a similar cohort in the Seychelles has 
consistently failed to find deficits (Myers et al. 2003; Davidson et al. 2010). 
 The existing literature on MeHg exposure and brain structure and function changes 
consists primarily of animal studies and observations of poisoning cases. Autopsies of 
individuals affected by MeHg contamination in Minamata showed a number of pathological 
changes. Lesions in the cerebrum tended to form selectively in the calcarine sulcus, transverse 
temporal gyrus, pre-central gyrus, and post-central gyrus. In the cerebellum, there was granule 
cell loss, while other cells were unaffected (Eto 2000). Fetal autopsies from Minamata showed, 
in several cases, characteristics of cerebral palsy, as well as diffuse neuronal hypoplasia, rather 
than localized cell destruction (Eto 2000).  
There are three mechanisms by which MeHg might cause cytotoxicity. These include 
disruption of intracellular Ca
2+
, induction of oxidative stress, or forming complexes with thiol-
containing compounds (Ceccatelli et al. 2010). Neuronal cell types are differentially susceptible 
to these mechanisms of cytotoxicity. For example, cytotoxicity of cerebellar granule cells 
initiates with Ca
2+
 disruption (Ceccatelli et al. 2010). Similar observations have been made in 
animal studies. In chick embryos, selective loss of cerebellar granule cells was observed, as well 
as poorer cell development (Bertossi et al. 2004). Multiple studies in developing rats found 
similar results, in addition to degeneration in the neostriatum (Sakamoto et al. 2002; Sakamoto et 
al. 1998; Kakita et al. 2000). 
A number of studies have examined changes to catecholamine signaling and processing 
after MeHg exposure. A 1997 study by Faro et al. found that chronic MeHg exposure in rats 
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resulted in increased striatal release of DA (Faro et al. 1997). Other studies found prenatally 
exposed rats had decreased monoamine oxidase (MAO) activity (Chakrabarti et al. 1998; 
Beyrouty et al. 2006). More recently, a Tiernan et al. study found that MeHg-induced DA release 
was associated with increases in DA synthesis, tyrosine hydroxylase activity, and intracellular 
levels of DA (Tiernan et al. 2013). 
There are currently few studies of gene-environment interactions examining MeHg, 
genes and behavioral outcomes. However, there are related studies which can be informative. 
One recent study examined inorganic Hg from dental amalgams and variants of metallothionein 
(MT). MT is a protein involved in the prevention of metal toxicity. This study found that while 
no associations were seen for genetic variants or exposure alone, boys who had both a genetic 
variant and exposure had pronounced negative associations with multiple domains of 
neurobehavior (Woods et al. 2013). Another study found that interactions between elevated 
blood Hg and variants of glutathione S-transferases (GSTs), another detoxification enzyme, were 
associated with reduced birth weight (Lee et al. 2010). This suggests that, in addition to 
interactions with DA related genes, genes related to metals detoxification should be considered. 
There continue to be questions about MeHg’s possible contribution to attention deficits 
that demand further study. While many studies have examined MeHg at different time points, the 
window of susceptibility remains unclear. For instance, associations with pre-natal exposure 
have been observed, but these studies generally only measure exposure near parturition or during 
pregnancy overall. Perhaps risk is most elevated during a specific point in pregnancy, as is the 
case with lead and cognition (Hu et al. 2006).  
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Objectives of this Work 
 There are many gaps in the literature regarding the role of environmental exposures in the 
etiology of ADHD and attention deficits more generally. Our long-term goal is to better 
understand the relationship between mercury and attention deficits. This is approached via our 
central hypothesis that MeHg contributes to ADHD via disruption of dopaminergic pathways. 
The objective for this work is thus to determine if there are associations between multiple 
measures of attentions deficits and explore the relevant windows of exposure, using the 
previously established ELEMENT (Early Life Exposure in Mexico to Environmental Toxicants) 
study.  
Here, we examine three specific aims: 
1. Explore the relationship between Hg exposure in multiple windows of exposure and 
screening instrument scores. This can be further broken down into several sub-aims 
i.  Explore the relationship between concurrent MeHg and inorganic Hg (IHg) and 
screening instrument scores. Our working hypothesis is that scores indicating 
attention deficits will be weakly associated with concurrent exposure. 
ii. Explore the relationship between prenatal MeHg (Trimesters 1, 2, 3 and delivery) 
and screening instrument scores. Our working hypothesis is that scores indicating 
attention deficits will be associated with high levels of exposure in the first two 
trimesters. 
iii. Explore the possible interactions between MeHg and Pb at the above time points. 
Our working hypothesis is that MeHg and Pb will act synergistically and be 
associated with further increases in attention deficits as measured by screening 
instruments. 
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2. Examine potential disruptions in dopaminergic pathways as a mechanism for MeHg 
effects on attention processes via study of genetic polymorphisms. Our working 
hypothesis is that genetic variants will be associated with attention deficits and that the 
nature of these associations will be modified by considering MeHg exposure. 
3. Explore the relationship between concurrent MeHg exposure and acoustic startle 
reflex (ASR) and prepulse inhibition (PPI). Our working hypothesis is that increased 
ASR and PPI deficits will be associated with high concurrent MeHg exposure, as 
suggested by previous animal studies 
This work is expected to narrow the relevant window of exposure for the previously observed 
association between MeHg exposure and attention deficits. It is also the first study of PPI deficits 
and MeHg exposure in humans. Additionally, this will further our understanding of 
dopaminergic signaling as a target of MeHg neurotoxicity and contributor to attention deficits.  
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Chapter 1 
Mercury, Lead-Mercury Interactions, and Attention Deficits in Children 
Abstract 
Attention deficit-hyperactivity disorder (ADHD) is one of the most common neurological 
disorders in school-aged children. Multiple exposures have been investigated as possible ADHD 
risk factors. Prenatal exposure to the neurotoxicant methylmercury (MeHg) has been previously 
associated with ADHD symptoms, but there is limited evidence for how postnatal MeHg 
exposure, inorganic Hg exposure, timing of prenatal MeHg exposure, or mixtures of neurotoxic 
metals might be relevant. Here, we examine the relationships between attention deficits, as 
measured by the Conners’ Continuous Performance Test II (CPT-II) and Conners’ Rating Scales-
Revised (CRS-R), and several time points of mercury exposure, and interactions with lead (Pb). 
Prenatal (Trimesters 1, 2, 3, and birth) and postnatal (ages 6-12) exposure to Hg and Pb were 
measured in participants from the Early Life Exposure in Mexico to Environmental Toxicants 
(ELEMENT) study. Concurrent and prenatal exposures were not significantly associated with 
CPT-II or CRS-R outcomes, although higher exposure generally corresponded to higher scores. 
A possible negative, but not statistically significant, interaction between Hg and Pb was seen. 
Interactions between the two metals related to increasing attention deficit scores in trimester 1, 
while interactions between the two related to decreasing scores in trimester 2. Several of these 
were statistically significant. No pattern was seen in later pregnancy or between prenatal Hg and 
concurrent Pb exposure. These findings suggest that MeHg is not associated with ADHD, except 
when considered in mixtures, although additional research is needed to confirm this. 
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) is characterized by persistent 
impulsivity, inattention, and hyperactivity that is present in multiple contexts and impairs 
functioning (American Psychiatric Association 2013). ADHD is one of the most common 
neurological disorder in school-aged children worldwide (Escobar et al. 2005; Polanczyk et al. 
2015). Measures of the worldwide prevalence of ADHD vary widely, but it is estimated at 7.2% 
worldwide (Polanczyk et al. 2014; Thomas et al. 2015). The CDC estimates a prevalence of 9.5% 
in children in the U.S. (Bloom et al. 2013).  
The existing literature suggests that ADHD is highly heritable. While the heritability is 
estimated to be 76%, the interactions between the genes involved are complex (Faraone and 
Mick 2010). Further, there is heterogeneity in the disorder which could potentially involve 
environmental influences or gene-environment interactions (Archer et al. 2011). These include 
environmental exposures such metals, including methylmercury (Karagas et al. 2012; Goodlad et 
al. 2013; Sanders et al. 2015).  
Methylmercury (MeHg), the organic form of mercury (Hg) and an established 
neurodevelopmental toxicant (Clarkson and Magos 2006), exposure has recently been linked 
with attention and cognition deficits (Karagas et al. 2012). Exposure to MeHg is primarily via 
fish and seafood consumption and is thus ubiquitous amongst populations that consume fish 
(Driscoll et al. 2013). A growing number of studies have investigated prenatal MeHg exposure 
and attention deficits. A study of 917 children in the Faroe Islands, aged approximately 7 years, 
found deficits in attention, as measured by the NES Continuous Performance Test, could be 
associated with cord blood mercury levels (Grandjean et al. 1997). Another study of 135 
pregnant mothers in the U.S. found associations between maternal hair mercury levels and 
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maternal fish consumption during pregnancy and lower cognitive scores in their 6-month old 
children (Oken et al. 2005). There is animal data in support of the aforementioned 
epidemiological studies. Mercury compounds have been shown to disrupt the function  of several 
neurotransmitters implicated in the etiology of deficits in attention and cognition (Faraone and 
Mick 2010) 
Lead exposure has been associated previously with many of the same outcomes as MeHg 
exposure, including cognitive deficits (Lanphear et al. 2000), behavioral deficits (Rice 2000), 
and diagnosed ADHD. Furthermore, both toxicants have been suggested to disrupt dopaminergic 
signaling (Tavakoli-Nezhad et al. 2001). A previous study by our group found that higher lead 
levels are associated with hyperactivity and impulsivity symptoms (Huang et al. 2015). Thus, 
clarifying how the two may interact is imperative to understanding their potential impact on the 
development of attention deficits. 
While there is evidence in support of an association between MeHg exposure and deficits 
in attention and cognition, outstanding questions remain. Some studies have revealed no 
association between MeHg exposure and symptoms of ADHD, as measured using an 
ADHD/DSM-IV related scale (Ha et al. 2009; Nicolescu et al. 2010), or measured attention via 
the German test battery for attention performance of children (Nicolescu et al. 2010) or finger-
tapping (Myers et al. 2003; van Wijngaarden et al. 2013). Gestation has been suggested as a 
susceptible period by several studies, but it is not clear if some periods of pregnancy are more 
susceptible. Though a recent paper by a panel of experts concludes that low-level exposure to 
MeHg may be associated with neurocognitive effects in children, they note that consideration 
needs to be given to better characterizing and resolving several factors. These include the timing 
and windows of exposure, the accuracy of the biomarker and exposure assessment, sex 
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differences, and the types of outcome measures (Karagas et al. 2012). Tackling such questions is 
particularly important given that fish consumption, while a major source of MeHg exposure, is a 
key source of dietary protein worldwide and also linked to beneficial neurological outcomes 
(Mahaffey et al. 2011).  
The objective of the current study was to address some of the limitations highlighted by 
Karagas et al (Karagas et al. 2012), and to further increase our understanding of whether MeHg-
exposure is associated with ADHD symptoms and measures of attention. Specifically, we aim to 
explore the relationship between Hg exposure in multiple windows of exposure and attention 
deficits, as measured by two screening instruments (Connors Continuous Performance Test and 
Conners’ Rating Scales-Revised). This includes, first, exploring the relationship between 
concurrent MeHg, inorganic mercury (IHg), and attention, where we hypothesize that scores 
indicating attention deficits will be at most weakly associated with exposure. This is based on the 
existing conflicting results, even in high exposure populations (Karagas et al. 2012). Second, we 
will examine the relationship between prenatal MeHg (Trimesters 1, 2, 3 and delivery) and 
attention, where we hypothesize that scores indicating deficits will be associated with high levels 
of exposure in the first two trimesters. We suspect the first two trimesters as the susceptible 
period based on animal studies which find deficits in the equivalent developmental period 
(Cagiano et al. 1990; Eccles and Annau 1982; Maier et al. 1997). Third, we will examine 
potential interactions between MeHg and Pb at the available time points, where we hypothesize 
that MeHg and Pb will act synergistically and be associated with further deficits. These aims 
capitalized upon the rich resources of a sequentially enrolled epidemiologic birth cohort series 
running since 1994 called the Early Life Exposures in Mexico to Environmental Toxicants 
(ELEMENT) study (Afeiche et al. 2011). 
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Methods 
ELEMENT Cohort 
The ELEMENT study, consisting of three sequentially enrolled cohorts, was initially 
designed to research the influence of maternal lead exposure on offspring neurodevelopment. 
Pertinent details of ELEMENT, such as inclusion and exclusion criteria, collection methods, and 
demographics can be found elsewhere (Afeiche et al. 2011; Tellez-Rojo et al. 2006). In brief, 
Cohort 1 subjects were recruited 1994-1995, Cohort 2 subjects were recruited 1997-2001, Cohort 
3 subjects were recruited 2001-2004 (Afeiche et al. 2011). In 2006 participants were recruited 
from all three cohorts for follow-up visits regarding behavioral outcomes. For analysis of 
concurrent exposures, children were included if their mothers were recruited into Cohorts 2 and 
3, had at least one mercury exposure value and at least one attention measure from the same 
visit. For analysis of prenatal exposure, mothers and children were included if the mother had at 
least one mercury exposure value from pregnancy or delivery and her child had at least one of 
the attention measures from the follow-up visits. Behavior outcomes at these visits were linked 
to exposure measures taken at the same time as the outcomes (i.e. concurrent exposures), as well 
as prenatal exposures obtained from the ELEMENT biorepository. 
The research protocol was approved by the ethics and research committees of the 
partnering institutions, including the National Institute of Public Health of Mexico, the Harvard 
School of Public Health, the Brigham and Women’s Hospital, the University of Michigan School 
of Public Health, the University of Toronto, and the participating hospitals. 
Human Biospecimens & Biomarker Analysis 
Blood, hair and urine samples were collected from the participating children at the 
follow-up visit. Venous whole blood samples were collected into vials certified for trace metals 
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analysis and stored at 4
o
C until analysis. Spot (second morning void) urine samples were 
collected and stored frozen until analysis. Scalp hair samples were obtained from each 
participant using stainless steel scissors and the proximal end was designated. Prenatal samples 
were collected from participating mothers at visits during the first, second and third trimesters, as 
well as at delivery. Venous whole blood samples were collected in the same manner as for 
childhood visits at the trimester visits. Cord blood was collected at delivery. Prenatal samples 
were frozen at -80
o
C until analysis. 
Mercury was analyzed in all samples as described elsewhere (Basu et al. 2014). Briefly, 
total mercury content was carried out using a Direct Mercury Analyzer 80 (DMA-80, Milestone 
Inc., CT). Daily instrument calibration, procedural blanks, replicates, and several certified 
reference materials were analyzed. Reference materials included CRM #13 for hair (National 
Institute for Environmental Studies, Japan), DOLT-4 (dogfish liver; National Research Council, 
Canada), and QMEQAS for blood and urine (Institut National de Santé Publique du Québec). 
Recoveries of the reference materials ranged from 80 to 110%. The analytical detection limit was 
less than 1.0 ng mercury. 
Lead was analyzed in whole blood samples collected from participants. The majority of 
the available blood samples (a subset of 342) were analyzed using Inductively Coupled Plasma 
Mass Spectrometry (ICPMS) (Agilent 7500c, Agilent Technologies, Palo Alto, CA) in an ISO-
designated clean room to minimize contamination as we have previously detailed (Huang et al. 
2015). As with mercury, procedural blanks, replicates, and several certified reference materials 
were analyzed. For quality control and assurance, accuracy and precision were estimated through 
the use of certified reference materials (Institut National de Santé du Québec, INSPQ, 
QMEQAS09), as well as replicated samples. The average detection limit was 0.03 μg/dL. Based 
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on the recoveries of the reference materials, the overall accuracy was 88.2% (SD= 9.5%). The 
remaining 70 blood samples were analyzed at the Michigan Department of Community Health 
using a similar ICPMS approach with a detection limit of 1.3 μg/dL and all values above the 
limit of detection (LOD). The overall accuracy was 102.4% (SD=2.0%) We performed cross-
validation between the two laboratories in 64 samples. These were 96.2% consistent after 
removal of two outliers. 
Attention Measures 
Two sets of instruments were used: the Connors Continuous Performance Test (CPT, 2
nd
 
Edition) and the parent-responses from the Conners’ Rating Scales-Revised (CRS-R). The CPT 
is a computer-administered task that produces multiple scores, including those for omission 
errors, commission errors, and mean and standard deviation of reaction time. All outcomes are 
scaled such that a higher score indicates greater attention problems. Participants were seated at a 
computer while presented with a task comprised of a series of images over approximately 15 
minutes. Participants were instructed to press the space bar in response to a target image, while 
ignoring non-target images. There is not a great deal of existing literature examining this test in 
Hispanic and Latino populations, but there is evidence that suggests ethnicity may not act as a 
major confounder for CPT assessments, particularly if images are used rather than text(Leany et 
al. 2012). 
The CRS-R uses parent-completed questionnaires that provide information about the 
extent to which a child’s difficulties managing attention are manifested as dysfunctions in 
everyday life. Each item of the questionnaire is linked to the DSM-IV criteria for ADHD-
inattentive subtype, ADHD-hyperactive-impulsive subtype, and ADHD-combined subtype. The 
CRS-R produces index scores for hyperactivity, inattention, and ADHD overall, as well as other 
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behaviors, such as perfectionism, opposition, and somatization. The Spanish version of the CRS-
R has previously been used in Hispanic and Latino populations (Ortiz-Luna and Acle-Tomasini 
2006; Montiel et al. 2008). 
Statistical Analysis  
Data were analyzed using R x64 3.0.1. Univariate descriptive statistics and graphical 
displays were obtained for all variables. Outliers were detected using the ExtremeValues 
package for R, which uses a distribution based method for identifying outliers (van der Loo 
2010). Spearman correlations were used to assess association among all biomarkers. Bivariate 
analyses were used to relate mercury biomarker values with demographic characteristics. 
Descriptive statistics are reported as mean (standard deviation), unless otherwise indicated. 
Linear models were constructed which included a number of covariates selected a priori 
for potential relevance to either the exposure or the analyzed attention measures. Maternal IQ 
was calculated based on the mothers’ scores on the Spanish Wechsler Adult Intelligence Scale 
(Tellez-Rojo et al. 2004; Wechsler 1968). Maternal education was the cumulative number of 
years that the mother attended school at time of recruitment. Information about smoking during 
pregnancy (yes/no) was obtained from a questionnaire administered to the mother during 
pregnancy. Mothers who responded “yes” at any point during pregnancy were excluded from 
analyses. As previously described (Fortenberry et al. 2014), direct questions about income were 
deemed too intrusive within this cohort. Thus, a continuous measure of socioeconomic status 
based on reported possessions and household assets was used instead. Maternal age and marital 
status at recruitment were also included, as were child age at the follow-up visit and child sex.  
The exposure measures were not normally distributed and were highly skewed. Because 
of this, they were log-transformed prior to entering into the models. Further, model diagnostics 
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revealed that CPT-II Omission Errors, CPT-II Commission Errors, CRS-R Distractibility Score, 
CRS-R Hyperactivity Score, CRS-R ADHD Index, and DSM-IV Inattention Symptoms did not 
meet normality and were highly skewed. Accordingly, these outcomes were also log-
transformed. Given these transformations, the actual beta coefficients are presented in tables and 
figures. However, in the text, we also provide interpretations that consider these transformations. 
Specifically, we calculated the difference in log-transformed outcomes for a 10% higher Hg 
concentration as ∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = (𝑒𝛽𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒∗ln⁡(1.10) − 1) ∗ 100. For outcomes not requiring log-
transformation (CPT-II Hit Reaction Time, DSM-IV Hyperactivity/Impulsivity Symptoms, and 
DSM-IV Total Symptoms) we used ∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = 𝛽𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 ∗ ln⁡(1.10). 
Models were also constructed to assess possible interactions between MeHg and Pb 
exposures. These models included MeHg, Pb, and their cross-product. All exposures were log-
transformed and centered, so that single effect coefficients in the models could be interpreted as 
the effect when the other metal was held constant at the geometric mean. Once again, the actual 
beta coefficients are presented in tables and figures, but interpretations which take 
transformations into account are presented in the text. These included models that looked for 
interactions between MeHg exposure and Pb exposure at the same time point and models 
assessing interactions between concurrent Pb exposure and prenatal MeHg. The latter was meant 
to replicate previous studies of Pb and MeHg interactions at these time points (Boucher et al. 
2012a). 
Results 
Population Characteristics 
 Overall, 466 Cohort 2 and 3 children with complete demographic information 
participated in the follow-up visit (Table 1.1). A slight majority of the child participants were 
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male. A majority of mothers had been married at the time they were recruited. Sixteen mothers 
reported smoking during pregnancy. Given the small proportion of our sample and the existing 
literature suggesting an association between maternal smoking status in pregnancy and later 
attention problems (Braun et al. 2006; Froehlich et al. 2011; Neuman et al. 2007), these mothers, 
and their children, were omitted from subsequent analyses. For any given psychometric outcome, 
a maximum of 17 outliers were removed. (Table 1.1) 
Exposure data for this cohort was previously reported for mercury (Basu et al. 2014) and 
lead (Huang et al. 2015; Zhang et al. 2012) and briefly summarized here. Concurrent mercury 
and lead exposure data is available for 72.8-96.4% of the children, depending on the biomarker. 
Blood, hair and urine mercury levels of participating children were 1.8 ± 1.3 μg/L, 0.60 ± 0.47 
μg/g, and 0.82 ± 0.93 μg/L respectively (Table 1.1). Across children, mercury levels in blood, 
hair and urine were correlated. Blood and hair mercury levels of the same individuals were most 
correlated (r=0.69, p<<0.001), while urine mercury levels were moderately correlated to both 
blood (r=0.39, p<<0.001) and hair (r=0.37, p<<0.001) mercury levels. Blood lead levels of 
participating children averaged 3.1 ± 1.8 μg/dL. Blood lead and blood mercury levels were not 
correlated (r=0.08, p=0.35).  
Prenatal exposure data is only available for participants from two of the three study 
cohorts. (Table 1.1) Mercury exposure levels were found to be 3.1 ± 1.8 μg/L in the first 
trimester, 3.1 ± 1.8 μg/L in the second, and 3.4 ± 2.6 μg/L in the third. Cord blood mercury 
levels were 4.4 ± 2.3 μg/L. Correlations between the individual trimester exposures are detailed 
in our previous work on exposure assessment in this population (Basu et al. 2014). Lead 
exposure levels were found to be 6.2 ± 4.4 μg/dL in the first trimester, 5.3 ± 3.3 μg/dL in the 
second, and 5.7 ± 3.3 μg/dL in the third. Cord blood lead levels were 4.9 ± 3.2 μg/dL. The lead 
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levels for all three trimesters were correlated (rTri1-Tri2=0.74, p<<0.001; rTri1-Tri3=0.67, p<<0.001; 
rTri2-Tri3=0.77, p<<0.001). Cord blood levels and trimester exposure levels were also correlated. 
Trimester 3 and cord blood were most strongly correlated (r=0.72, p<<0.001), followed by 
trimester 2 (r=0.54, p<0.001), and then trimester 1 (r=0.40, p<0.001). Prenatal lead and mercury 
levels were not correlated to each other. 
Table 1.1 Demographic Characteristics, Exposure Assessment, and Psychological Testing 
  
N Mean(SD) Median Range
466 9.1 (1.3) 9.3 (6.9, 12.5)
466 6.7 (2.5) 6.5 (1, 14)
466 26.0 (5.5) 26 (14, 44)
466 10.9 (2.6) 11 (2, 20)
466 92.6 (18.5) 91 (60, 182)
Total N N(%)
466 237 (50.9%)
466 16 (3.4%)
466 343 (73.6%)
N Mean(SD) Median Range
314 1.8 (1.3) 1.5 (0.23, 8.5)
435 0.60 (0.47) 0.46 (0.06, 3.1)
436 0.82 (0.93) 0.50 (0.02, 7.0)
320 3.1 (1.8) 2.4 (0.47, 11.0)
N Mean(SD) Median Range
123 3.1 (1.8) 2.7 (0.82, 10.5)
168 3.1 (1.8) 2.8 (0.68, 10.7)
147 3.4 (2.6) 2.7 (0.46, 14.6)
86 4.4 (2.3) 3.9 (1.4, 12.7)
249 6.2 (4.4) 5.4 (1.2, 23.3)
260 5.3 (3.3) 4.5 (0.9, 20.3)
246 5.7 (3.3) 5.0 (1.1, 7.3)
211 4.9 (3.2) 4.1 (0.90, 20.0)
N Mean (SD) Median Range
443
438 53.4 (9.7) 52.0 (40, 88)
432 55.0 (9.5) 53.0 (42, 83)
440 53.8 (9.8) 52.0 (40, 86)
438 52.8 (9.3) 51.5 (40, 84)
428 56.4 (9.3) 54.0 (41, 81)
435 54.9 (9.3) 53.0 (40, 81)
439
431 51.8 (8.7) 49.3 (38.5, 83.7)
422 51.6 (8.2) 52.7 (31.7, 67.6)
433 49.7 (10.0) 50.0 (21.6, 76.7)
Maternal IQ
DEMOGRAPHIC CHARACTERISTICS
Child Age
Household SES Level
Maternal Age at Recruitment
Maternal Education Level at Recruitment
Urine (μg/L)
Prenatal Exposure
EXPOSURE ASSESSMENT
Sex of Child (Male)
Maternal Smoking During Pregnancy ("Ever Smoked")
Maternal Marital Status ("Married")
Mercury (μg/L or μg/g)
Blood (μg/L)
Exposure at Follow-up Visit
Lead (μg/dL)
Trimester 1 Blood
Trimester 3 Blood
Cord Blood
Trimester 2 Blood
Omission Errors
Commission Errors
Hair (μg/g)
Lead (μg/dL)
Mercury (μg/L)
Trimester 1 Blood
Trimester 2 Blood
Trimester 3 Blood
Cord Blood
Blood
ADHD Index
Hit Reaction Time
CPT-II Scores
PSYCHOLOGICAL TESTING
CRS-R Scores
Cognitive Problems/Distraction
Hyperactivity
DSM IV Total
DSM IV Inattention
DSM IV Hyperactivity-Impulsivity
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Linear Models 
Concurrent Mercury Exposure Associations 
Concurrent exposure was not significantly associated with CPT-II or CRS-R outcome 
measures. In Figure 1.1, the top series depicts the results of models where outcome measures 
were log-transformed. Thus, a 10% higher blood Hg concentration corresponds to a 0.14 unit 
higher (95% CI: -0.09, 0.37) CPT-II Omissions score (calculated as 0.14 = (𝑒0.015∗ln⁡(1.10) −
1) ∗ 100). The same increase in hair Hg concentration corresponded to a 0.06 unit higher (95% 
CI: -0.12, 0.25) score for that outcome, while a 10% higher urine Hg concentration was related to 
a 0.13 unit higher (95% CI: -0.01, 0.28) score. This indicates higher Hg levels tended to show 
higher likelihood to fail to respond to targets during the CPT-II, although none of these were 
statistically significant. Among this group of models (Figure 1.1), higher exposures generally 
corresponded to increasing scores. Increasing scores represent greater attention deficit 
symptoms. A notable exception to this was CPT-II commission scores, where a 10% higher 
blood or hair Hg concentration was related to a 0.16 unit lower (95% CI: -0.47, 0.16) or a 0.10 
unit lower (95% CI: -0.33, 0.12) score, respectively. Similarly, a 10% higher blood or urine Hg 
concentration was related to a 0.12 unit lower (95% CI: -0.38, 0.14) or a 0.04 unit lower (95% 
CI: -0.21, 0.13) CRS-R Hyperactivity score (Figure 1.1). 
Additionally, the lower series in Figure 1.1 depicts the models where log transformation 
was not necessary. For example, a 10% higher blood Hg concentration corresponded to a 0.01 
unit higher (95% CI: -0.15, 0.17) DSM-IV Hyperactivity/Impulsivity score (calculated as 
0.01 = 0.094 ∗ ln⁡(1.10)). The same increase in hair Hg concentration corresponded to a 0.07 
unit higher (95% CI: -0.06, 0.19) score for that outcome, while a 10% higher urine Hg 
concentration corresponded to a 0.03 unit higher (95% CI: -0.07, 0.12) score. Among this group 
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of models, higher exposures generally corresponded to increasing scores, which represent greater 
attention deficit symptoms (Figure 1.1).  
Prenatal Mercury Exposure Associations 
Prenatal exposure was not significantly associated with CPT-II or CRS-R outcome 
measures. In Figure 1.2, as with Figure 1.1, the top series depicts the results of models where 
outcome measures were log-transformed. Thus, a 10% higher trimester 1 blood Hg concentration 
corresponded to a 0.24 unit higher (95% CI: -0.41, 0.89) CRS-R Distractibility score. The same 
increase in trimester 2 blood Hg concentration corresponded to a 0.34 unit higher  
(95% CI: -0.16, 0.85) score for that outcome, while a 10% higher trimester 3 Hg concentration 
corresponded to a 0.10 unit higher (95% CI: -0.37, 0.57) score. This indicates participants with 
higher Hg levels tended to have slightly higher distractibility symptoms, although none of these 
were statistically significant. The magnitude of these relationships was largest for trimester 2 
exposure. This pattern was also observed for CPT-II omissions, while CRS-R Hyperactivity, 
ADHD and DSM-IV Inattention scores had the greatest unit increase for a 10% higher exposure 
in trimester 1. The magnitude of these relationships was progressively lower in trimesters 2 and 
3. However, for CPT-II commission scores, a 10% higher trimester 1 blood Hg concentration 
corresponded to a 0.02 unit decrease (95% CI: -0.58, 0.57) in that score. For the same increase in 
trimester 2 blood Hg concentration, this was a 0.34 unit lower (95% CI: -0.86, 0.19) score, while 
that increase in trimester 3 Hg concentration corresponded to a 0.13 unit lower (95% CI: -0.60, 
0.36) score (Figure 1.2). 
Again, the lower series in Figure 1.2 depicts the models where log transformation was not 
necessary. Here, a 10% higher trimester 1 blood Hg concentration corresponded to a 0.22 unit 
higher (95% CI: -0.15, 0.58) DSM-IV Hyperactivity/Impulsivity score. The same increase in 
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trimester 2 blood Hg concentration corresponded to a 0.15 unit higher (95% CI: -0.16, 0.45) 
score for that outcome, while a 10% higher trimester 3 Hg concentration was related to a 0.08 
unit higher (95% CI: -0.23, 0.38) score. This indicates participants with higher Hg levels tended 
to show higher levels of distractibility symptoms, with the largest magnitude of difference 
observed in trimester 1 and then progressively smaller magnitudes in trimesters 2 and 3. 
However, once again none of these were statistically significant. This pattern was also observed 
for DSM-IV Total scores. For CPT-II hit reaction time, however, a 10% higher trimester 1 blood 
Hg concentration corresponded to a 0.29 unit decrease (95% CI: -0.64, 0.06) in that score. For 
the same increase in trimester 2 blood Hg concentration and trimester 3 Hg concentration, there 
was a 0.05 unit higher (95% CI: -0.23, 0.32) and a 0.12 unit higher (95% CI: -0.13, 0.36) score, 
respectively (Figure 1.2). 
When associations with cord blood Hg concentrations were considered, the patterns 
observed across the trimesters for CPT-II commissions, CRS-R Distractibility scores, ADHD 
Index, DSM-IV Inattention score, CPT-II Hit Reaction Time, DSM-IV Hyperactivity/Impulsivity 
score, and DSM-IV Total score were continued. However, for CPT-II Omissions score a 10% 
higher cord blood Hg concentration corresponded to a 0.26 unit higher (95% CI: -0.35, 0.88) 
score, a greater magnitude than the observed peak at trimester 2. For CRS-R Hyperactivity score, 
a 10% higher cord blood Hg concentration was associated with a 0.17 unit higher (95% CI: -
0.51, 0.84) score, a reversal of the observed pattern across the trimesters. However, once again, 
none of these were statistically significant (Figure 1.3). 
Concurrent Lead-Mercury Interactions 
In models that consider potential interactions between Hg and Pb, a negative relationship 
was generally observed, although this was not statistically significant (Figure 1.4). In several 
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cases, although higher Hg and Pb concentrations were individually related to higher attention 
scores while the other metal is held constant at the geometric mean, higher levels of both 
exposures together were associated with lower scores. For example, a 10% higher Hg 
concentration while Pb is held constant at the geometric mean corresponded to a 0.03 unit higher 
(95% CI: -0.35, 0.42) hyperactivity score, while the same increase in Pb while Hg is held 
constant corresponded to a 0.21 unit higher (95% CI: -0.35, 0.42) score. However, a 10% higher 
concentration of both metals corresponded to a 0.08 unit lower (95% CI: -0.78, 0.61) score. A 
similar relationship was observed for ADHD index, DSM-IV inattention, and DSM-IV total 
symptoms. 
Additionally, for distractibility and commission errors, higher levels of one metal 
corresponded to higher scores while the other is held constant, while higher levels of the other 
corresponded to lower scores, but higher levels of both corresponded to an even further lower 
score of interest. For example, a 10% higher Hg concentration while Pb concentration is held 
constant at the geometric mean corresponded to a 0.21 unit higher (95% CI: -0.22, 0.65) 
distractibility score, while the same increase in Pb while Hg is held constant was related to a 0.15 
unit decrease (95% CI: -0.65, 0.35). A 10% higher level of both metals the corresponded to a 
further 0.20 unit lower (95% CI: -0.96, 0.57) score. None of these associations were statistically 
significant (Figure 1.4). 
However, for three of the measures, higher levels of both metals corresponded to higher 
attention scores. For example, a 10% higher Hg concentration while Pb is held constant 
corresponded to a 0.28 unit higher (95% CI: -0.09, 0.65) omission error score, while the same 
increase in Pb concentration while Hg is held constant corresponded to a 0.14 unit higher (95% 
CI: -0.28, 0.56) score. A 10% higher level of both metals corresponded to a further 0.09 unit 
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lower (95% CI: -0.54, 0.74) score. The same pattern was observed for hit reaction time. For 
DSM-IV hyperactivity-impulsivity, a 10% higher Hg levels while Pb is held constant 
corresponded to a 0.09 unit higher (95% CI: -0.14, 0.33) score, while the same increase in Pb 
levels corresponded to a 0.01 unit lower (95% CI: -0.28, 0.26) score. However, a 10% higher 
level of both metals then corresponded to a 0.06 unit higher (95% CI: -0.36, 0.47) score. Again, 
none of these associations were statistically significant (Figure 1.4). 
Prenatal Lead-Mercury Interactions 
 When examining potential interactions of prenatal exposure to these metals, in general, 
an increasing relationship was seen for the interactions in trimester 1, a decreasing relationship 
was seen in trimester 2, and no pattern was seen in trimester 3 (Figure 1.5). In trimester 1, among 
the CRS-R outcomes, higher levels of individual concentrations of both metals, while the other is 
held constant at the geometric mean, consistently correspond to higher scores, while higher 
levels of both metals corresponded to an even higher score. Two of these were statistically 
significant and several others had a p-value less than 0.10. For example, a 10% higher Hg 
concentration while Pb is held constant corresponded to a 0.38 unit higher (95% CI: -0.02, 0.79) 
DSM-IV total symptoms and a 10% higher Pb concentration while Hg is held constant 
corresponded to a 0.03 unit higher (95% CI: -0.54, 0.60) score. The same increase in both metals 
then corresponded to a further 1.28 unit higher (95% CI: 0.11, 2.44) score. Notably, the increase 
in the interaction term is often much larger in magnitude than that for the individual metals. This 
could potentially indicate a synergistic relationship, but due to the design of this study this 
cannot be determined conclusively. 
 Among the CPT outcomes, there was not a single pattern, but a similar relationship with 
exposure to both metals was observed. For omission errors, a 10% higher Hg concentration while 
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Pb is held constant corresponded to a 0.01 unit higher (95% CI: -0.56, 0.59), while a 10% higher 
Pb concentration while Hg is held constant corresponded to a 0.56 unit lower (95% CI: -1.36, 
0.21) score. A 10% higher level of both then corresponded to an additional 0.19 unit higher (95% 
CI: -1.44, 1.85) omission errors. A similar pattern was observed for commission errors, although 
the direction of the relationships for higher individual levels of Hg and Pb was reversed. In the 
case of hit reaction time, a 10% higher Hg concentration while Pb was held constant 
corresponded to a 0.28 unit lower (95% CI: -0.65, 0.09) score and a 10% higher Pb concentration 
while Hg was held constant corresponded to a 0.49 unit lower (95% CI: -1.00, 0.02). However, a 
10% higher level of both then corresponded to a 0.27 unit higher (95% CI: -0.79, 1.32) hit 
reaction time score. None of these, however, were statistically significant (Figure 1.5). 
 In the second trimester, a similarly consistent pattern was observed, but in the opposite 
direction as trimester 1 for lead and the interaction term. For example, a 10% higher level of Hg 
while Pb is held constant corresponded to a 0.09 unit higher (95% CI: -0.32, 0.49) DSM-IV 
hyperactivity-impulsivity score, while a 10% higher level of Pb while Hg is held constant 
corresponded to a 0.24 unit lower (95% CI: -0.73, 0.24) score. A 10% higher level of both 
exposures then corresponded to an additionally 0.85 unit lower (95% CI: -1.64, -0.05) score. A 
similar relationship was observed for distractibility, hyperactivity, DSM-IV inattention, DSM-IV 
total symptom score, omission errors, and hit reaction time. For ADHD index, a higher level of 
Hg or Pb individually corresponded to a lower score, while higher level of both corresponds to 
an additionally lower score. The interaction associations for all of the CRS-R outcomes were at 
least marginally statistically significant, but none of the CPT outcomes were (Figure 1.5). 
 In the third trimester, as with the first trimester, higher levels of the individual metals 
were generally associated with higher attention scores, but the overall pattern was less clear cut. 
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For example, a 10% higher level of Hg while Pb was held constant corresponded to a 0.60 unit 
lower (95% CI: -1.18, -0.02) score and a 10% higher level of Pb while Hg was held constant 
corresponded to a 0.32 unit lower (95% CI: -1.11, 0.46) hyperactivity score. However, a 10% 
higher level of both exposures then corresponded to a 0.20 unit higher (95% CI: -0.98, 1.40) 
score. A similar pattern was observed for ADHD index, DSM-IV inattention, DSM-IV 
hyperactivity-impulsivity, DSM-IV total symptoms, and omission errors. For distractibility, a 
higher level of Hg corresponded to lower scores, while higher levels of Pb corresponded to 
higher scores. Higher levels of Hg and Pb then corresponded to an additionally higher score. 
However, one of the associations for interactions was statistically significant. Additionally, 
higher individual levels of each metal corresponded to higher hit reaction time scores. An 
increase in both then corresponded to an additionally higher score (Figure 1.5). 
 The major exception to this pattern was for commission errors. There, a 10% higher level 
of Hg while Pb was held constant corresponded to a 0.03 unit lower (95% CI: -0.56, 0.51) score 
and a 10% higher level of Pb while Hg was held constant corresponded to a 0.48 unit lower 
(95% CI: -1.21, 0.25) commission error score. A 10% higher level of both metals was then 
corresponded to a further 0.15 unit lower (95% CI: -1.26, 0.97) score. (Figure 1.5) 
Prenatal Mercury-Concurrent Lead Interactions 
 Several models were constructed to model potential interactions between prenatal Hg 
exposure and concurrent Pb exposure (Figure 1.6). However, in these models, there was not as 
consistent of a pattern as what was seen in the prenatal exposure interactions. In trimester 1, a 
higher level of Hg and Pb levels alone corresponded to higher scores, while a higher level of 
both corresponded to lower scores for several of the hyperactivity related CRS-R outcomes 
(hyperactivity, ADHD index, DSM-IV hyperactivity-impulsivity, and DSM-IV total symptoms). 
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In the second trimester, higher Hg levels corresponded to lower attention scores, higher Pb levels 
corresponded to higher attention scores, and higher levels of both corresponded to an 
additionally higher score for all three of the DSM-IV symptom scales and hit reaction time. Also, 
across all three trimesters, individual increases in Hg and Pb exposures were related to higher 
omission error scores, and an increase in both was related to an additional increase in that score. 
However, none of these associations were statistically significant. 
Discussion 
The aim of the current study was to characterize the association between prenatal 
(Trimesters 1, 2, 3 and delivery) and postnatal (ages 6-12 years) mercury exposures and CPT-II 
and CRS-R scores, and in general we found no significant relationships. In our cohort, we found 
that concurrent exposure to Hg, as measured in blood, hair, and urine, generally corresponded to 
higher CRS-R and CPT-II scores, although this relationship was not significant (Figure 1.1). 
Prenatal Hg exposure typically corresponded to higher CRS-R and CPT-II scores, although these 
relationships were not statistically significant (Figure 1.2). A negative but not statistically 
significant relationship was seen for postnatal MeHg and Pb interactions. 
In our cohort, girls were more likely to have greater attention deficit symptoms in all but 
one measure. This was significant for measures related to inattention symptoms: distractibility, 
ADHD index, DSM-IV inattention and total symptoms, and CPT-II hit reaction time. They also 
had significantly fewer errors of commission on the CPT-II, which is a measure related to 
impulsivity. Although it was thought that ADHD predominantly affected boys, more recent 
research suggests that boys are more likely to be referred for treatment (Bruchmüller et al. 2012; 
Biederman et al. 2005). Other studies have suggested that girls with ADHD inattention 
symptoms have greater internalizing symptoms and perceived peer deviation (Becker et al. 2013; 
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Cardoos et al. 2012), which could have a compounding effect on symptoms over time. The 
finding that girls had less impulsivity on the CPT replicates previous work (Hasson and Fine 
2012).  
Additionally, maternal age, maternal education, and marital status were consistently 
associated with lower attention deficit symptoms. The association with maternal age was 
consistent with previous work, where the offspring of younger mothers had the greatest risk for 
ADHD later in life (Chang et al. 2014; Sagiv et al. 2013). Previous work has also reported that 
low maternal education may be a risk factor for attention deficits (Sagiv et al. 2013; Gurevitz et 
al. 2014), as was marital status (Sagiv et al. 2013).  
Our cohort represents an intermediate exposure level compared to many existing studies 
that included postnatal exposure (Basu et al. 2014). This is particularly true of blood and urine, 
where our exposure levels were higher than those in several other studies, although our 
population’s exposure was still low compared to populations like that in the Faroe Islands and 
the Seychelles, where exposure is substantially higher (Figure 1.1.D). For studies using hair as a 
biomarker, we represent a comparatively low exposure group to several of the existing studies, 
which again include the Faroe Islands and the Seychelles (Figure 1.1.D). Notably, exposure is 
generally higher in the Seychelles than the Faroe Islands, but the deficits consistently observed in 
the Faroe Islands, but not in the Seychelles (Karagas et al. 2012; Myers et al. 2003; Debes et al. 
2006). Sources of MeHg exposure and resulting nutritional differences related to the 
consumption of fish have been suggested as a possible reason for this (Davidson et al. 2008; 
Stokes-Riner et al. 2011).  
We represent a much lower level of exposure than other studies which have previously 
used cord blood to assess prenatal exposure. Venous blood levels during the trimesters are not 
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shown on this comparison, because to our knowledge, we are the first study to examine exposure 
during each trimester using maternal venous blood Hg concentrations. Previous studies have also 
used maternal hair Hg levels collected near delivery. Depending on the length of hair used, this 
can represent a longer period of pregnancy, but often represents exposure during the third 
trimester (Grandjean et al. 2005; Sakamoto et al. 2007). 
 
Figure 1.1.D Relative exposure levels of a selection of existing studies of postnatal exposure and 
ADHD symptoms (Ha et al. 2009; Nicolescu et al. 2010; van Wijngaarden et al. 2013; Boucher 
et al. 2012a; Debes et al. 2006; Bellinger et al. 2007; DeRouen et al. 2006; Kim et al. 2013; Cao 
et al. 2010; Davidson et al. 1998)  
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Figure 1.2.D Relative exposure levels of a selection of existing studies of prenatal exposure and 
ADHD symptoms (van Wijngaarden et al. 2013; Boucher et al. 2012a; Debes et al. 2006; 
Davidson et al. 1998; Sagiv et al. 2012)  
 
A few previous studies have examined postnatal Hg exposure and various attention 
measures. In a cohort of Faroese children at age 14 years with exposure levels 1.5-2.0 times that 
observed in our cohort, postnatal exposure measured in blood and hair was found to only be 
weakly related to increasing levels of attention deficits. Similarly to our study, they also 
observed a number of associations in the opposite direction of what was anticipated (Debes et al. 
2006). Of their battery of tests, which included a continuous performance test, a significant 
association was only observed for one test (the NES2 finger tapping test) and hair Hg, although 
this was no longer significant and smaller in magnitude after adjustment with covariates (Debes 
et al. 2006).  
A few previous studies have examined associations between inorganic Hg and 
neurobehavioral outcomes, but have failed to find a significant difference based on exposure 
(Bellinger et al. 2007; DeRouen et al. 2006). The New England Children’s Amalgam Trial 
compared urinary Hg levels and a battery of neuropsychological tests in two groups of 6-10 year 
old children. They found that there was no difference in test performance between their two 
study groups. The mean urinary Hg level in our study was intermediate to the mean levels of 
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each of their study groups (Bellinger et al. 2007). Another randomized control trial looking at 
dental amalgams in 8-10 year old children in Lisbon also examined urinary Hg and 
neurobehavioral outcomes over a series of several years. Mean urinary Hg levels were 
approximately 1.5-4.0 times those in our population. Although there were observable differences 
in the urinary Hg in their study groups, they too observed no statistically significant differences 
in attention between the groups (DeRouen et al. 2006). Our study found that urinary Hg levels 
generally corresponded to higher attention scores, but that this was not statistically significant. 
One association, between urinary Hg and omission errors approached but did not meet statistical 
significance (p=0.076). 
The greatest magnitude of increase in those scores was generally observed in Trimester 1 
(hyperactivity, ADHD index, all three DSM-IV symptom scales) and Trimester 2 (distractibility 
and omission errors). (Figure 1.2) Previous studies have assessed prenatal Hg exposure via total 
Hg concentrations in maternal hair (van Wijngaarden et al. 2013; Sagiv et al. 2012; Oken et al. 
2005) or cord blood (Grandjean et al. 1999). Studies using hair to assess exposure during 
pregnancy generally either took a long length of hair cut to correspond to each trimester 
(Cernichiari et al. 1995) or used the few centimeters closed to the scalp, representing exposure in 
the final trimester and at delivery (Oken et al. 2005). Here, we use whole blood collected from 
participating mothers during each trimester of pregnancy, in addition to cord blood.  
The Faroe Islands studies of cognition at 7 and 14 years examined associations with cord 
blood exposure and found that increasing cord blood Hg was associated with increasing CPT hit 
reaction time. Mean cord blood exposure in this population was approximately 5 times that 
observed in our cohort (Grandjean et al. 1997; Debes et al. 2006). We also observed such a 
relationship, although it was not statistically significant (Figure 1.2, 1.3). Sagiv et al. examined a 
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cohort of children and mothers from New Bedford, Massachusetts. They found that Hg 
concentrations in maternal hair collected postpartum were associated with ADHD-related 
behaviors, as measured using CRS-R and a CPT. In particular, they saw higher risk with higher 
Hg exposure and DSM-IV inattention and hyperactivity/impulsivity scores (Sagiv et al. 2012). 
Our results for DSM-IV hyperactivity/impulsivity score at trimester 3 were consistent, although 
not statistically significant, with their findings, although our results for cord blood and that 
outcome were not consistent. Our results for DSM-IV inattention were not consistent with their 
findings (Figure 1.2, 1.3). However, they did also find some non-linearity and a protective effect 
of maternal fish consumption during pregnancy (Sagiv et al. 2012). The Seychelles Child 
Development Study, which follows mothers and children similarly to our study, has previously 
reported no adverse effects with prenatal MeHg exposure (van Wijngaarden et al. 2013; 
Davidson et al. 2008). Additionally, because we did not examine maternal fish intake or related 
nutritional factors at this time, any deficits in relation to MeHg exposure could be lessened via 
negative confounding. (Davidson et al. 2008; Stokes-Riner et al. 2011).  
Most studies of concurrent Hg exposure, as measured in blood or hair, have found no 
statistically significant associations between exposure and attention related outcomes, while 
observing associations between lead exposure and outcome measures (Ha et al. 2009; Nicolescu 
et al. 2010; Kim et al. 2013). In a case-control study in Omaha, NE, Kim et al found that 
postnatal Pb, where our levels are 1.5-3.0 times those in their population, was associated with 
case status, but Hg, where our levels were 4.5 times those in their population, was not. They did 
not directly examine interaction terms, but stratified by location within a “lead investigation 
area” (Kim et al. 2013). Both Ha et al. and Nicolescu et al. used a methodology similar to what 
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we used here and also found that lead, but not Hg levels were associated with ADHD related 
symptoms (Ha et al. 2009; Nicolescu et al. 2010).  
While this study did not examine lead individually in models, but rather as a covariate in 
our Hg-Pb interaction models, a previous study in our group found that low levels of concurrent 
blood lead (<5 µg/dL) was associated with increased hyperactivity and impulsivity behaviors. 
This paper used a slightly different methodology than we did here. The associations they 
observed were non-linear and only present at certain exposure levels and were not present in 
linear models (Huang et al. 2015). Thus, our results are generally consistent with the existing 
understanding of concurrent metals exposure and attention deficits. Additional analyses with our 
data that incorporates lead as a binary covariate, using 5 µg/dL, the level at which associations 
were previously observed in our population, as a cut point, may yield results like those observed 
by Huang et al. 
We also examined potential interactions between Hg exposure and Pb exposure in our 
cohort. Concurrent exposures to both metals generally corresponded to inhibitory or antagonistic 
interactions, wherein one or both metals individually corresponded to higher attention deficit 
scores, but higher exposure to both corresponded to lower attention deficit scores. However, 
none of these relationships were statistically significant (Figure 1.4). Prenatal exposures to both 
metals, though, did have a strong pattern of associations, particularly in relation to CRS-R 
outcomes (Figure 1.5). In Trimester 1, increases in both metals were consistently related to 
higher attention scores. This was statistically significant for two of the CRS-R outcomes 
(hyperactivity and DSM-IV total symptoms) and marginally statistically significant for two 
others (distractibility and ADHD index). In Trimester 2, increases in one or both metals 
corresponded with lower scores. These were statistically significant for four of the CRS-R 
43 
 
outcomes (ADHD index and the three DSM-IV symptom scales) and marginally significant for 
two others (distractibility and hyperactivity). Trimester 3 was similar to the first trimester, but 
much less clear cut. 
A few studies have examined interactions between lead and mercury, generally using 
concurrent and cord blood levels. A study by Boucher et al found associations between cognitive 
deficits and both concurrent lead and prenatal lead, as measured in cord blood, but no association 
with MeHg at either of those respective time points. However, they did observe that associations 
between behavioral outcomes were more pronounced for concurrent Pb and lower levels of 
concurrent MeHg and for cord Pb and higher levels of cord MeHg (Boucher et al. 2012b). 
Another study suggested that the interaction of prenatal lead and methylmercury, as measured in 
cord blood, was sub-additive (Yorifuji et al. 2011).  
An additional study by Boucher et al examined ADHD-type behaviors in relation to 
prenatal MeHg exposure and postnatal Pb exposure. They found that MeHg was associated with 
greater teacher-reported ADHD behaviors and Pb was associated with greater hyperactivity and 
impulsivity (Boucher et al. 2012a). We examined prenatal MeHg, by trimester, and concurrent 
Pb levels (Figure 1.6). However, there were no consistently observed associations in those 
analyses.  
There were several limitations to this study. Trimester blood samples and cord blood 
samples were only available for a small subset of the overall cohort, limiting the sample sizes in 
those analyses. We used observations from mother-child pairs where there was at least one 
prenatal exposure measure and attention measures at the follow-up visit. It is possible that this 
could lead to selection bias. Individuals may not have completed follow-up visits for many 
reasons, but it is possible that individuals with particularly high exposure or more severe deficits 
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did not participate. We used parent reports for the CRS-R, but not teacher reports. Previous 
studies examining correlation between parent-reported and teacher-reported ADHD symptoms 
have shown that there can be considerable variation between the two sources (Lavigne et al. 
2012). Additionally, our procedure for outliers made sure that data was representative of the 
majority for the available data and was not unduly influenced by outliers, but this may have led 
to the exclusion of real, but extreme, values. 
 While our study yielded few significant results, it still adds to the existing body of 
knowledge regarding the potential role of MeHg in the development of ADHD. It supports the 
suggestion that childhood exposure likely plays little or no role in the development of the 
disorder. Additional analyses examining possible negative confounding due to fish consumption 
could help clarify the observed relationships, particularly those with prenatal exposure.  
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Figures 
Figure 1.1 Results from linear regressions of CPT and CRS-R outcomes with exposures concurrent with the follow-up visit. In the top 
series, points and brackets represent beta coefficients and 95% confidence intervals for associations between the log-transformed CPT 
and CRS-R outcomes and log-transformed Hg concentration. In the bottom series, points and brackets represent beta coefficients and 
95% confidence intervals for associations between the CPT and CRS-R outcome measures and log-transformed Hg concentration. 
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Figure 1.2 Results from linear regressions of CPT and CRS-R outcomes with prenatal exposures. In the top series, points and brackets 
represent beta coefficients and 95% confidence intervals for associations between the log-transformed CPT and CRS-R outcomes and 
log-transformed Hg concentration. In the bottom series, points and brackets represent beta coefficients and 95% confidence intervals 
for associations between the CPT and CRS-R outcome measures and log-transformed Hg concentration. 
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Figure 1.3 Results from linear regressions of CPT and CRS-R outcomes with cord blood mercury level. In the right column, points 
and brackets represent beta coefficients and 95% confidence intervals for associations between the log-transformed CPT and CRS-R 
outcomes and log-transformed Hg concentration. In the left column, points and brackets represent beta coefficients and 95% 
confidence intervals for associations between the CPT and CRS-R outcome measures and log-transformed Hg concentration. 
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Figure 1.4 Results from interaction models of CPT and CRS-R outcomes with exposures concurrent with the follow-up visit. In the 
top series, points and brackets represent beta coefficients and 95% confidence intervals for associations between the log-transformed 
CPT and CRS-R outcomes and geometric mean of Hg exposure, geometric mean of Pb exposure, and the interaction between the two. 
In the bottom series, points and brackets represent beta coefficients and 95% confidence intervals for associations between the CPT 
and CRS-R outcome measures and geometric mean of Hg exposure, geometric mean of Pb exposure, and the interaction between the 
two. 
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Figure 1.5 Results from interaction models of CPT and CRS-R outcomes with prenatal mercury and lead exposure. In the top series, 
points and brackets represent beta coefficients and 95% confidence intervals for associations between the log-transformed outcomes 
and geometric mean of Hg exposure, geometric mean of Pb exposure, and the interaction between the two. In the bottom series, points 
and brackets represent beta coefficients and 95% confidence intervals for associations between the CPT and CRS-R outcome 
measures and geometric mean of Hg exposure, geometric mean of Pb exposure, and the interaction between the two. 
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Figure1.6 Results from interaction models of CPT and CRS-R outcomes with prenatal mercury and concurrent lead exposure. In the 
top series, points and brackets represent beta coefficients and 95% confidence intervals for associations between the log-transformed 
CPT and CRS-R outcomes and geometric mean of prenatal Hg exposure, geometric mean of concurrent Pb exposure, and the 
interaction between the two. In the bottom series, points and brackets represent beta coefficients and 95% confidence intervals for 
associations between the CPT and CRS-R outcome measures and geometric mean of prenatal Hg exposure, geometric mean of 
concurrent Pb exposure, and the interaction between the two. 
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Appendix 1 
Supplemental Tables 
Table S1.1.1 Full models for CPT and CRS-R outcomes and concurrent blood Hg exposure. 
Darker shades of blue indicate larger positive betas, while darker shades of red indicate larger 
negative betas. 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.044 NS 0.088 0.040
Intercept 4.105 <<0.001 3.992 <<0.001 4.011 <<0.001 3.908 <<0.001 54.85 <<0.001
log (Exposure) 0.004 -0.012 0.001 0.003 0.094
Sex of Child: Female 0.057 0.004 0.012 0.043 0.036 0.053 0.010 1.716
Age of Child at Visit -0.002 0.011 0.003 0.013 0.675
Cohort: 2a 0.028 0.001 -0.004 -0.009 -0.741
Cohort: 3 0.002 0.014 -0.011 0.030 0.803
SES Level -2.7E-04 -0.006 -0.002 -7.5E-04 -0.296
Maternal Age -0.004 0.065 -0.003 0.069 -0.004 0.052 -0.005 0.018 -0.245 0.028
Maternal Education -0.004 -0.011 0.006 -0.008 0.065 -0.005 -0.599 0.016
Maternal IQ -2.8E-04 0.001 0.028 0.001 0.068 8.4E-04 0.096 0.010
Maternal Marital 
Status: Married
-0.015 0.020 8.8E-04 -0.010 0.931
Beta P-value Beta P-value Beta P-value Beta P-value
0.031 0.001 NS <<0.001
Intercept 55.97 <<0.001 3.911 <<0.001 3.675 <<0.001 68.60 <<0.001
log (Exposure) 0.152 0.015 -0.016 0.197
Sex of Child: Female 3.329 0.005 0.007 -0.049 0.038 2.659 0.020
Age of Child at Visit 0.446 0.004 0.013 -1.061
Cohort: 2a -0.253 -0.028 -0.026 1.684
Cohort: 3 0.034 0.086 0.011 0.067 2.827
SES Level -0.261 0.002 0.005 -0.304
Maternal Age -0.244 0.035 -3.3E-04 -2.8E-04 -0.172
Maternal Education -0.481 0.063 -0.002 -0.006 0.231
Maternal IQ 0.070 0.074 -4.1E-04 0.002 0.029 -0.066 0.073
Maternal Marital 
Status: Married
0.687 -0.004 0.018 -3.192 0.016
Model
DSM Total (N=298)
log(Omissions) 
(N=298)
log(Commisions) 
(N=300)
Hit Reaction Time 
(N=300)
Blood
log(Distractibility) 
(N=298)
log(Hyperactivity) 
(N=298)
log(ADHD) (N=298)
log(DSM 
Inattention) (N=298)
DSM Hyperactivty-
Impulsivity (N=298)
Model
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Table S1.1.2 Full models for CPT and CRS-R outcomes and concurrent hair Hg exposure. 
Darker shades of blue indicate larger positive betas, while darker shades of red indicate larger 
negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
0.037 NS NS NS NS
Intercept 4.100 <<0.001 4.064 <<0.001 4.119 <<0.001 4.007 <<0.001 60.67 <<0.001
log (Exposure) 0.010 0.003 0.014 0.011 0.702
Sex of Child: Female 0.046 0.006 0.003 0.030 0.076 0.037 0.029 0.602
Age of Child at Visit -0.002 5.5E-04 -0.006 0.002 -0.050
Cohort: 2a 0.006 0.006 -8.4E-04 -0.010 -0.154
Cohort: 3 -0.018 -0.014 -0.041 -0.008 -1.815
SES Level 9.6E-04 -0.004 2.0E-04 6.3E-04 -0.252
Maternal Age -1.9E-04 -3.3E-04 -8.3E-04 -6.7E-04 -0.039
Maternal Education -0.006 -0.012 0.002 -0.009 0.024 -0.006 -0.492 0.027
Maternal IQ -4.6E-04 0.001 0.060 5.4E-04 2.5E-04 0.064 0.044
Maternal Marital 
Status: Married
-0.037 0.053 2.3E-04 -0.018 -0.026 -0.286
Beta P-value Beta P-value Beta P-value Beta P-value
0.073 <<0.001 NS <<0.001
Intercept 61.71 <<0.001 4.091 <<0.001 3.777 <<0.001 70.77 <<0.001
log (Exposure) 0.646 0.007 -0.011 -0.953
Sex of Child: Female 2.359 0.017 0.007 -0.036 0.043 2.107 0.030
Age of Child at Visit -0.269 -0.011 0.006 -1.508 0.032
Cohort: 2a 0.149 -0.007 -3.8E-04 0.714
Cohort: 3 -2.340 0.068 0.016 0.044 2.278
SES Level -0.135 8.8E-04 0.003 -0.245
Maternal Age -0.040 -6.6E-04 -7.2E-04 -0.092
Maternal Education -0.511 0.023 -0.002 -0.006 0.174
Maternal IQ 0.048 -4.9E-04 0.001 0.013 -0.055 0.075
Maternal Marital 
Status: Married
-0.688 -0.011 0.023 -3.611 0.001
Model
DSM Total (N=425)
log(Omissions) 
(N=416)
log(Commisions) 
(N=416)
Hit Reaction Time 
(N=425)
Hair
log(Distractibility) 
(N=423)
log(Hyperactivity) 
(N=422)
log(ADHD) (N=426)
log(DSM 
Inattention) (N=425)
DSM Hyperactivty-
Impulsivity (N=425)
Model
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Table S1.1.3 Full models for CPT and CRS-R outcomes and concurrent urine Hg exposure. 
Darker shades of blue indicate larger positive betas, while darker shades of red indicate larger 
negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
0.035 NS NS NS NS
Intercept 4.093 <<0.001 4.046 <<0.001 4.082 <<0.001 3.976 <<0.001 58.46 <<0.001
log (Exposure) 0.004 -0.004 0.005 0.007 0.263
Sex of Child: Female 0.046 0.006 0.003 0.031 0.068 0.037 0.030 0.738
Age of Child at Visit -7.7E-04 -1.3E-04 -0.004 0.005 0.013
Cohort: 2a 0.001 0.004 -0.003 -0.012 -0.486
Cohort: 3 -0.018 -0.019 -0.034 0.002 -1.683
SES Level 0.001 -0.003 5.9E-04 7.4E-04 -0.233
Maternal Age -2.5E-04 -1.0E-04 -8.0E-04 -8.2E-04 -0.014
Maternal Education -0.005 -0.012 0.001 -0.009 0.026 -0.005 -0.504 0.021
Maternal IQ -5.9E-04 0.001 0.015 5.8E-04 1.9E-04 0.072 0.022
Maternal Marital 
Status: Married
-0.041 0.034 -0.005 -0.023 -0.029 -0.447
Beta P-value Beta P-value Beta P-value Beta P-value
0.079 <<0.001 NS <<0.001
Intercept 59.84 <<0.001 4.048 <<0.001 3.797 <<0.001 70.07 <<0.001
log (Exposure) 0.306 0.014 0.076 0.001 0.085
Sex of Child: Female 2.420 0.015 0.012 -0.037 0.0384 1.817 0.060
Age of Child at Visit -0.149 -0.007 0.005 -1.426 0.040
Cohort: 2a -0.035 -0.010 -0.007 1.355
Cohort: 3 -2.007 0.079 0.005 0.049 2.498
SES Level -0.121 7.5E-04 0.003 -0.285
Maternal Age -0.034 -3.3E-05 -5.7E-04 -0.069
Maternal Education -0.492 0.027 -0.001 -0.004 0.142
Maternal IQ 0.049 -6.2E-04 0.001 0.0476 -0.047
Maternal Marital 
Status: Married
-0.880 -0.011 0.025 -3.914 <0.001
Model
DSM Total (N=425)
log(Omissions) 
(N=413)
log(Commisions) 
(N=414)
Hit Reaction Time 
(N=422)
Urine
log(Distractibility) 
(N=423)
log(Hyperactivity) 
(N=422)
log(ADHD) (N=426)
log(DSM 
Inattention) (N=425)
DSM Hyperactivty-
Impulsivity (N=425)
Model
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Table S1.1.4 Full models for concurrent blood Hg and Pb exposure interactions. Darker shades 
of blue indicate larger positive betas, while darker shades of red indicate larger negative betas. 
“centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS NS
Intercept 4.228 <<0.001 3.980 <<0.001 4.177 <<0.001 3.838 <<0.001 55.205 <0.001
centhg 0.022 0.003 0.025 0.034 0.959
centpb -0.016 0.022 0.009 0.010 -0.118
Sex of Child: Female 0.077 0.016 0.026 0.058 0.060 0.073 0.019 2.259
Age of Child at Visit -0.011 0.016 -0.009 0.017 0.830
Cohort: 3 -0.069 -0.014 -0.070 0.020 0.862
SES Level 1.9E-04 -0.007 -0.001 0.001 -0.333
Maternal Age -0.003 -0.004 -0.004 -0.004 -0.266 0.080
Maternal Education -0.002 -0.012 0.052 -0.009 -0.004 -0.850 0.022
Maternal IQ -3.2E-04 0.002 0.054 0.001 0.001 0.116 0.037
Maternal Marital 
Status: Married
-0.030 -0.029 -0.027 -0.038 0.119
centhg*centpb -0.021 -0.008 -0.043 -0.017 0.601
Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.070 NS 0.006
Intercept 59.885 <0.001 3.805 <<0.001 3.871 <<0.001 73.329 <<0.001
centhg 1.520 0.030 -0.009 0.611
centpb 0.618 0.014 0.010 1.917
Sex of Child: Female 4.033 0.022 0.009 -0.001 -0.683
Age of Child at Visit 0.261 0.012 -0.005 -1.462
Cohort: 3 -2.243 0.125 0.029 0.039 -0.199
SES Level -0.352 0.002 0.004 -0.417
Maternal Age -0.268 0.086 -0.001 -0.003 -0.013
Maternal Education -0.538 -0.006 -0.014 0.064 0.841 0.016
Maternal IQ 0.093 2.20E-04 0.003 0.025 -0.130 0.014
Maternal Marital 
Status: Married
-1.281 -3.50E-04 0.048 -4.948 0.006
centhg*centpb -1.287 0.010 -0.032 0.652
Concurrent Blood
log(Distractibility) 
(N=150)
log(Hyperactivity) 
(N=149)
log(ADHD) (N=151)
log(DSM Inattention) 
(N=151)
DSM Hyperactivty-
Impulsivity (N=149)
Model
DSM Total (N=152)
log(Omissions) 
(N=146)
log(Commisions) 
(N=150)
Model
Hit Reaction Time 
(N=151)
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Table S1.2.1 Full models for CPT and CRS-R outcomes and first trimester blood Hg exposure. 
Darker shades of blue indicate larger positive betas, while darker shades of red indicate larger 
negative betas. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS 0.084 NS
Intercept 4.084 <<0.001 4.112 <<0.001 4.071 <<0.001 3.754 <<0.001 57.94 <0.001
log (Exposure) 0.025 0.040 0.052 0.040 2.284
Sex of Child: Female 0.042 -0.003 0.031 0.024 0.317
Age of Child at Visit 7.2E-04 -0.001 -7.6E-04 0.023 0.161
Cohort: 3 -0.010 -0.033 -0.006 0.061 0.552
SES Level 3.4E-04 -0.008 5.5E-05 -5.3E-04 -0.407
Maternal Age 0.002 2.3E-04 -2.3E-05 0.001 0.013
Maternal Education -0.002 -0.017 0.063 -0.012 -0.008 -0.758
Maternal IQ -0.001 0.002 3.6E-04 4.3E-04 0.073
Maternal Marital 
Status: Married
-0.087 0.037 -0.059 -0.087 0.030 -0.116 0.004 -2.118
Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.001 NS 0.003
Intercept 66.32 <<0.001 4.110 <<0.001 4.041 <<0.001 80.12 <<0.001
log (Exposure) 2.632 -0.008 -0.002 -3.059
Sex of Child: Female 1.886 0.043 -0.013 -0.348
Age of Child at Visit -0.426 -0.008 -0.015 -1.730
Cohort: 3 -2.608 0.112 0.075 0.003 2.479
SES Level -0.420 -0.004 0.005 -0.338
Maternal Age 0.058 -0.002 -0.001 -0.109
Maternal Education -0.782 0.004 -0.001 0.835 0.080
Maternal IQ 0.044 -0.001 4.2E-04 -0.149 0.030
Maternal Marital 
Status: Married
-5.054 0.033 -0.027 0.054 -3.181
Model
DSM Total (N=120)
log(Omissions) 
(N=118)
log(Commisions) 
(N=113)
Hit Reaction Time 
(N=119)
Trimester 1
log(Distractibility) 
(N=118)
log(Hyperactivity) 
(N=118)
log(ADHD) (N=119)
log(DSM 
Inattention) (N=118)
DSM Hyperactivty-
Impulsivity (N=116)
Model
 56 
 
Table S1.2.2 Full models for CPT and CRS-R outcomes and second trimester blood Hg 
exposure. Darker shades of blue indicate larger positive betas, while darker shades of red 
indicate larger negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS NS
Intercept 3.886 <<0.001 3.996 <<0.001 3.942 <<0.001 3.667 <<0.001 48.36 0.001
log (Exposure) 0.036 0.003 0.021 0.039 1.518
Sex of Child: Female 0.041 0.005 0.030 0.019 1.490
Age of Child at Visit 0.008 0.008 0.003 0.025 0.904
Cohort: 3 0.030 0.007 0.008 0.095 2.558
SES Level 0.001 -0.003 0.004 0.001 -0.176
Maternal Age -0.001 -0.001 -0.003 -0.001 -0.178
Maternal Education 0.003 -0.007 -0.003 -0.002 -0.189
Maternal IQ -8.4E-04 8.3E-04 7.3E-04 3.3E-04 0.063
Maternal Marital 
Status: Married
-0.027 -0.041 -0.031 -0.045 -1.510
Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.007 NS 0.033
Intercept 56.42 <0.001 4.058 <<0.001 3.962 <<0.001 62.38 <<0.001
log (Exposure) 1.340 0.019 -0.035 0.478
Sex of Child: Female 1.786 0.007 -0.033 1.033
Age of Child at Visit 0.200 -0.012 -0.007 -0.817
Cohort: 3 0.108 0.088 0.031 2.350
SES Level -0.138 -0.002 -0.002 -0.441
Maternal Age -0.118 -0.001 1.1E-04 -0.056
Maternal Education -0.340 0.003 -0.005 0.625 0.089
Maternal IQ 0.041 -6.7E-04 0.001 -0.079
Maternal Marital 
Status: Married
-2.197 0.007 0.035 -2.306
Model
DSM Total (N=165)
log(Omissions) 
(N=159)
log(Commisions) 
(N=159)
Hit Reaction Time 
(N=163)
Trimester 2
log(Distractibility) 
(N=163)
log(Hyperactivity) 
(N=163)
log(ADHD) (N=164)
log(DSM 
Inattention) (N=163)
DSM Hyperactivty-
Impulsivity (N=163)
Model
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Table S1.2.3 Full models for CPT and CRS-R outcomes and third trimester blood Hg exposure. 
Darker shades of blue indicate larger positive betas, while darker shades of red indicate larger 
negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS 0.045 NS
Intercept 3.716 <<0.001 3.762 <<0.001 3.770 <<0.001 3.399 <<0.001 48.38 0.004
log (Exposure) 0.010 -0.043 -0.003 -0.006 0.784
Sex of Child: Female 0.074 0.019 0.019 0.054 0.093 0.049 1.980
Age of Child at Visit 0.020 0.028 0.017 0.043 0.059 0.989
Cohort: 3 0.032 0.043 0.011 0.116 1.440
SES Level 0.005 0.002 0.006 0.008 -0.056
Maternal Age -8.8E-04 -0.002 -0.002 -9.0E-04 -0.175
Maternal Education -9.5E-04 -0.011 -0.011 -0.007 -0.579
Maternal IQ 4.0E-04 0.002 0.049 0.002 0.091 0.002 0.076 0.108
Maternal Marital 
Status: Married
-0.048 -0.068 0.070 -0.042 -0.069 0.055 -1.669
Beta P-value Beta P-value Beta P-value Beta P-value
NS <<0.001 NS 0.004
Intercept 48.79 0.002 3.860 <<0.001 3.741 <<0.001 69.97 <<0.001
log (Exposure) -0.344 0.003 -0.013 1.225
Sex of Child: Female 3.276 0.087 0.015 9.3E-04 -1.085
Age of Child at Visit 0.794 0.004 0.011 -1.873
Cohort: 3 0.235 0.172 0.005 0.092 1.364
SES Level 0.109 0.004 -0.002 -0.199
Maternal Age -0.108 0.003 3.4E-04 -0.061
Maternal Education -0.602 -0.002 -0.005 0.642 0.081
Maternal IQ 0.101 -0.001 9.8E-04 -0.062
Maternal Marital 
Status: Married
-3.240 -0.005 0.034 -2.348
Model
DSM Total (N=143)
log(Omissions) 
(N=140)
log(Commisions) 
(N=138)
Hit Reaction Time 
(N=142)
Trimester 3
log(Distractibility) 
(N=141)
log(Hyperactivity) 
(N=140)
log(ADHD) (N=142)
log(DSM 
Inattention) (N=141)
DSM Hyperactivty-
Impulsivity (N=143)
Model
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Table S1.2.4 Full models for CPT and CRS-R outcomes and cord blood Hg exposure. Darker 
shades of blue indicate larger positive betas, while darker shades of red indicate larger negative 
betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS NS
Intercept 3.905 <<0.001 3.701 <<0.001 3.845 <<0.001 3.956 <<0.001 36.35 0.075
log (Exposure) -0.015 0.017 -0.034 -0.020 -1.623
Sex of Child: Female 0.053 -0.002 0.010 0.033 1.861
Age of Child at Visit 0.019 0.052 0.075 0.021 0.014 3.238 0.073
Cohort: 2a 0.086 0.050 0.056 0.091 -1.258
Cohort: 3 0.103 0.174 0.020 0.094 0.115 8.796 0.056
SES Level 0.002 -0.004 -0.001 0.002 -0.343
Maternal Age -0.004 -0.004 -0.002 -0.003 -0.159
Maternal Education 0.007 -0.002 0.004 0.004 -0.190
Maternal IQ -0.002 -0.001 -6.3E-04 -0.002 -0.010
Maternal Marital 
Status: Married
-0.044 -0.047 -0.036 -0.052 -0.556
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 40.67 0.035 3.325 <<0.001 2.886 <<0.001 55.33 0.005
log (Exposure) -1.100 0.027 -0.004 1.785
Sex of Child: Female 2.306 -0.027 -0.050 1.792
Age of Child at Visit 2.308 0.026 0.079 0.0211 -1.028
Cohort: 2a 2.486 0.014 -0.102 1.113
Cohort: 3 8.293 0.061 0.137 0.051 0.123 4.139
SES Level -0.071 -0.003 -0.007 -0.131
Maternal Age -0.170 0.006 0.084 0.003 -0.170
Maternal Education -0.133 0.002 0.001 0.137
Maternal IQ -0.038 0.002 0.003 0.0818 0.025
Maternal Marital 
Status: Married
-1.299 -0.008 0.018 1.063
Model
Model
DSM Total (N=87)
log(Omissions) 
(N=83)
log(Commisions) 
(N=80)
Hit Reaction Time 
(N=83)
Delivery
log(Distractibility) 
(N=87)
log(Hyperactivity) 
(N=84)
log(ADHD) (N=87)
log(DSM 
Inattention) (N=87)
DSM Hyperactivty-
Impulsivity (N=86)
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Table S1.3.1 Full models for first trimester Hg and Pb exposure interactions. Darker shades of 
blue indicate larger positive betas, while darker shades of red indicate larger negative betas. 
“centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.042 NS 0.066 NS
Intercept 4.108 4.185 4.179 3.667 64.891 0.001
centhg 0.054 0.059 0.063 0.094 0.059 4.052 0.073
centpb 0.039 0.018 0.008 0.035 0.010
Sex of Child: Female 0.036 -0.033 0.022 0.018 0.752
Age of Child at Visit -0.005 -0.002 -0.006 0.026 -0.122
Cohort: 3 -0.043 -0.069 -0.034 0.060 -1.757
SES Level 0.006 0.002 0.011 0.009 0.091
Maternal Age 0.003 -0.001 -3.3E-04 0.002 -0.119
Maternal Education -0.005 -0.030 0.004 -0.020 0.052 -0.009 -1.317 0.030
Maternal IQ -0.001 0.004 0.015 0.001 0.001 0.149 0.080
Maternal Marital 
Status: Married
-0.089 0.067 -0.105 0.027 -0.106 0.027 -0.135 0.005 -3.590
centhg*centpb 0.201 0.065 0.238 0.027 0.191 0.077 0.138 9.335
Beta P-value Beta P-value Beta P-value Beta P-value
0.042 0.003 NS 0.006
Intercept 72.078 <0.001 4.029 <<0.001 4.081 <<0.001 79.173 <<0.001
centhg 4.003 0.068 0.001 -0.001 -2.929
centpb 0.330 -0.061 0.014 -5.144 0.063
Sex of Child: Female 1.237 0.064 0.066 -0.023 -0.619
Age of Child at Visit -0.732 -0.004 -0.013 -1.926
Cohort: 3 -5.386 0.112 0.031 -0.017
SES Level 0.158 -0.006 0.009 -0.241
Maternal Age -0.004 7.5E-04 -0.003 -0.033
Maternal Education -1.349 0.028 0.012 -0.008 1.045 0.055
Maternal IQ 0.121 -0.002 0.046 4.6E-04 -0.190 0.015
Maternal Marital 
Status: Married
-6.578 0.018 -0.028 0.066 -3.245
centhg*centpb 13.398 0.035 0.020 0.087 2.790
Trimester 1
log(Distractibility) 
(N=88)
log(Hyperactivity) 
(N=88)
log(ADHD) (N=89)
log(DSM Inattention) 
(N=88)
DSM Hyperactivty-
Impulsivity (N=86)
Model
DSM Total (N=90)
log(Omissions) 
(N=89)
log(Commisions) 
(N=83)
Model
Hit Reaction Time 
(N=89)
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Table S1.3.2 Full models for second trimester Hg and Pb exposure interactions. Darker shades 
of blue indicate larger positive betas, while darker shades of red indicate larger negative betas. 
“centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS 0.098 NS
Intercept 3.879 3.834 3.907 3.587 43.856 0.011
centhg 0.030 0.010 -0.001 0.030 0.915
centpb -0.074 0.072 -0.041 -0.079 0.065 -0.081 0.046 -2.552
Sex of Child: Female 0.045 0.024 0.048 0.034 2.880
Age of Child at Visit 0.006 0.021 0.004 0.027 1.321
Cohort: 3 -0.017 0.001 -0.041 0.038 2.197
SES Level 0.005 0.003 0.010 0.009 0.123
Maternal Age 0.001 -0.003 -0.001 0.001 -0.206
Maternal Education 0.007 -0.008 1.6E-04 0.005 -0.033
Maternal IQ -0.001 0.002 2.6E-05 -1.6E-04 0.062
Maternal Marital 
Status: Married
-0.039 -0.055 -0.035 -0.066 0.091 -1.375
centhg*centpb -0.115 0.091 -0.138 0.068 -0.142 0.046 -0.149 0.025 -8.869 0.041
Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.056 NS 0.013
Intercept 52.383 0.002 4.047 <<0.001 3.938 <<0.001 70.158 <<0.001
centhg 0.286 0.041 -0.069 0.048 1.562
centpb -4.783 0.060 -0.039 -0.052 -0.340
Sex of Child: Female 2.957 0.012 -0.033 -0.052
Age of Child at Visit 0.364 -0.004 -0.011 -1.193
Cohort: 3 -3.046 0.107 -0.012 3.400
SES Level 0.214 -0.004 -0.006 -0.637 0.076
Maternal Age -0.027 5.6E-04 0.001 0.066
Maternal Education -0.069 0.002 -7.4E-04 0.563
Maternal IQ 0.026 -0.001 0.001 -0.131 0.027
Maternal Marital 
Status: Married
-3.382 0.013 0.029 -2.453
centhg*centpb -10.476 0.013 -0.033 -0.096 -2.483
Trimester 2
log(Distractibility) 
(N=112)
log(Hyperactivity) 
(N=112)
log(ADHD) (N=113)
log(DSM Inattention) 
(N=112)
DSM Hyperactivty-
Impulsivity (N=112)
Hit Reaction Time 
(N=113)
Model
DSM Total (N=112)
log(Omissions) 
(N=110)
log(Commisions) 
(N=111)
Model
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Table S1.3.3 Full models for third trimester Hg and Pb exposure interactions. Darker shades of 
blue indicate larger positive betas, while darker shades of red indicate larger negative betas. 
“centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS 0.035 NS
Intercept 3.410 3.435 <<0.001 3.558 3.316 34.723 0.098
centhg -0.023 -0.063 0.046 -0.031 -0.026 -0.295
centpb 0.003 -0.034 -0.015 -0.026 -0.511
Sex of Child: Female 0.069 0.034 0.041 0.060 0.087 0.068 0.043 2.756
Age of Child at Visit 0.040 0.085 0.043 0.030 0.043 0.073 1.710
Cohort: 3 0.085 0.065 0.047 0.087 4.188
SES Level 0.010 0.010 0.012 0.088 0.013 0.048 0.555
Maternal Age 0.001 -0.001 -0.001 4.2E-04 -0.177
Maternal Education -0.001 -0.012 -0.009 -0.002 -0.660
Maternal IQ 0.001 0.003 0.028 0.002 0.002 0.141 0.081
Maternal Marital 
Status: Married
-0.077 0.047 -0.097 0.034 -0.067 -0.105 0.009 -1.644
centhg*centpb 0.040 0.021 0.028 0.042 4.973
Beta P-value Beta P-value Beta P-value Beta P-value
0.097 0.002 NS 0.006
Intercept 26.416 3.739 3.631 78.588 <0.001
centhg -1.975 -0.010 -0.003 0.244
centpb -0.659 -0.006 -0.050 1.221
Sex of Child: Female 4.080 0.051 0.018 -0.031 -1.495
Age of Child at Visit 2.179 0.010 0.022 -2.544 0.049
Cohort: 3 3.646 0.187 0.013 0.129 0.524
SES Level 0.604 0.005 -0.004 -0.036
Maternal Age -0.055 0.004 -0.001 -0.029
Maternal Education -0.589 0.002 -0.002 0.542
Maternal IQ 0.147 0.056 -0.001 0.001 -0.079
Maternal Marital 
Status: Married
-5.187 0.035 -0.036 0.028 -2.560
centhg*centpb 2.033 0.039 -0.016 5.303 0.082
log(DSM Inattention) 
(N=114)
DSM Hyperactivty-
Impulsivity (N=111)
Model
Model
DSM Total (N=115)
log(Omissions) 
(N=113)
log(Commisions) 
(N=111)
Hit Reaction Time 
(N=115)
Trimester 3
log(Distractibility) 
(N=113)
log(Hyperactivity) 
(N=112)
log(ADHD) (N=114)
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Table S1.4.1 Full models for Trimester 1 Hg and concurrent Pb exposure interactions. Darker 
shades of blue indicate larger positive betas, while darker shades of red indicate larger negative 
betas. “centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS NS
Intercept 4.077 <<0.001 4.089 <<0.001 4.094 <<0.001 3.497 <<0.001 61.915 0.001
centhg -0.010 0.055 0.044 0.006 1.143
centpb -0.020 0.037 0.009 0.010 1.032
Sex of Child: Female 0.038 -0.002 0.021 0.014 0.310
Age of Child at Visit -0.001 0.016 0.005 0.037 0.537
Cohort: 3 -0.012 0.005 -0.005 0.095 1.126
SES Level 0.001 -0.012 -0.003 0.006 -0.563
Maternal Age -0.002 -0.007 0.060 -0.005 -0.003 -0.273
Maternal Education -0.005 -0.017 0.087 -0.009 -0.013 -1.049 0.054
Maternal IQ 0.001 0.003 0.051 0.002 0.004 0.037 0.146 0.073
Maternal Marital 
Status: Married
-0.095 0.088 -0.074 -0.096 0.058 -0.115 0.025 -2.840
centhg*centpb -0.009 -0.011 -0.056 0.008 -0.433
Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.047 NS 0.032
Intercept 35.336 0.052 4.106 <<0.001 3.950 <<0.001 80.165 <0.001
centhg 2.532 0.031 -0.018 -2.398
centpb 2.246 0.042 -0.025 1.870
Sex of Child: Female 0.949 0.033 -0.024 -2.740
Age of Child at Visit 2.064 0.005 0.012 -1.801
Cohort: 3 2.782 0.117 0.095 0.514
SES Level -0.080 -0.009 -0.002 -0.534
Maternal Age -0.130 -0.003 -0.007 0.071 -0.110
Maternal Education -0.857 0.009 -0.015 1.253 0.034
Maternal IQ 0.174 0.042 -0.003 0.043 0.002 -0.179 0.046
Maternal Marital 
Status: Married
-5.710 0.023 0.005 0.050 -4.368 0.094
centhg*centpb -0.397 0.014 -0.022 1.243
Trimester 1 Hg*Concurrent Pb
log(Distractibility) 
(N=83)
log(Hyperactivity) 
(N=80)
log(ADHD) (N=82)
log(DSM Inattention) 
(N=82)
DSM Hyperactivty-
Impulsivity (N=79)
Model
DSM Total (N=80)
log(Omissions) 
(N=80)
log(Commisions) 
(N=82)
Model
Hit Reaction Time 
(N=82)
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Table S1.4.2 Full models for Trimester 2 Hg and concurrent Pb exposure interactions. Darker 
shades of blue indicate larger positive betas, while darker shades of red indicate larger negative 
betas. “centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS NS
Intercept 3.802 <<0.001 3.961 <<0.001 4.123 <<0.001 3.742 <<0.001 61.706 <0.001
centhg -0.029 0.009 -0.020 -0.019 -0.865
centpb -0.009 0.015 0.005 0.008 0.612
Sex of Child: Female 0.022 0.011 0.015 0.012 0.350
Age of Child at Visit 0.016 0.020 -0.010 0.019 0.227
Cohort: 3 0.011 0.020 -0.078 0.010 -2.000
SES Level 0.006 -0.006 0.003 0.006 -0.189
Maternal Age -0.002 -0.007 0.026 -0.006 0.095 -0.003 -0.301 0.099
Maternal Education 0.002 -0.009 -0.003 -0.004 -0.582
Maternal IQ 9.6E-05 0.002 0.001 0.002 0.111
Maternal Marital 
Status: Married
-0.051 -0.040 -0.038 -0.070 0.071 -2.081
centhg*centpb 0.022 0.007 -0.037 0.015 0.230
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 27.970 0.099 4.163 <<0.001 4.000 <<0.001 66.439 <0.001
centhg -0.255 0.014 -0.062 -1.366
centpb 0.907 0.021 0.008 1.696
Sex of Child: Female 1.580 -0.004 -0.040 -0.953
Age of Child at Visit 2.490 0.076 -0.015 -0.009 -1.095
Cohort: 3 5.939 0.041 -0.017 -1.479
SES Level 0.244 -0.006 -0.005 -0.595
Maternal Age -0.217 -4.2E-04 -0.002 -0.069
Maternal Education -0.451 0.008 -0.012 0.977 0.027
Maternal IQ 0.116 0.098 -0.001 0.003 0.096 -0.076
Maternal Marital 
Status: Married
-2.960 -0.017 0.027 -4.220 0.058
centhg*centpb 1.301 0.048 -0.054 0.907
Trimester 2 Hg*Concurrent Pb
log(Distractibility) 
(N=102)
log(Hyperactivity) 
(N=102)
log(ADHD) (N=103)
log(DSM Inattention) 
(N=102)
DSM Hyperactivty-
Impulsivity (N=101)
Hit Reaction Time 
(N=104)
Model
DSM Total (N=109)
log(Omissions) 
(N=100)
log(Commisions) 
(N=104)
Model
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Table S1.4.3 Full models for Trimester 3 Hg and concurrent Pb exposure interactions. Darker 
shades of blue indicate larger positive betas, while darker shades of red indicate larger negative 
betas. “centhg” refers to centered, log-transformed mercury concentration and “centpb” refers to 
centered, log-transformed lead concentration. 
 
 
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
NS 0.045 NS 0.063 NS
Intercept 3.543 <<0.001 3.715 <<0.001 3.959 <<0.001 3.358 <<0.001 48.514 0.011
centhg -0.005 -0.040 -0.009 -0.012 0.929
centpb -0.003 0.060 0.083 -0.002 0.008 1.227
Sex of Child: Female 0.057 0.016 0.028 0.062 0.097 0.571
Age of Child at Visit 0.034 0.037 0.004 0.040 1.555
Cohort: 3 0.057 0.034 -0.042 0.076 2.987
SES Level 0.008 -0.011 0.001 0.009 -0.447
Maternal Age -0.003 -0.009 0.019 -0.006 0.093 -0.004 -0.460 0.024
Maternal Education -0.004 -0.009 -0.007 -0.008 -0.743
Maternal IQ 0.002 0.004 0.005 0.003 0.062 0.004 0.007 0.179 0.026
Maternal Marital 
Status: Married
-0.082 0.046 -0.069 -0.042 -0.087 0.038 -0.966
centhg*centpb -0.030 -0.006 -0.016 -0.033 2.371
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS 0.042
Intercept 46.743 0.012 3.779 <<0.001 3.669 <<0.001 76.003 <0.001
centhg -0.809 0.007 -0.011 1.167
centpb 1.035 0.006 0.009 1.640
Sex of Child: Female 2.808 0.004 -0.003 -2.380
Age of Child at Visit 1.021 0.009 0.019 -1.868
Cohort: 3 -1.126 0.121 0.112 -0.127
SES Level -0.137 0.001 -0.002 -0.430
Maternal Age -0.314 0.002 -0.003 -0.049
Maternal Education -0.465 0.008 -0.011 0.937 0.029
Maternal IQ 0.161 0.049 -0.001 0.002 -0.118
Maternal Marital 
Status: Married
-3.538 -0.033 0.038 -3.157
centhg*centpb -0.228 0.060 -0.044 0.981
log(DSM Inattention) 
(N=96)
DSM Hyperactivty-
Impulsivity (N=94)
Model
Model
DSM Total (N=96)
log(Omissions) 
(N=95)
log(Commisions) 
(N=98)
Hit Reaction Time 
(N=98)
Trimester 3 Hg*Concurrent Pb
log(Distractibility) 
(N=95)
log(Hyperactivity) 
(N=96)
log(ADHD) (N=97)
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Chapter 2 
Mercury Exposure-Genetic Interactions and Attention Deficits in Children from  
Mexico City 
Abstract 
Attention deficit-hyperactivity disorder (ADHD) is a common psychological disorder 
among school-aged children. ADHD is strongly heritable and a number of potential genes have 
been identified as risk factors. However, there is still relatively limited information about the 
interactions of these identified genes and environmental exposures. We examine the interactions 
of dopamine related candidate SNPs (rs6347, rs40184, rs4680, rs1800497, rs1800955, and 
rs27072) and blood and hair mercury and the ADHD index and DSM-IV total symptom scores of 
the Conners’ Rating Scales-Revised (CRS-R), as measured in participants from the Early Life 
Exposure in Mexico to Environmental Toxicants (ELEMENT) study. Participants had a mean 
(SD) blood Hg concentration of 1.8 (1.3) μg/L and hair Hg concentration of 0.60 (0.47) μg/g. We 
found that rs1800497 and rs27072, genotypes containing the T allele were consistently 
associated with higher ADHD Index and DSM-IV Total scores. Mercury exposure was generally 
not significantly associated with the outcome measures. Two interactions between the chosen 
SNPs and exposure approached statistical significance. The hair Hg association with DSM-IV 
total symptom score differed by rs1800955 genotype (p=0.058) and ADHD index differed by 
rs4680 heterozygous genotype (p=0.025). Our study suggests that COMT and DRD4 genotype 
may modify the effect of postnatal MeHg exposure on two measures of attention in children.  
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) is characterized by persistent 
impulsivity, inattention, and hyperactivity that is present in multiple contexts and impairs 
functioning (American Psychiatric Association 2013). ADHD is one of the most common 
neurological disorder in school-aged children worldwide (Escobar et al. 2005; Polanczyk et al. 
2015). Measures of the worldwide prevalence of ADHD vary widely, but it is estimated at 7.2% 
worldwide (Polanczyk et al. 2014; Thomas et al. 2015), with the CDC estimating a prevalence of 
9.5% in children in the U.S. (Bloom et al. 2013).  
The existing literature suggests that ADHD is highly heritable. While the heritability is 
estimated to be 76%, the interactions between the genes involved are complex (Faraone and 
Mick 2010). Candidate genes for ADHD risk are primarily dopaminergic and serotonergic. 
While the risk associated with these genes is generally small and cannot individually explain the 
entirety of a person’s risk, these findings, especially related to the dopaminergic genes, have 
been consistent (Thapar et al. 2013; Swanson et al. 2007).  
However, what is known about the genetics of ADHD cannot account fully for the 
heritability of the disorder (Schachar 2014). Further, there is heterogeneity in the disorder which 
could potentially involve environmental influences or gene-environment interactions (Thapar et 
al. 2013; Archer et al. 2011). These include environmental exposures such as maternal smoking 
during pregnancy (Thapar et al. 2013; Neuman et al. 2007), exposure to polychlorinated 
biphenyls (PCBs) (Boucher et al. 2009; Eubig et al. 2010; Schantz et al. 2003), and exposure to 
metals (Goodlad et al. 2013; Karagas et al. 2012; Sanders et al. 2015).  
 A number of epidemiological studies have examined the relationship between MeHg 
exposures and later behavioral and cognitive effects. Studies examining concurrent MeHg 
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exposure generally do not find an association with attention deficits (Ha et al. 2009; Nicolescu et 
al. 2010). More studies have found associations with prenatal exposure. A 1997 study in the 
Faroe Islands found attention deficits related to high cord blood levels of MeHg (Grandjean et al. 
1997). A more recent study by Grandjean et al. and a study by Oken et al. found similar results 
(Grandjean et al. 2012; Oken et al. 2005). However, a similar cohort in the Seychelles has 
consistently failed to find deficits (Myers et al. 2003; Davidson et al. 2010). 
A number of studies have examined changes to catecholamine signaling and processing 
after MeHg exposure. A 1997 study by Faro et al. found that chronic intrastriatal MeHg exposure 
in rats resulted in increased striatal release of DA (Faro et al. 1997). The same group later found 
that there was a dose-dependent relationship between MeHg administration and DA release (Faro 
et al. 2000). Further, a later study by Tiernan et al found that in addition to increased release of 
DA, MeHg administration increased DA production (Tiernan et al. 2013). Other studies found 
prenatally exposed rats had decreased monoamine oxidase (MAO) activity (Chakrabarti et al. 
1998; Beyrouty et al. 2006). More recently, a Tiernan et al. study found that MeHg-induced DA 
release was associated with increases in DA synthesis, tyrosine hydroxylase activity, and 
intracellular levels of DA (Tiernan et al. 2013). Given that monoamine neurotransmitters have 
been consistently associated with ADHD, interactions between MeHg and genes related to 
neurotransmitter signaling and processing are a viable direction for research (Asherson and 
Gurling 2011). 
Here, we aim to examine potential disruptions in dopaminergic pathways as a mechanism 
for MeHg effects on attention processes via study of genetic polymorphisms. We hypothesize 
that genetic variants will be associated with attention deficits and that the nature of these 
associations will be modified by considering MeHg exposure. There are currently few studies of 
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gene-environment interactions examining MeHg, genes and behavioral outcomes, and there is a 
need for more studies which examine gene-environment interactions (Yolton et al. 2014). 
Several studies examining Hg, genes related to its toxicokinetics and behavior have been done 
(Yolton et al. 2014; Woods et al. 2013; Basu et al. 2014a), but there are fewer studies looking at 
MeHg, genes related to ADHD, and behavior. For example, a study by Woods et al observed 
interactions between inorganic Hg and catechol-O-methyltransferase (COMT) genotype among 
boys (Woods et al. 2014), but did not examine MeHg.  
Methods 
ELEMENT Cohort 
The ELEMENT study, consisting of three sequentially enrolled cohorts, was initially 
designed to research the influence of maternal lead exposure on offspring neurodevelopment. 
Pertinent details of ELEMENT, such as inclusion and exclusion criteria, collection methods, and 
demographics can be found elsewhere (Tellez-Rojo et al. 2006; Afeiche et al. 2011). In brief, 
Cohort 1 subjects were recruited 1994-1995, Cohort 2 subjects were recruited 1997-2001, Cohort 
3 subjects were recruited 2001-2004 (Afeiche et al. 2011). In 2006 participants were recruited 
from all three cohorts for follow-up visits regarding behavioral outcomes. For analysis of 
concurrent exposures, children were included if their mothers were recruited into Cohorts 2 and 
3, had at least one mercury exposure value and at least one attention measure from the same 
visit. Behavior outcomes at these visits were linked to exposure measures taken at the same time 
as the outcomes (i.e. concurrent exposures). 
The research protocol was approved by the ethics and research committees of the 
partnering institutions, including the National Institute of Public Health of Mexico, the Harvard 
School of Public Health, the Brigham and Women’s Hospital, the University of Michigan School 
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of Public Health, the University of Toronto, and the participating hospitals. 
Human Biospecimens and Mercury Analysis 
Blood, hair and urine samples were collected from the participating children. Venous 
whole blood samples were collected into vials certified for trace metals analysis and stored at 
4
o
C until analysis. Spot (second morning void) urine samples were collected and stored frozen 
until analysis. Scalp hair samples were obtained from each participant using stainless steel 
scissors and the proximal end was designated. Mercury was analyzed in all samples as described 
elsewhere (Basu et al. 2014b). Briefly, total mercury content was carried out using a Direct 
Mercury Analyzer 80 (DMA-80, Milestone Inc., CT). Daily instrument calibration, procedural 
blanks, replicates, and several certified reference materials were analyzed. Reference materials 
included CRM #13 for hair (National Institute for Environmental Studies, Japan), DOLT-4 
(dogfish liver; National Research Council, Canada), and QMEQAS for blood (Institut National 
de Santé Publique du Québec). Recoveries of the reference materials ranged from 80 to 110%. 
The analytical detection limit was less than 1 ng mercury.  
Attention Measures 
Two outcome measures from the parent responses of the Conners’ Rating Scales-Revised 
(CRS-R) were used. The CRS-R uses parent-completed questionnaires that provide information 
about the extent to which a child’s difficulties managing attention are manifested as dysfunctions 
in everyday life. Each item of the questionnaire is linked to the DSM-IV criteria for ADHD-
inattentive subtype, ADHD-hyperactive-impulsive subtype, and ADHD-combined subtype. The 
CRS-R produces index scores for hyperactivity, inattention, and ADHD overall, as well as other 
behaviors, such as perfectionism, opposition, and somatization. Here, the ADHD Index and the 
DSM-IV Total Symptoms score were used. 
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DNA Extraction and Genotyping 
 Genotyping was performed as previously described (Fortenberry et al. 2014). In brief, the 
University of Michigan Sequencing Core performed DNA extraction and genotyping. Genomic 
DNA was extracted from venous blood stored in 8.5ml Paxgene tubes, following the purification 
of DNA from cell lystate from compromised samples on the Qiagen Autopure LS® protocol. 
Genotyping was performed using the Sequenom MassARRAY iPLEX Platform (Bruker 
Instruments, Billerica, MA) (Gabriel et al. 2009). Population sizes for each SNP were based on 
the ability to make a successful call for each individual, which was done using the 
SpectroTYPER software supplied by Sequenom. The overall call rate was calculated as 
𝑁⁡𝑜𝑓⁡𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠⁡𝑤𝑖𝑡ℎ⁡𝑔𝑒𝑛𝑜𝑡𝑦𝑝𝑒⁡𝑐𝑎𝑙𝑙
𝑁⁡𝑜𝑓⁡𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠⁡𝑖𝑛⁡𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
. The genes used in this study were selected for their relevance to 
ADHD (Li et al. 2014; Gatt et al. 2015). 
Statistical Analysis  
Univariate descriptive statistics and graphical displays were obtained for all variables. 
Data were analyzed using R x64 3.0.1. Outliers were detected using the ExtremeValues package 
for R, which uses a distribution based method for identifying outliers (van der Loo 2010). 
Spearman correlations were used to assess associations among all biomarkers. Bivariate analyses 
were used to relate mercury biomarker values with demographic characteristics. Data are 
reported as mean (standard deviation), unless otherwise indicated.  
Linear models were constructed, including a number of covariates selected for potential 
relevance to either the exposure or the analyzed attention measures. Maternal IQ was calculated 
based on the mothers’ scores on the Spanish Wechsler Adult Intelligence Scale (Tellez-Rojo et 
al. 2004; Wechsler 1968). Maternal education was the cumulative number of years that the 
mother attended school at time of recruitment. Information about smoking during pregnancy 
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(yes/no) was obtained from a questionnaire administered to the mother during pregnancy. 
Mothers who responded “yes” at any point during pregnancy were excluded from analyses. As 
previously described (Fortenberry et al. 2014), direct questions about income were deemed too 
intrusive within this cohort. Thus, a measure of socioeconomic status based on reported 
possessions and household assets was used instead. Maternal age and marital status at the time of 
recruitment were also included, as were child age at the follow-up visit and child sex.  
Exposure measures were log-transformed prior to entering into the models. Further, 
model diagnostics revealed that the ADHD Index did not meet normality and was highly skewed. 
Thus, this outcome was log-transformed in all subsequent analyses. Given this transformation, 
the actual beta coefficients are presented in tables and figures. However, in the text, we also 
provide interpretations that consider the transformation. Specifically, we calculated the 
difference in the outcome for a 10% higher Hg concentration as 
∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = (𝑒𝛽𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒∗ln⁡(1.10) − 1) ∗ 100. For DSM-IV Total Symptoms, which did not 
require log-transformation, we used ∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = 𝛽𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 ∗ ln⁡(1.10). 
Similarly, in the ADHD Index models, where the outcome was log-transformed, actual 
beta coefficients are shown in tables and figures, while in the text we provide interpretations for 
the genotypes that consider that transformation. Specifically, we calculated the percent 
difference in the outcome for a given genotype as%∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = (𝑒𝛽𝑆𝑁𝑃 − 1) ∗ 100. This was 
unneeded for DSM-IV Total Symptoms. 
Possible interactions between MeHg and the DA related genes were assessed using 
models that included MeHg exposure, genotype as a categorical variable, and their cross-
product. Exposures were log-transformed and centered. The models could then be interpreted as 
the change as MeHg was increased for the group with a given genotype. Once again, the actual 
 77 
 
beta coefficients are presented in tables and figures, but interpretations that consider 
transformations are presented in the text. 
Results 
Population Characteristics 
 Overall, 466 Cohort 2 and 3 children with complete demographic information 
participated in the follow-up visit. A slight majority of child participants were male. A majority 
of mothers had been married at the time they were recruited. Sixteen mothers reported smoking 
during pregnancy. Given the small proportion of our sample and the existing literature 
suggesting an association between maternal smoking status in pregnancy and later attention 
problems (Neuman et al. 2007; Braun et al. 2006; Froehlich et al. 2011), these mothers, and their 
children, were omitted from subsequent analyses. (Table 2.1) 
Exposure data for this cohort was previously reported for mercury (Basu et al. 2014b) 
and briefly summarized here. Concurrent mercury exposure data is available for 67.4-93.3% of 
the children, depending on the biomarker. Blood and hair mercury levels of participating 
children were 1.8 ± 1.3 μg/L and 0.60 ± 0.47 μg/g respectively (Table 2.1). Blood and hair 
mercury levels of the same individuals were correlated (r=0.69, p<0.001). Two outcome 
measures from the CRS-R test were available from 443 participants at the follow-up visit. For 
any given outcome, a maximum of eight outliers were removed. (Table 2.1)  
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Table 2.1 Demographic Characteristics, Exposure Assessment, Psychological Testing, & 
Genotypes 
  
N Mean(SD) Median Range
466 9.1 (1.3) 9.3 (6.9, 12.5)
466 6.7 (2.5) 6.5 (1, 14)
466 26.0 (5.5) 26 (14, 44)
466 10.9 (2.6) 11 (2, 20)
466 92.6 (18.5) 91 (60, 182)
Total N N(%)
466 237 (50.9%)
466 16 (3.4%)
466 343 (73.6%)
N Mean(SD) Median Range
314 1.8 (1.3) 1.5 (0.23, 8.5)
435 0.60 (0.47) 0.46 (0.06, 3.1)
N Mean (SD) Median Range
443
440 53.8 (9.8) 52.0 (40, 86)
435 54.9 (9.3) 53.0 (40, 81)
Total N N(%)
90 (87.4)
13 (12.6)
156 (80.4)
38 (19.6)
120 (44.8)
114 (42.5)
34 (12.7)
59 (24.7)
118 (49.4)
62 (25.9)
53 (31.9)
107 (64.5)
6 (3.6)
171 (60.6)
97 (34.4)
14 (5.0)
rs6347
rs40184
rs4680
rs1800497
rs1800955
rs27072
DAT1/ 
SLC6A3
DAT1/ 
SLC6A3
COMT
Taq1A 
DRD2/ 
ANKK1
DAT1/ 
SLC6A3
DRD4 166
282
103
194
268
239
Sex of Child (Male)
Maternal Smoking During Pregnancy   
("Ever Smoked")
Maternal Marital Status ("Married")
GENOTYPES
DEMOGRAPHIC CHARACTERISTICS
Child Age
Household SES Level
Maternal Age at Recruitment
Maternal Education Level at Recruitment
Maternal IQ
EXPOSURE ASSESSMENT
Blood Mercury (μg/L)
Hair Mercury (μg/g)
PSYCHOLOGICAL TESTING
TT
CADS Scores
ADHD Index
DSM IV Total
GG
AA
AG
GG
AG
TT
CT
CC
CC
CT
TT
GA
AA
CC
TC
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Crude Associations 
 Crude associations were computed for both outcomes and the genotypes of interests 
(Table 2.2). Of these, several were statistically significant (p<0.05) or nearly so (p<0.10). The 
mean ADHD Index score for the AG genotype of rs40184 (DAT1) was lower than that of the 
GG genotype (p=0.083). The mean DSM-IV Total score for that genotype was also lower, but 
this was not statistically significant. Lower scores for ADHD Index and DSM-IV Total score 
both indicate fewer ADHD-related symptoms.  
 Conversely, for rs27072 (DAT1), the mean ADHD Index and DSM-IV Total score for 
the CT and TT genotypes was higher than that of the CC genotype (p=0.041, 0.034). Similarly, 
for rs1800497 (DRD2 Taq1A), both the TC and TT genotypes had higher average ADHD Index 
and DSM-IV Total scores than the CC genotype (pTC=0.005, 0.002; pTT=0.022, 0.045). 
 There were no observable or statistically significant patterns for the mean outcome scores 
for rs6347 (DAT1) or rs4680 (COMT). For rs1800955 (DRD4), the mean ADHD Index and 
DSM-IV Total scores were higher for the CT and CC genotypes than for the TT genotype, but 
this was not statistically significant. 
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Table 2.2 Crude Means of Outcomes by Genotype. Means with p<0.10 are shown in bold. 
 
Linear Models 
Adjusted Associations 
 Associations that were adjusted for our selected covariates were computed for both 
outcomes and the genotypes of interests (Table 2.3). Statistically significant associations were 
only observed in the adjusted linear models for rs1800497 and rs27072 and psychometric 
outcomes. For rs1800497, the TC and TT genotypes were consistently associated with higher 
ADHD Index and DSM-IV Total scores, as they were in the crude associations. So, TC was 
associated with a 8.01% (95% CI: 2.32, 14.03) higher ADHD Index score than the CC reference 
group, while TT was associated with a 7.27% (95% CI: 0.79, 14.17) higher ADHD Index score 
than the CC group (calculated as %∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒𝑇𝐶 = (𝑒
0.077 − 1) ∗ 100 and %∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒𝑇𝑇 =
(𝑒0.070 − 1) ∗ 100). Similarly, TC was associated with a 4.89 (95% CI: 1.73, 8.06) unit increase 
in DSM-IV Total scores compared to the CC reference group, while TT was associated with a 
Mean (SD) P-Value Mean (SD) P-Value
AA 53.48 (9.32) 55.73 (10.23)
AG 54.92 (11.28) 0.644 55.08 (10.34) 0.829
GG 54.20 (10.01) 56.03 (10.86)
AG 51.18 (9.02) 0.083 53.05 (8.93) 0.119
GG 53.85 (9.47) 55.89 (10.04)
GA 54.53 (10.56) 0.685 55.94 (11.04) 0.973
AA 53.35 (10.50) 0.720 54.65 (10.13) 0.542
CC 50.51 (8.39) 51.88 (8.67)
TC 54.86 (10.36) 0.005 56.95 (11.12) 0.002
TT 54.44 (9.70) 0.022 55.32 (9.30) 0.062
TT 53.21 (10.58) 54.81 (10.50)
CT/CC 54.85 (10.47) 0.314 56.16 (10.34) 0.437
CC 53.03 (9.29) 54.51 (9.82)
CT/TT 55.65 (11.03) 0.041 57.21 (11.05) 0.033
DAT1/ 
SLC6A3
a
Sample sizes range from 102-282. Sample sizes and genotype frequencies are shown in Supplmental 
Table 1.
rs27072
Taq1A 
DRD2/ 
ANKK1
DRD4
ADHD Index DSM Total
rs6347
SNP
a
DAT1/ 
SLC6A3
DAT1/ 
SLC6A3
COMT
rs40184
rs4680
rs1800497
rs1800955
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3.23 (95% CI: -0.42, 6.88) unit increase in DSM-IV total scores compared to the CC group. For 
rs27072, the CT and TT genotypes were also consistently associated with higher ADHD Index 
and DSM-IV Total scores, as they were in the crude associations.  
 Among the other SNPs, although there are no statistically significant associations, several 
patterns are notable. For rs1800955 SNP, the CT/CC genotypes were associated with higher 
scores than the TT genotype, while for rs40184, the AG genotype was associated with lower 
scores than the GG genotype, although this was not statistically significant. For rs6347, the AG 
genotype was associated with higher ADHD Index scores than the AA genotype, but not DSM-
IV Total scores. A more complicated pattern is present for rs4680: the GA genotype was 
associated with higher ADHD Index and DSM-IV Total scores than the GG genotype, while the 
AA genotype was generally associated with lower scores than the GG genotype, although this 
was, again, not statistically significant. Thus, GA was associated with a 1.50% (95% CI: -3.06, 
6.28) higher ADHD Index score than the GG reference group, while AA was associated with a 
0.514% (95% CI: -7.09, 6.52) lower ADHD Index score than the GG group. Similarly, GA was 
associated with a 0.378 (95% CI: -2.30, 3.06) unit increase in DSM-IV Total scores compared to 
the GG reference group, while AA was associated with a 0.708 (95% CI: -4.71, 3.30) unit 
decrease in DSM-IV Total scores compared to the GG group.   
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Table 2.3 Adjusted
a
 associations of outcomes and genotypes. Beta coefficients with p<0.10 are 
shown in bold. 
 
 
Gene-Environment Interactions 
 Models that included genotypes, exposures and the cross-product of genotype and 
exposure were constructed for both outcomes (Table 2.4). Only two interactions between the 
chosen SNPs and exposure approached statistical significance. The hair Hg association with 
DSM-IV total symptom score differed by rs1800955 (DRD4) genotype (p=0.058). Among the 
TT genotype, a 10% increase in hair Hg was associated with a 0.392 unit increase (95% CI:  
-3.06, 6.28) in DSM-IV total symptom score. However, among the CT/CC genotypes, a 10% 
increase in hair Hg exposure was associated with a 0.076 unit decrease (95% CI: -0.306, 0.154) 
in DSM-IV total symptom score. 
β (Std Error) P-Value β (Std Error) P-Value
AA Ref (0) Ref (0)
AG 0.017 (0.051) 0.734 -0.848 (3.08) 0.783
GG Ref (0) Ref (0)
AG -0.043 (0.033) 0.204 -2.43 (2.00) 0.226
GG Ref (0) Ref (0)
GA 0.015 (0.023) 0.526 0.378 (1.37) 0.782
AA -0.005 (0.035) 0.883 -0.708 (2.04) 0.729
CC Ref (0) Ref (0)
TC 0.077 (0.028) 0.006 4.90 (1.61) 0.003
TT 0.070 (0.032) 0.028 3.23 (1.86) 0.084
TT Ref (0) Ref (0)
CT/CC 0.045 (0.032) 0.156 2.31 (1.81) 0.203
CC Ref (0) Ref (0)
CT/TT 0.041 (0.022) 0.057 2.60 (1.25) 0.039
ADHD Index DSM Total
SNP
b
DAT1/ 
SLC6A3
DAT1/ 
SLC6A3
COMT
Taq1A 
DRD2/ 
ANKK1
rs6347
rs40184
rs4680
rs1800497
DRD4
DAT1/ 
SLC6A3
a
Adjusted for sex of child, age of child at follow-up, study cohort, SES, maternal age, maternal 
education, maternal IQ, and maternal marital status
b
Sample sizes range from 102-282 participants. Sample sizes and genotype frequencies are shown 
in Supplmental Table 1
rs27072
rs1800955
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 Additionally, the hair Hg association with ADHD index score differed by rs4680 
(COMT) genotype, but this was only statistically significant for the GA genotype (p=0.025). 
Among the GG genotype, a 10% increase in hair Hg was associated with a 0.182 unit decrease 
(95% CI: -0.554, 0.193) in ADHD index score. However, among the GA genotype, a 10% 
increase in hair Hg exposure was associated with a 0.484 unit increase (95% CI: 0.041, 0.930) in 
ADHD index score. An increase in scores was also observed among the AA genotype: there, a 
10% increase in hair Hg was associated with a 0.183 unit increase (95% CI: -0.542, 0.913) in 
ADHD index score. 
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Table 2.4 Gene-environment interactions of Hg exposure and selected genotypes.
a 
 Beta 
coefficients with p<0.10 are shown in bold. 
 
 
  
β (Std Error) P-Value β (Std Error) P-Value β (Std Error) P-Value β (Std Error) P-Value
-0.035 (0.031) 0.262 -0.383 (1.87) 0.839 -0.004 (0.025) 0.879 0.591 (1.55) 0.704
AA Ref (0) Ref (0) Ref (0) Ref (0)
AG 0.020 (0.052) 0.697 -0.447 (3.16) 0.888 0.049 (0.054) 0.368 0.877 (3.35) 0.794
0.069 (0.069) 0.319 3.21 (4.14) 0.441 0.053 (0.061) 0.388 2.69 (3.76) 0.476
-0.010 (0.022) 0.665 -0.057 (1.33) 0.966 -0.008 (0.018) 0.651 -0.429 (1.11) 0.700
GG Ref (0) Ref (0) Ref (0) Ref (0)
AG -0.053 (0.036) 0.142 -3.16 (2.16) 0.145 -0.042 (0.035) 0.241 -1.98 (2.13) 0.354
-0.001 (0.052) 0.978 -1.77 (3.10) 0.570 0.014 (0.048) 0.763 0.487 (2.90) 0.867
-0.032 (0.025) 0.210 -0.919 (1.48) 0.534 -0.019 (0.020) 0.342 -0.813 (1.19) 0.493
GG Ref (0) Ref (0) Ref (0) Ref (0)
GA 0.015 (0.025) 0.550 0.481 (1.46) 0.742 0.009 (0.024) 0.708 0.021 (1.40) 0.988
AA 0.003 (0.038) 0.944 -0.717 (2.21) 0.746 -0.009 (0.035) 0.801 -0.934 (2.08) 0.654
0.052 (0.037) 0.153 1.60 (2.13) 0.455 0.070 (0.031) 0.025 2.88 (1.82) 0.116
0.030 (0.050) 0.550 0.838 (2.93) 0.775 0.038 (0.043) 0.380 0.877 (2.57) 0.734
-0.012 (0.033) 0.713 -0.387 (1.90) 0.838 -0.008 (0.029) 0.792 -0.117 (1.72) 0.946
CC Ref (0) Ref (0) Ref (0) Ref (0)
TC 0.077 (0.030) 0.010 5.43 (1.70) 0.002 0.074 (0.028) 0.010 4.81 (1.65) 0.004
TT 0.074 (0.034) 0.031 4.04 (1.97) 0.042 0.070 (0.033) 0.032 3.32 (1.91) 0.083
0.006 (0.041) 0.881 0.127 (2.35) 0.957 0.031 (0.036) 0.394 0.939 (2.12) 0.658
-0.019 (0.052) 0.713 -2.47 (2.96) 0.405 -0.003 (0.041) 0.934 -2.41 (2.43) 0.321
0.025 (0.038) 0.508 1.50 (2.15) 0.486 0.067 (0.040) 0.097 4.11 (2.29) 0.075
TT Ref (0) Ref (0) Ref (0) Ref (0)
CT/CC 0.053 (0.033) 0.116 2.63 (1.88) 0.163 0.038 (0.032) 0.237 1.99 (1.83) 0.279
-0.019 (0.047) 0.682 -1.22 (2.65) 0.646 -0.071 (0.045) 0.122 -4.91 (2.57) 0.058
0.001 (0.021) 0.974 0.431 (1.18) 0.717 0.013 (0.018) 0.479 1.23 (1.04) 0.235
CC Ref (0) Ref (0) Ref (0) Ref (0)
CT/TT 0.035 (0.023) 0.135 2.43 (1.32) 0.067 0.038 (0.022) 0.086 2.55 (1.28) 0.047
-0.023 (0.034) 0.492 -2.24 (1.95) 0.251 0.003 (0.028) 0.923 -1.87 (1.64) 0.254
c
log(Hg) values are centered
Blood
b
Hair
ADHD Index DSM Total ADHD Index DSM Total
rs6347
log(Hg)
c
Genotype
log(Hg)*AG
b
Sample sizes range from 89-273 participants. Sample sizes and genotype frequencies are shown in Supplmental Table 2.
rs1800955
log(Hg)
Genotype
log(Hg)*CT/CC
rs27072
log(Hg)
Genotype
log(Hg)*CT/TT
rs1800497
log(Hg)
Genotype
log(Hg)*TC
log(Hg)*TT
log(Hg)*AG
rs4680
a
Adjusted for sex of child, age of child at follow-up, study cohort, SES, maternal age, maternal education, maternal IQ, and maternal marital status
log(Hg)
Genotype
log(Hg)*GA
log(Hg)*AA
rs40184
log(Hg)
Genotype
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Discussion 
In our study cohort, we found associations between increased CRS-R scores and the TC 
and TT genotypes of rs1800497 (Taq1A DRD2) and rs27072 (DAT1/SL6A3). These remained 
statistically significant after adjustment for demographic covariates. Additionally, the AG 
genotype of rs40184 (DAT1/SL6A3) was associated with lower CRS-R scores, but this was only 
marginally statistically significant for ADHD index and not significant for DSM-IV total 
symptoms. However, neither was statistically significant after adjustment. When examining 
interactions between our candidate SNPs and Hg exposure, only two such interactions were 
statistically significant. Both only involved hair Hg exposure. For rs1800955 (DRD4), increasing 
Hg was associated with increasing ADHD symptoms for the TT genotype, but a decrease in 
those scores for all other genotypes. A similar differential association was noted for rs4680 
(COMT), where increasing hair Hg exposure was associated with decreasing ADHD index 
scores for the GG genotype, but increasing scores about the GA and AA genotypes. This was 
only statistically significant for the GA genotype, however. 
As with our study of MeHg at multiple time points and attention deficits, in our cohort, 
girls were more likely to have greater attention deficit symptoms in all measures. This was 
frequently significant or marginally significant. Although it was thought that ADHD 
predominantly affected boys, more recent research suggests that boys are more likely to be 
referred for treatment (Bruchmüller et al. 2012; Biederman et al. 2005). Other studies have 
suggested that girls with ADHD inattention symptoms have greater internalizing symptoms and 
perceived peer deviation (Becker et al. 2013; Cardoos et al. 2012), which could have a 
compounding effect on symptoms over time. Additionally, maternal age, maternal education, and 
marital status were consistently associated with lower attention deficit symptoms. The 
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association with maternal age was consistent with previous work, where the offspring of younger 
mothers had the greatest risk for ADHD later in life (Chang et al. 2014; Sagiv et al. 2013). 
Previous work has also reported that low maternal education may be a risk factor for attention 
deficits (Sagiv et al. 2013; Gurevitz et al. 2014).  
The increased attention scores with the T risk allele of rs1800497 is consistent with 
previous studies (Pan et al. 2015). While rs27072 has been associated with ADHD, the C allele is 
generally found to be the risk allele (Feng et al. 2005; Gizer et al. 2009; Ouellet-Morin et al. 
2008), although this has been inconsistent (Shang et al. 2011; Genro et al. 2008; Friedel et al. 
2007). There has been some evidence that the association with the C allele of rs27072 is only 
seen in ADHD without the presence of comorbid disorders, such as conduct disorder (Zhou et al. 
2008). 
To date, there are only a few studies of ADHD-related candidate genes and concurrent 
MeHg exposure. (Nigg et al. 2010; Tarver et al. 2014). Existing studies generally examine other 
outcomes, a different series of candidate genes, different time points, or all of these. One such 
study examined several of our candidate genes, in addition to toxicokinetic related SNPs, in 
relation to prenatal MeHg exposure and cognition at age 8 years. That study presented evidence 
for MeHg-gene interactions with transferrin (TF), paraoxonase 1 (PON1), brain-derived 
neurotrophic factor (BDNF), and progesterone receptor (PGR), but not with our candidate genes 
(Julvez et al. 2013). Another found evidence for an interaction between prenatal MeHg exposure 
and apolipoprotein E (APOE) genotype on neurodevelopmental outcomes (Ng et al. 2013). Many 
existing studies of gene-Hg interactions and ADHD examined cigarette smoking, alcohol use, 
and other factors (Nigg et al. 2010).  
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However, there have been studies of some of our SNPs with other forms of Hg, such as 
inorganic Hg as measured in urine. A study by Woods et al examined urinary Hg exposure and 
several COMT SNPs, including rs4680, and found that the A allele of rs4680 was associated 
with impaired attention, as was exposure. They also found evidence of an interaction between 
exposure and the A allele of rs4680, in the direction of further attention deficits. However, this 
was specific to boys (Woods et al. 2014). Our findings are somewhat consistent with theirs, in 
that we observed some interactions in the direction of further deficits, but not entirely. Additional 
analyses in our cohort with sex stratification and with urinary Hg levels in addition to our current 
biomarkers could help clarify what is attributable to the different forms of Hg and possible sex 
differences.  
 There are several limitations to our study that must be addressed. We used a candidate 
gene approach for this study. Although candidate gene studies are useful, it is likely that there is 
variability we are unable to capture with this approach. In particular, a number of studies have 
suggested that the greatest risk comes from deficits in neurotransmitter systems, rather than in 
single genes (Hawi et al. 2015). Additionally, our procedure for outliers ensured that data was 
representative of the majority for the available data and was not unduly influenced by outliers, 
but this may have led to the exclusion of real, but extreme, values. A maximum of 8 outcome 
measure outliers and 4 exposure measure outliers were removed. 
 We observed associations with increased attention deficits for the TC and TT genotypes 
of rs1800497 (Taq1A DRD2) and rs27072 (DAT1/SL6A3). Our study suggests that COMT and 
DRD4 genotype may modify the effect of postnatal MeHg exposure on two measures of 
attention in children. Considering genetic factors, such as these, could help explain the 
discrepancies between studies of MeHg and attention deficits that are not explained by 
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differences in nutritional factors, such as fish consumption. Further study with additional 
biomarkers of exposure and examination of other time points could help us to understand these 
potential interactions. 
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Appendix 2 
Supplemental Tables 
Table S2.1.1 Sample sizes and genotype frequencies for crude and adjusted main effect models 
(found in Tables 2.2 and 2.3) 
 
 
  
N Percentage N Percentage
AA 89 87.3 90 87.4
AG 13 12.7 13 12.6
Total N 102 103
GG 154 80.2 156 80.4
AG 38 19.8 38 19.6
Total N 192 194
GG 119 44.7 120 44.8
GA 113 42.5 114 42.5
AA 34 12.8 34 12.7
Total N 266 268
CC 59 24.9 59 24.7
TC 116 48.9 118 49.4
TT 62 26.2 62 25.9
Total N 237 239
TT 53 32.1 53 31.9
CT/CC 112 67.9 113 68.1
Total N 165 166
CC 170 60.7 171 60.6
CT/TT 110 39.3 111 39.4
Total N 280 282
ADHD Index DSM Total
rs4680
rs1800497
rs1800955
rs27072
SNP
rs6347
rs40184
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Table S2.1.2 Sample sizes and genotype frequencies for adjusted models (found in Table 2.4) 
 
  
N Percentage N Percentage N Percentage N Percentage
AA 77 86.5 78 86.7 86 87.8 87 87.9
AG 12 13.5 12 13.3 12 12.2 12 12.1
Total N 89 90 98 99
GG 137 80.6 139 80.8 150 81.5 152 81.7
AG 33 19.4 33 19.2 34 18.5 34 18.3
Total N 170 172 184 186
GG 108 45.0 109 45.0 114 44.0 115 44.1
GA 103 42.9 104 43.0 111 42.9 112 42.9
AA 29 12.1 29 12.0 34 13.1 34 13.0
Total N 240 242 259 261
CC 53 24.9 53 24.7 58 25.3 58 25.1
TC 107 50.2 109 50.7 112 48.9 114 49.4
TT 53 24.9 53 24.7 59 25.8 59 25.5
Total N 213 215 229 231
TT 50 33.6 50 33.3 52 32.9 52 32.7
CT/CC 99 66.4 100 66.7 106 67.1 107 67.3
Total N 149 150 158 159
CC 148 59.4 149 59.4 166 61.3 167 61.2
CT/TT 101 40.6 102 40.6 105 38.7 106 38.8
Total N 249 251 271 273
DSM Total
rs27072
SNP
rs6347
rs40184
rs4680
rs1800497
rs1800955
Blood Hair
ADHD Index DSM Total ADHD Index
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Table S2.2.1 Crude and adjusted main effects models of rs6347. Darker shades of blue indicate 
larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
 
Table S2.2.2 Crude and adjusted main effects models of rs40184. Darker shades of blue indicate 
larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 3.965 <<0.001 3.965 <<0.001 55.733 <<0.001 49.091 0.004
genotype: AG 0.024 0.017 -0.656 -0.848
Sex of Child: Female 0.024 1.946
Age of Child at Visit -0.015 -0.257
Cohort: 2a 0.042 1.245
Cohort: 3 0.019 0.941
SES Level 0.004 -0.141
Maternal Age -7.7E-04 0.107
Maternal Education -0.010 -0.631
Maternal IQ 0.003 0.012 0.156 0.020
Maternal Marital 
Status: Married
-0.052 -2.400
rs6347 (DAT1/SLC6A3)
log(ADHD) DSM Total
Model
Beta P-value Beta P-value Beta P-value Beta P-value
0.083 NS NS NS
Intercept 3.977 <<0.001 4.132 <<0.001 56.032 <<0.001 62.228 <0.001
genotype: AG -0.055 0.083 -0.043 -2.979 -2.431
Sex of Child: Female 0.046 0.082 3.301 0.036
Age of Child at Visit -0.008 -0.285
Cohort: 2a -0.055 0.082 -2.723
Cohort: 3 -0.011 -0.817
SES Level 0.001 -0.116
Maternal Age -0.002 -0.021
Maternal Education -0.008 -0.590 0.081
Maternal IQ 4.7E-04 0.034
Maternal Marital 
Status: Married
-0.001 0.385
Model
rs40184 (DAT1/SLC6A3)
log(ADHD) DSM Total
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Table S2.2.3 Crude and adjusted main effects models of rs4680. Darker shades of blue indicate 
larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
 
Table S2.2.4 Crude and adjusted main effects models of rs1800497. Darker shades of blue 
indicate larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 3.972 <<0.001 4.108 <<0.001 55.892 <<0.001 56.334 <0.001
genotype: GA 0.009 0.015 0.047 0.378
genotype: AA -0.012 -0.005 -1.245 -0.708
Sex of Child: Female 0.046 0.040 3.776 0.004
Age of Child at Visit -0.007 0.249
Cohort: 2a -0.019 -0.809
Cohort: 3 -0.030 -0.547
SES Level -0.001 -0.187
Maternal Age -0.003 -0.127
Maternal Education -0.009 0.053 -0.486 0.076
Maternal IQ 0.001 0.052
Maternal Marital 
Status: Married
0.011 0.708
rs4680 (COMT)
log(ADHD) DSM Total
Model
Beta P-value Beta P-value Beta P-value Beta P-value
0.014 0.007 0.008 0.006
Intercept 3.909 <<0.001 4.175 <<0.001 51.881 <<0.001 58.957 <0.001
genotype: TC 0.079 0.005 0.077 0.006 5.068 0.002 4.895 0.003
genotype: TT 0.073 0.022 0.070 0.028 3.441 0.062 3.227 0.084
Sex of Child: Female 0.044 0.056 3.266 0.014
Age of Child at Visit -0.014 0.021
Cohort: 2a -0.024 -1.821
Cohort: 3 -0.094 0.043 -3.256
SES Level 0.002 -0.087
Maternal Age -0.003 -0.130
Maternal Education -0.009 0.047 -0.549 0.044
Maternal IQ 0.001 0.029
Maternal Marital 
Status: Married
-0.011 -0.124
rs1800497 (Taq1A DRD2/ANKK1)
log(ADHD) DSM Total
Model
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Table S2.2.4 Crude and adjusted main effects models of rs1800955. Darker shades of blue 
indicate larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
 
Table S2.2.6 Crude and adjusted main effects models of rs27072. Darker shades of blue indicate 
larger positive betas, while darker shades of red indicate larger negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 3.956 <<0.001 4.003 <<0.001 54.811 <<0.001 59.251 <0.001
genotype: CT/CC 0.031 0.045 1.348 2.308
Sex of Child: Female 0.034 1.851
Age of Child at Visit -0.001 -0.448
Cohort: 2a -0.021 -0.449
Cohort: 3 0.021 0.405
SES Level -0.005 -0.476
Maternal Age -0.002 -0.033
Maternal Education -0.014 0.036 -0.604
Maternal IQ 0.002 0.071 0.084
Maternal Marital 
Status: Married
0.033 1.513
Model
rs1800955 (DRD4)
log(ADHD) DSM Total
Beta P-value Beta P-value Beta P-value Beta P-value
0.041 0.025 0.033 0.011
Intercept 3.956 <<0.001 4.055 <<0.001 54.515 <<0.001 55.987 <0.001
genotype: CT/TT 0.044 0.041 0.041 0.057 2.702 0.033 2.595 0.039
Sex of Child: Female 0.054 0.014 3.494 0.006
Age of Child at Visit 2.1E-05 0.317
Cohort: 2a -0.026 -1.763
Cohort: 3 -0.029 -1.161
SES Level -5.4E-04 -0.180
Maternal Age -0.003 -0.092
Maternal Education -0.010 0.035 -0.614 0.022
Maternal IQ 8.9E-04 0.057
Maternal Marital 
Status: Married
-0.006 -0.249
rs27072 (DAT1/SLC6A3)
log(ADHD) DSM Total
Model
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Table S2.3.1 Gene-Environment interaction model for rs6347. “centhg” refers to centered, log-
transformed mercury concentration. Darker shades of blue indicate larger positive betas, while 
darker shades of red indicate larger negative betas. 
 
 
 
Table S2.3.2 Gene-Environment interaction model for rs40184. “centhg” refers to centered, log-
transformed mercury concentration. Darker shades of blue indicate larger positive betas, while 
darker shades of red indicate larger negative betas. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 3.859 <<0.001 42.917 0.016 4.057 <<0.001 56.327 0.002
centhg -0.035 -0.383 -0.004 0.591
genotype: AG 0.020 -0.447 0.049 0.877
Sex of Child: Female 0.024 2.005 0.012 1.336
Age of Child at Visit -0.007 0.343 -0.029 -1.052
Cohort: 2a 0.053 2.161 0.038 1.174
Cohort: 3 0.062 3.760 -0.004 -0.852
SES Level 0.001 -0.422 0.005 -0.027
Maternal Age -0.003 -0.053 2.0E-04 0.154
Maternal Education -0.006 -0.575 -0.009 -0.649
Maternal IQ 0.003 0.007 0.188 0.007 0.003 0.015 0.144 0.040
Maternal Marital 
Status: Married
-0.038 -0.733 -0.045 -2.114
centhg*genotype: AG 0.069 3.209 0.053 2.695
rs6347 (DAT1/SLC6A3)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
Model
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 4.126 <<0.001 61.049 <0.001 4.139 <<0.001 62.440 <0.001
centhg -0.010 -0.057 -0.008 -0.429
genotype: AG -0.053 -3.161 -0.042 -1.982
Sex of Child: Female 0.044 3.339 0.046 0.040 2.954
Age of Child at Visit -0.008 -0.268 -0.011 -0.378
Cohort: 2a -0.059 0.078 -2.756 -0.058 0.076 -2.909
Cohort: 3 0.003 -0.340 -0.018 -1.125
SES Level -0.001 -0.230 -1.8E-04 -0.165
Maternal Age -0.003 -0.112 -0.001 -0.001
Maternal Education -0.007 -0.480 -0.008 -0.619 0.082
Maternal IQ 0.001 0.050 0.001 0.043
Maternal Marital 
Status: Married
0.009 1.766 0.006 0.747
centhg*genotype: AG -0.001 -1.766 0.014 0.487
rs40184 (DAT1/SLC6A3)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
Model
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Table S2.3.3 Gene-Environment interaction model for rs4680. “centhg” refers to centered, log-
transformed mercury concentration. Darker shades of blue indicate larger positive betas, while 
darker shades of red indicate larger negative betas. 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 4.132 <<0.001 56.379 <0.001 4.149 <<0.001 57.830 <0.001
centhg -0.032 -0.919 -0.019 -0.813
genotype: GA 0.015 0.481 0.009 0.021
genotype: AA 0.003 -0.717 -0.009 -0.934
Sex of Child: Female 0.047 0.050 3.771 0.007 0.043 0.057 3.571 0.007
Age of Child at Visit -0.008 0.272 -0.013 0.006
Cohort: 2a -0.015 -0.536 -0.018 -0.790
Cohort: 3 -0.022 0.056 -0.049 -1.341
SES Level -0.002 -0.292 -0.001 -0.194
Maternal Age -0.003 -0.213 -0.002 -0.095
Maternal Education -0.009 0.073 -0.477 0.098 -0.010 0.039 -0.539 0.054
Maternal IQ 0.001 0.063 0.001 0.059
Maternal Marital 
Status: Married
0.025 1.991 0.027 1.332
centhg*genotype: GA 0.052 1.596 0.070 0.025 2.877
centhg*genotype: AA 0.030 0.838 0.038 0.877
rs4680 (COMT)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
Model
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Table S2.3.4 Gene-Environment interaction model for rs1800497. “centhg” refers to centered, 
log-transformed mercury concentration. Darker shades of blue indicate larger positive betas, 
while darker shades of red indicate larger negative betas. 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
0.040 0.006 0.022 0.014
Intercept 4.184 <<0.001 56.804 <0.001 4.221 <<0.001 60.387 <0.001
centhg -0.012 -0.387 -0.008 -0.117
genotype: TC 0.077 0.010 5.426 0.002 0.074 0.010 4.807 0.004
genotype: TT 0.074 0.031 4.036 0.042 0.070 0.032 3.325 0.083
Sex of Child: Female 0.039 3.300 0.018 0.037 3.106 0.023
Age of Child at Visit -0.014 0.243 -0.019 -0.193
Cohort: 2a -0.022 -1.551 -0.023 -1.587
Cohort: 3 -0.079 -2.042 -0.111 0.020 -3.757
SES Level 3.7E-04 -0.164 3.1E-04 -0.122
Maternal Age -0.004 0.063 -0.251 0.062 -0.003 -0.100
Maternal Education -0.009 0.089 -0.470 -0.010 0.043 -0.544 0.055
Maternal IQ 6.8E-04 0.039 0.001 0.028
Maternal Marital 
Status: Married
-5.3E-05 0.892 -0.005 0.270
centhg*genotype: TC 0.006 0.127 0.031 0.939
centhg*genotype: TT -0.019 -2.469 -0.003 -2.412
rs1800497 (Taq1A DRD2/ANKK1)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
Model
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Table S2.3.4 Gene-Environment interaction model for rs1800955. “centhg” refers to centered, 
log-transformed mercury concentration. Darker shades of blue indicate larger positive betas, 
while darker shades of red indicate larger negative betas. 
 
 
 
Table S2.3.6 Gene-Environment interaction model for rs27072. “centhg” refers to centered, log-
transformed mercury concentration. Darker shades of blue indicate larger positive betas, while 
darker shades of red indicate larger negative betas. 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value
NS NS NS NS
Intercept 4.019 <<0.001 60.385 <0.001 4.065 <<0.001 62.496 <0.001
centhg 0.025 1.499 0.067 0.097 4.108 0.075
genotype: CT/CC 0.053 2.635 0.038 1.987
Sex of Child: Female 0.036 1.836 0.019 1.015
Age of Child at Visit -3.6E-04 -0.372 -0.007 -0.730
Cohort: 2a -0.015 0.080 -0.016 -0.169
Cohort: 3 0.036 1.706 -0.004 -0.815
SES Level -0.010 -0.663 -0.006 -0.488 0.095
Maternal Age -0.004 -0.171 -0.002 -0.019
Maternal Education -0.015 0.030 -0.668 0.082 -0.017 0.015 -0.801 0.041
Maternal IQ 0.002 0.036 0.100 0.078 0.002 0.031 0.106 0.062
Maternal Marital 
Status: Married
0.057 3.234 0.043 1.973
centhg*genotype: 
CT/CC
-0.019 -1.219 -0.071 -4.908 0.058
rs1800955 (DRD4)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
Model
Beta P-value Beta P-value Beta P-value Beta P-value
0.081 0.021 0.069 0.023
Intercept 4.072 <<0.001 55.781 <0.001 4.083 <<0.001 56.893 <0.001
centhg 0.001 0.431 0.013 1.235
genotype: CT/TT 0.035 2.433 0.067 0.038 0.086 2.553 0.047
Sex of Child: Female 0.055 0.020 3.863 0.005 0.050 0.026 3.358 0.009
Age of Child at Visit -2.6E-04 0.420 -0.003 0.210
Cohort: 2a -0.026 -1.615 -0.025 -1.753
Cohort: 3 -0.018 -0.355 -0.042 -1.921
SES Level -0.002 -0.256 -0.002 -0.195
Maternal Age -0.004 0.057 -0.223 0.087 -0.003 -0.084
Maternal Education -0.009 0.074 -0.525 0.064 -0.011 0.024 -0.660 0.017
Maternal IQ 0.001 0.066 0.124 0.001 0.066
Maternal Marital 
Status: Married
-4.8E-04 0.573 0.001 -0.254
centhg*genotype: 
CT/TT
-0.023 -2.244 0.003 -1.872
Model
rs27072 (DAT1/SLC6A3)
Blood Hair
log(ADHD) DSM Total log(ADHD) DSM Total
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Chapter 3 
Relationships between Acoustic Startle Reflex, Prepulse Inhibition, and Methylmercury 
in Adolescents 
Abstract 
Prepulse inhibition (PPI) is a sensorimotor gating process in the startle reflex that is 
modified under different behavioral conditions (e.g. during attention tasks). This can be impaired 
in a number of behavioral disorders, such as attention deficit disorder. Although extensively 
studied in animal models, few studies have explored the use of the PPI to assess neurological 
effects of toxicants in humans. We aim to describe the relationship between acoustic startle 
reflex (ASR), PPI and MeHg exposure in a cohort of adolescents. We report on recordings from 
231 adolescents aged 8-17 years from the Early Life Exposure in Mexico to Environmental 
Toxicants (ELEMENT) study. We used quantile regression to examine relationships between 
blood and hair Hg levels and PPI. ASR without a prepulse was non-linearly associated with 
MeHg exposure. For both target and non-target ASR response magnitudes with prepulses, higher 
MeHg generally corresponded to higher ASR magnitudes, especially in the right tail of their 
respective distributions. There was a linear, but not necessarily significant, association with 
increased inhibition with MeHg in the 25
th
 percentile and median of the PPI distribution in trials 
with an attended tone, but a linear association with decreased inhibition in the 75
th
 percentile. 
These findings add to our understanding of ASR and PPI, particularly in the context of 
environmental exposures. 
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Introduction 
The startle reflex is a well-characterized response to a sudden, unexpected loud sound, 
and involves the sudden contraction of the facial muscles, an increase in skin conductance, and 
an increase in heart rate (Li et al. 2009). The startle reflex is typically reduced when the startling 
stimulus is preceded by a weaker stimulus to which the person needs to attend, referred to as a 
prepulse. This is referred to as prepulse inhibition (PPI). PPI is a basic attention mechanism in 
the brain: a sensorimotor gating process that helps focus attention on stimuli that requires a 
response. The weaker stimulus causes the later startling stimulus to be “gated out,” resulting in 
the characteristic inhibition (Alvarez-Blanco et al. 2009; Braff et al. 2001). At the neuronal level, 
the prepulse induces a negative feedback loop, inhibiting the startle initiating neurons. Thus, the 
resulting startle is not as great (Li et al. 2009). 
In subjects with ADHD, the observed change in magnitude is not as great (Braff et al. 
2001). This is most noticeable when subjects are asked to use selective attention, typically via a 
task (Filion and Poje 2003). Additionally, deficits in PPI in ADHD cases have been observed to 
be remediated with methylphenidate treatment (Hawk et al. 2003; Schulz-Juergensen et al. 
2014). This is notable because methylphenidate, an extremely common treatment for ADHD, 
acts on dopamine signaling (Jenson et al. 2015). 
Although PPI deficits in different psychiatric conditions and how they respond to a 
number of psychiatric drugs have been relatively well characterized in humans (Braff et al. 2001; 
Kohl et al. 2013), studies of PPI and environmental exposures in humans are comparatively few. 
Those that have been completed generally focus on tobacco use, alcohol, or psychosocial 
stressors. Some animal studies, however, suggest that one potential environmental exposure of 
interest is methylmercury. 
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Methylmercury (MeHg) exposure has been linked with attention and cognition deficits 
(Karagas et al. 2012), which is not surprising as this organic form of mercury (Hg) is an 
established neurodevelopmental toxicant (Clarkson and Magos 2006). Exposure to MeHg is 
primarily via fish and seafood consumption and is thus ubiquitous amongst populations that 
consume fish (Driscoll et al. 2013). Mercury exposure has been suggested to modify the 
processing and release of several neurotransmitters, particularly dopamine, which have been 
implicated in the etiology of deficits in attention and cognition (Faraone and Mick 2010). It has 
previously been suggested that PPI might be useful as a measure of dopaminergic function 
(Swerdlow et al. 2003). The remediation of PPI deficits in ADHD with methylphenidate 
treatment, which acts on dopamine levels (Hawk et al. 2003; Schulz-Juergensen et al. 2014), also 
suggests MeHg may have effects on PPI deficits. 
To our knowledge, no studies have examined the relationship between Hg exposure and 
PPI in humans. To date, only a few animal studies have been conducted examining MeHg and 
PPI. Wu et al found that rats with MeHg poisoning had deficits in PPI, though there was not a 
clear dose-response relationship (Wu et al. 1985). Vezer at al found similar results in sub-
chronically dosed rats (Vezer et al. 2005). Beyrouty et al saw disrupted unmodified startle 
responses after prenatal MeHg exposure in rats, with few significant difference in behavioral 
tests, including motor activity, swimming performance, and a functional observation battery 
(Beyrouty et al. 2006). 
Here, we aim to explore the relationship between concurrent MeHg exposure and both 
the basic acoustic startle reflex (ASR) and prepulse inhibition (PPI). We hypothesize that 
increased ASR and deficient PPI will be associated with high concurrent MeHg exposure, as 
suggested by the existing animal studies.  
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Methods 
ELEMENT Cohort 
The ELEMENT study, consisting of three sequentially enrolled cohorts, was initially 
designed to research the influence of maternal lead exposure on offspring neurodevelopment. 
Pertinent details of ELEMENT, such as inclusion and exclusion criteria, collection methods, and 
demographics can be found elsewhere (Tellez-Rojo et al. 2006; Afeiche et al. 2011). In brief, 
Cohort 1 subjects were recruited 1994-1995, Cohort 2 subjects were recruited 1997-2001, Cohort 
3 subjects were recruited 2001-2004 (Afeiche et al. 2011). In 2006 participants were recruited 
from all three cohorts for follow-up visits regarding behavioral outcomes. For analysis of 
concurrent exposures, children were included if they had at least one mercury exposure value 
and also had electromyography response data.  
The research protocol was approved by the ethics and research committees of the 
partnering institutions, including the National Institute of Public Health of Mexico, the Harvard 
School of Public Health, the Brigham and Women’s Hospital, the University of Michigan School 
of Public Health, the University of Toronto, and the participating hospitals. 
Human Biospecimens and Mercury Analysis 
Blood and hair samples were collected from the participating children at the follow-up 
visit. Venous whole blood samples were collected into vials certified for trace metals analysis 
and stored at 4
o
C until analysis. Scalp hair samples were obtained from each participant using 
stainless steel scissors and the proximal end was designated. Mercury was analyzed in all 
samples as described elsewhere (Basu et al. 2014). Briefly, total mercury content was carried out 
using a Direct Mercury Analyzer 80 (DMA-80, Milestone Inc., CT). Daily instrument 
calibration, procedural blanks, replicates, and several certified reference materials were analyzed. 
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Reference materials included CRM #13 for hair (National Institute for Environmental Studies, 
Japan), DOLT-4 (dogfish liver; National Research Council, Canada), and QMEQAS for blood 
and urine (Institut National de Santé Publique du Québec). Recoveries of the reference materials 
ranged from 80 to 110%. The analytical detection limit was less than 1.0 ng mercury.  
PPI Recording and Analysis 
 Participants were placed in an isolated setting during the clinic visit. Surface electrodes 
(Ambu, Balerup, Denmark) were affixed to participants over their orbicularis oculi muscle (for 
eyeblink), wrist, and chest to measure electromyography (EMG), skin conductance, and heart 
rate, respectively. Using integrated stimulus and presentation software (BIOPAC, Goleta, CA) 
participants were then presented with a series of tones at 75 dB over headphones until they could 
accurately distinguish between high (1200 Hz) and low (400 Hz) pitched tones and short (5 
second) and long (8 second) duration tones. Following this, during the tone discrimination task, 
three randomly presented blocks of tones in a pseudorandom order were presented, including a 
total of 36 startle probes (a 50 ms burst of white at 102dB). Each block included 6 presentations 
each of the low and high frequency tones, and 3 during the intertrial interval (ITI; i.e. those with 
no tone). Startle probes that were presented with tones came either 120 ms or 240 ms after the 
onset of the tone (referred to as a stimulus onset asynchrony, SOA). Prior to starting the 
discrimination task, participants were instructed to press the space bar in response to the long 
tones. Thus, this selected pitch was considered the “target tone” as it was the one the participant 
was expected to attend to. The other tone was considered the “non-target tone” as the participant 
did not need to respond (and therefore attend) to this tone. A cartoon diagram of example 
responses is shown in Figure 3.1.I. After the participant completed the task, the electrodes were 
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removed. This methodology follows a similar design to that used in other studies of prepulse 
inhibition (Hawk et al. 2003). 
 PPI was calculated for each block as 
(𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝑋−𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝐼𝑇𝐼)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝐼𝑇𝐼
, where 
average magnitude X is the average magnitude of responses in the presence of a tone within the 
given block and average magnitude ITI is the average magnitude of responses during the ITI of 
the same block. We considered PPI for target tones and non-target tones separately, and 
responses within a block were averaged. Because there may be differences in the extent of PPI 
when the SOA is 120 ms or 240 ms, we considered PPI separately for these SOA as well as PPI 
when considering all target or non-target responses irrespective of the SOA.  
 
Figure 3.1.I Cartoon of acoustic stimuli vs expected EMG results. This shows the startle probes 
for ITI trials and those with prepulses. Response magnitudes (shown for response A) are 
calculated as the peak EMG value less the baseline EMG value. PPI is then calculated as 
(𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝐵−𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝐴)
𝐴𝑣𝑒𝑟𝑎𝑔𝑒⁡𝑀𝑎𝑔𝑛𝑖𝑡𝑢𝑑𝑒⁡𝐴
.  
 
Statistical Analysis  
Data were analyzed using R x64 3.0.1. Univariate descriptive statistics and graphical 
displays were obtained for all variables. Outliers were detected using the ExtremeValues 
package for R, which uses a distribution based method for identifying outliers (van der Loo 
2010). Because most values of PPI were negative, this package was not suitable for outlier 
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detection. Thus, outliers were identified and removed by identifying the values of the 1
st
 and 99
th
 
percentiles. Spearman correlations were used to assess association among all biomarkers. 
Bivariate analyses (correlations with t-test) were used to relate mercury biomarker values with 
demographic characteristics. Descriptive statistics are reported as mean (standard deviation), 
unless otherwise indicated.  
The crude and adjusted associations between the neurological outcomes and mercury 
were estimated using quantile regression. A distribution of residuals from linear modeling 
deviated from normality. Because a large portion of the distribution for PPI included negative 
values, log-transformation to correct this was not possible. Thus, we sought alternative methods 
that would yield valid inferences. Quantile regression enables us to study shifts at any quantile of 
the distribution, rather than at the mean as done in ordinary linear regression. We examined the 
25
th
, 50
th
, and 75
th
 percentiles, since these are representative of the overall distribution. This 
enables us to look at the tails of the distribution in addition to the center. Additionally, 
regressions were run with exposure as a continuous variable and as quartiles of exposure 
(referred to as “Low”, “Medium-Low”, “Medium-High”, and “High”). 
Models included a number of covariates selected for potential relevance to either the 
exposure or the analyzed attention measures. Maternal IQ was calculated based on the mothers’ 
scores on the Spanish Wechsler Adult Intelligence Scale (Tellez-Rojo et al. 2004; Wechsler 
1968). Maternal education was the cumulative number of years that the mother attended school 
at time of recruitment. Smoking during pregnancy (yes/no) was obtained from a questionnaire 
administered to the mother at or before 1-month post-partum. A “yes” response at any point in 
pregnancy was coded as a yes for this covariate. Because only a small number of mothers 
reported smoking during pregnancy, data from children whose mothers’ smoked were excluded 
 110 
 
from analyses. As previously described (Fortenberry et al. 2014), direct questions about income 
were deemed too intrusive within this cohort. Thus, a measure of socioeconomic status based on 
reported possessions and household assets was used instead. Maternal age and marital status at 
recruitment were also included, as were child age at the follow-up visit and child sex. Protocol 
block sequence was also included. 
Because we were using the quantile regression method, outcome measures were not 
transformed. However, exposure measures were log-transformed prior to entering into the 
models, given their high skewness. The actual beta coefficients are presented in tables and 
figures. However, in the text, we also provide interpretations that consider the transformation. 
Specifically, we calculated the difference in the outcome for a 10% higher Hg concentration as 
∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒 = 𝛽𝑒𝑥𝑝𝑜𝑠𝑢𝑟𝑒 ∗ ln⁡(1.10). These differences in the outcomes are given for the 25
th
, 
50
th
, and 75
th
 percentiles of the outcome distribution. 
Results 
Population Characteristics 
 Overall, 450 children participated in the visit where startle response was tested. Of these, 
231 had complete covariates and at least one of the startle response measures. A slight majority 
of participants were male (Table 3.1). A majority of mothers had been married at the time they 
were recruited. Six mothers reported smoking during pregnancy. Given this small proportion of 
smokers in our sample and the existing literature suggesting an association between maternal 
smoking status in pregnancy and later attention problems (Duncan et al. 2001a; Popke et al. 
1997), these mothers, and their children, were omitted from subsequent analyses.  
Exposure data for this cohort was previously reported for mercury (Basu et al. 2014) and 
briefly summarized here. Mercury exposure data is available for 88.8-91.0% of the children, 
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depending on the biomarker. Blood and hair mercury levels of participating children were 2.07 ± 
2.03 µg/L and 0.53 ± 0.44 µg/g respectively (Table 3.1). Blood and hair mercury levels of the 
same individuals were correlated (r=0.75, p<0.001). 
 The EMG data, including outcomes related to EMG response amplitude and calculated 
PPI, were available at least in part from 231 participants.  
Table 3.1 
 
  
N Mean(SD) Median Range
231 13.13 (2.53) 12.3 (8.1, 17.4)
231 6.63 (2.63) 6.0 (1.0, 13.5)
231 26.11 (5.22) 26.0 (16.0, 42.0)
231 10.73 (2.98) 11.0 (1.0, 20.0)
233 92.32 (17.46) 91.0 (60.0, 138.0)
Total N N(%)
231 125 (54.11)
231 6 (2.60)
231 168 (72.73)
N Mean(SD) Median Range
212 2.07 (2.03) 1.37 (0.18, 11.6)
207 0.53 (0.44) 0.38 (0.07, 2.5)
N Mean (SD) Median Range
180 2.95 (2.56) 2.10 (0.51, 16.13)
188 2.21 (1.96) 1.57 (0.51, 10.62)
138 2.13 (1.87) 1.41 (0.52, 9.44)
148 2.28 (2.04) 1.47 (0.50, 12.02)
169 1.94 (1.51) 1.37 (0.51, 7.39)
128 2.06 (1.79) 1.51 (0.51, 8.94)
139 2.04 (1.65) 1.37 (0.52, 8.16)
160 0.002 (0.909) -0.175 (-0.827, 5.20)
115 -0.152 (0.781) -0.398 (-0.872, 4.86)
133 -0.046 (0.752) -0.226 (-0.843, 4.83)
146 -0.151 (0.602) -0.331 (-0.808, 2.85)
115 -0.162 (0.699) -0.415 (-0.857, 2.52)
124 -0.177 (0.573) -0.369 (-0.863, 2.36)
Sex of Child (Male)
Maternal Smoking During Pregnancy ("Ever Smoked")
Maternal Marital Status ("Married")
EXPOSURE ASSESSMENT
DEMOGRAPHIC CHARACTERISTICS
Child Age
Household SES Level
Maternal Age at Recruitment
Maternal Education Level at Recruitment
Maternal IQ
TRIAL RESPONSES
EMG MAGNITUDE
Mercury (μg/L or μg/g)
Blood (μg/L)
Hair (μg/g)
Non-Target (All)
Non-Target (120 SOA)
Non-Target (240 SOA)
Target (240 SOA)
ITI
Target (All)
Target (120 SOA)
Target (240 SOA)
Non-Target (All)
Non-Target (240 SOA)
PRE-PULSE INHIBITION
Target (All)
Target (120 SOA)
Non-Target (120 SOA)
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Quantile Regression for Response Magnitude 
Quantile regression models were constructed that considered exposure in two different 
ways. First, exposure was considered as a continuous log-transformed variable to look for linear 
associations. Then, quartiles of exposure were considered to examine possible non-linearity. In 
all models using quartiles of exposure used the “Low” group as the reference group. 
Table 3.2 Upper ends of exposure quartiles 
 
Baseline Acoustic Startle Response 
 The baseline ASR response, i.e. that evoked during the ITI, showed non-linear 
associations with blood Hg at all quantiles of the response distribution (Figure 3.1). The pattern 
of association appeared U-shaped, with greater responses in the medium-low and medium-high 
exposure groups compared with the low group (some even reaching statistical significance), but 
not in the highest exposure group. This pattern was stronger for the higher quartiles of the 
distribution. A similar pattern was seen with hair Hg. 
For instance, the medium-low exposure group of blood Hg was associated with a 0.376 
unit increase (95% CI: 0.039, 0.713) in the 25
th
 percentile, a 0.214 unit increase (95% CI: -0.658, 
1.09) in the median, but a 0.640 unit increase (95% CI: -0.379, 1.66) in the 75
th
 percentile, as 
compared to the low exposure group. The medium-high exposure group of blood Hg was 
associated with a 0.510 unit increase (95% CI: -0.079, 1.10) in the 25
th
 percentile, a 0.685 unit 
increase (95% CI: -0.455, 1.83) in the median, but a 1.69 unit increase (95% CI: 0.198, 3.19) in 
the 75
th
 percentile, as compared the low exposure group. In the high exposure group of blood Hg 
Blood (μg/L) Hair (μg/g)
Low 0.815 0.240
Medium-Low 1.37 0.381
Medium-High 2.49 0.528
High 11.56 0.657
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was associated with a 0.260 unit increase (95% CI: -0.155, 0.675) in the 25
th
 percentile, a 0.107 
unit increase (95% CI: -0.866, 1.08) in the median, but a 0.124 unit increase (95% CI: -1.14, 
1.39) in the 75
th
 percentile, as compared to the low exposure group.  
A similar pattern was observed with hair Hg exposure. In the 25
th
 and 75
th
 percentile, the 
same U-shaped pattern where the largest magnitude of association was seen in the medium-low 
and medium-high exposure groups. Again, the largest magnitudes of association overall were 
observed in the upper-tail of the outcome distribution. There was a deviation from the pattern in 
the median of the distribution. There, the medium-low exposure group of hair Hg was associated 
with a 0.484 unit increase (95% CI: -0.130, 1.10) and the medium-high exposure group was 
associated with a 0.307 unit increase (95% CI: -0.440, 1.05) as compared to the low exposure 
group. However, in the high exposure group, a 0.563 unit increase (95% CI: -0.262, 1.39) as 
compared the low exposure group. 
Quantile Regression of Prepulse Inhibition 
TARGET 
 There were several linear associations between exposure and prepulse inhibition for some 
startle probe types (Figures 3.2A and 3.2B). In the 25
th
 percentile, there was a linear association 
between exposure and both broad responses and 240 ms tone responses. A 10% increase in blood 
Hg was associated with a 0.001 unit decrease (95% CI: -0.011, 0.009; p=0.063) in the 25
th
 
percentile of all target response magnitudes, while a 10% increase in hair Hg was associated with 
a 0.001 unit increase (95% CI: -0.011, 0.012) in the same (calculated as ∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒𝐵𝑙𝑜𝑜𝑑 =
−0.001 = −0.011 ∗ ln⁡(1.10) and ∆𝑂𝑢𝑡𝑐𝑜𝑚𝑒𝐻𝑎𝑖𝑟 = 0.001 = 0.006 ∗ ln⁡(1.10) based on the 
log-transformation used in the models). For 240 ms tone target responses, a 10% increase in 
blood Hg was associated with a 0.004 unit increase (95% CI: -0.011, 0.019; p=0.069) in the 25
th
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percentile of response magnitude, while a 10% increase in hair Hg was associated with a 0.002 
unit decrease (95% CI: -0.016, 0.012). There were also linear associations between exposure and 
the 75
th
 percentile of the broad responses. There, a 10% increase in blood Hg levels was 
associated with a 0.045 unit increase (95% CI: 0.006, 0.085; p=0.058) in the 75
th
 percentile, 
while a 10% increase in hair Hg levels was associated with a 0.062 unit increase (95% CI: 0.028, 
0.097; p=0.035) in the same. Additionally, a 10% increase in hair Hg levels was associated with 
a 0.029 unit increase (95% CI: -0.002, 0.059) in the median distribution of 120 ms tone. 
However, this was not observed for blood Hg exposure (Figures 3.2A-B). 
A U-shaped pattern of response was noted for the median of the distribution of all target 
responses and both biomarkers (Figure 3.2C). However, while both have the greatest magnitude 
of difference, as compared to the low reference group, in the medium-low or medium-high 
exposure groups, for hair Hg exposure these were increases compared to the reference, while for 
blood this was a decrease compared to the reference group. A 10% increase in blood Hg 
exposure was associated with a 0.003 unit increase (95% CI: -0.020, 0.025) in the median of all 
target responses when examined linearly. When examining the exposure as quartiles, the 
medium-low group was associated with a 0.120 unit decrease (95% CI: -0.360, 0.119) in the 
median as compared to the low exposure group, the medium-high group was associated with a 
0.064 unit decrease (95% CI: -0.433, 0.306), and the high exposure group was associated with a 
0.058 unit decrease (95% CI: -0.433, 0.306). A similar pattern was observed for the 25
th
 
percentile of the 120 ms tone distribution and blood Hg exposure. However, none of these 
associations was significant. 
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NON-TARGET 
 There were several linear associations between non-target PPI responses and blood Hg 
exposure, but not hair Hg exposure (Figures 3.3A and 3.3B). Generally, there was much less of a 
consistent pattern between exposure and PPI for non-target tones than for the target tones. Most 
notably, a 10% increase in blood Hg exposure was associated with a 0.010 (95% CI: 0.0003, 
0.020; p=0.045) unit increase in the 25
th
 percentile and a 0.008 (95% CI: -0.005, 0.021) unit 
increase in the median, but a 0.014 (95% CI: -0.046, 0.018) unit decrease in the 75
th
 percentile of 
the 120 ms tone non-target responses. Additionally, a 10% increase in blood Hg exposure was 
associated with a 0.003 unit increase (95% CI: -0.003, 0.009) in the 25
th
 percentile of the 
distribution of all non-target responses and a 0.005 unit decrease (95% CI: -0.015, 0.005) in the 
median of the 240 ms tone non-target response distribution.  
 A 10% increase in hair Hg was associated with a 0.006 unit increase (95% CI: -0.002, 
0.014) in the 25
th
 percentile of the broad response distribution. However, when examining 
exposure by quartile, a U-shaped pattern of responses was observed (Figure 3.3C). The medium-
low exposure group was associated with a 0.083 unit decrease (95% CI: -0.270, 0.104) in the 25
th
 
percentile of the broad non-target responses, as compared to the low exposure group, and the 
medium-high exposure group was associated with a 0.156 unit decrease (95% CI: -0.350, 0.038) 
as compared to the reference. The high exposure group was then associated with a 0.066 unit 
decrease (95% CI: -0.240, 0.108) in the 25
th
 percentile of the broad non-target responses as 
compared to the low exposure group. Thus, the higher exposure groups had decreasing PPI as 
compared to the low exposure group, but the magnitude difference of this peaked in the medium-
high group. A similar pattern was observed for the median of the 120 ms tone and the 75
th
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percentile of the 240 ms tone non-target response distribution. None of these were statistically 
significant. 
Discussion 
 Our objective for this work was to examine the relationships between MeHg exposure 
and acoustic startle reflex (ASR) and prepulse inhibition (PPI). We found that ITI responses 
corresponded non-linearly to increasing MeHg, where the greatest magnitude of difference was 
in the medium-low and medium-high exposure groups. All three of the higher quartiles of 
exposure were associated with higher response magnitudes than that of the reference group. This 
was strongest in the 75
th
 percentile of the distribution, suggesting that percentile of the 
distribution was most sensitive to any changes. These results suggest that in general, individuals 
with higher MeHg have a greater startle response. 
For target PPI responses, higher MeHg generally corresponded to less PPI in the upper 
tail of the distribution. However, it was notable that in the 25
th
 percentile, higher Hg generally 
corresponded to more negative values of PPI (more inhibition), while in the 75
th
 percentile, 
higher Hg generally corresponded to more positive values of PPI (less inhibition). Similarly, 
among non-target responses, there was little pattern to linear or non-linear relationships and only 
one linear association was statistically significant (120 ms tone responses vs blood Hg in the 25
th
 
percentile). However, a pattern opposite to that seen in the target responses was observed. There, 
for broad and 120 ms tone responses, in the 25
th
 percentile and median, higher Hg generally 
corresponds to more positive values of PPI (less inhibition), and in the 75
th
 percentile, higher Hg 
generally corresponded to more negative values of PPI (more inhibition). For 240 ms tone 
responses, higher Hg generally corresponded to more inhibition at all points in the distribution.  
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This study represents, to our knowledge, the first study of ASR and PPI in relation to 
MeHg exposure in human subjects. Existing studies of PPI in humans are generally meant to 
characterize deficits in the context of psychological disorders (Braff et al. 2001). There are 
studies of PPI in relation to smoking (Duncan et al. 2001a; Popke et al. 1997; Kumari et al. 2001; 
Della Casa et al. 1998), psychosocial stressors (Rahman et al. 2003), and drug use (Abel et al. 
2003; Duncan et al. 2001b), but there are few published studies examining relationships with 
pollutant exposures. 
 Existing studies of PPI and MeHg are primarily in animal models. An early study looking 
at this relationship, looked at the startle reflex via cutaneous stimuli. That study found that 
animals that had been sub-chronically dosed with MeHg led to less PPI and exaggerated reaction 
to startling stimuli (Wu et al. 1985). However, a later study by Vezer et al. found that both the 
ASR responses were lower in the rats that were dosed with MeHg. They also found that PPI was 
reduced in the dose groups, which was consistent with the previous study by Wu et al (Vezer et 
al. 2005).  
 Other animal studies of PPI look specifically at prenatal exposure or exposure with other 
neurotoxic metals. While Carratu et al. found no relationship between prenatal MeHg exposure 
and later ASR and PPI measurements (Carratu et al. 2006), Beyrouty et al. found that prenatally 
dosed rats had higher mean startle responsiveness than controls (Beyrouty et al. 2006). A study 
by Geyer et al. also reported impaired ASR performance (Geyer et al. 1985). Commissaris et al. 
examined chronic low-level lead exposure in rats and found no effect on ASR, but that lead 
dosed rats had some facilitation instead of inhibition in response to prepulses (Commissaris et al. 
2000). 
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PPI deficits are observed in in multiple neurological disorders (Braff et al. 2001). These 
deficits are best characterized in schizophrenia (Braff et al. 1999; Geyer et al. 2001), but have 
also been observed in obsessive compulsive disorder, Tourette’s syndrome, and bipolar disorder 
(Kohl et al. 2013). There may be deficits in other disorders, such as post-traumatic stress 
disorder, but these are still being characterized (Kohl et al. 2013). Many in this diverse group of 
disorders share deficits in gating processes and possible abnormalities in the cortico-striato-
pallido-pontine domain (Swerdlow et al. 2001). Deficits are also seen in individuals with risk 
factors for psychotic disorders (Ziermans et al. 2011) and in unaffected siblings of patients with 
bipolar disorder (Giakoumaki et al. 2007), suggesting PPI deficits may be observable for 
disorders in a sub-clinical state. 
There are several limitations that could have affected our results. First, although we 
controlled for age, our cohort did cover a wide age range. Differences in processing at different 
ages and stages of neurodevelopment have been documented (Kofler et al. 2013). Second, PPI 
deficits in ADHD tends to be most prominent during tasks which require selective attention, 
rather than passive attention (Hawk et al. 2003). Further study of their omission and commission 
errors during the startle testing could help to address this limitation. Additionally, our procedure 
for outliers made sure that data was representative of the majority for the available data and was 
not unduly influenced by outliers, but this may have led to the exclusion of real, but extreme, 
values. 
 Our study suggests that acoustic startle responses in children are non-linearly associated 
with MeHg exposure. Additionally, there was a linear, but not necessarily significant, association 
with increased inhibition with MeHg in the 25
th
 percentile and median of the PPI distribution in 
trials with an attended tone, but a linear association with decreased inhibition in the 75
th
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percentile. These findings add to our understanding of ASR and PPI, particularly in the context 
of environmental exposures rather than clinical symptoms of psychological disorders. Additional 
studies repeating this methodology can help to confirm these relationships, as would expanding 
the study to biomarkers of other forms of Hg or additional time points. 
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Figures 
 
Figure 3.1 Results from Quantile Regression by Quartile of Exposure for Response Magnitude ITIs; point and 95% confidence 
intervals represent the association between the quartile of exposure for each biomarker (blood or hair) and the τ = 25th, 50th, or 75th 
percentile of the distribution of ITI response magnitude as compared to the reference group. Displayed values are the coefficients and 
the 95% confidence intervals.  
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Figure 3.2A Results from Quantile Regressions for Prepulse Inhibition and Blood Exposure in Target Trials; point and 95% 
confidence intervals represent the association between blood exposure (μg/L) and the τ = 25th, 50th, or 75th percentile of the 
distribution of the target response magnitudes. 
 
Figure 3.2B Results from Quantile Regressions for Prepulse Inhibition and Hair Exposure in Target Trials; point and 95% confidence 
intervals represent the association between hair exposure (μg/g) and the τ = 25th, 50th, or 75th percentile of the distribution of the target 
response magnitudes. 
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Figure 3.2C Results from Quantile Regression by Quartile of Exposure for Prepulse Inhibition in Target trials; point and 95% 
confidence intervals represent the association between the quartile of exposure for the biomarker (blood) and the τ = 25th, 50th, or 75th 
percentile of the distribution of target response magnitude. 
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Figure 3.2D Results from Quantile Regression by Quartile of Exposure for Prepulse Inhibition in Target trials; point and 95% 
confidence intervals represent the association between the quartile of exposure for the biomarker (hair) and the τ = 25th, 50th, or 75th 
percentile of the distribution of target response magnitude.  
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Figure 3.3A Results from Quantile Regressions for Prepulse Inhibition and Blood Exposure in Non-Target Trials; point and 95% 
confidence intervals represent the association between blood exposure (μg/L) and the τ = 25th, 50th, or 75th percentile of the 
distribution of the non-target response magnitudes. 
 
Figure 3.3B Results from Quantile Regressions for Prepulse Inhibition and Hair Exposure in Non-Target Trials; point and 95% 
confidence intervals represent the association between hair expsoure (μg/g) and the τ = 25th, 50th, or 75th percentile of the distribution 
of the non-target response magnitudes.  
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Figure 3.3C Results from Quantile Regression by Quartile of Exposure for Prepulse Inhibition in Non-target trials; point and 95% 
confidence intervals represent the association between the quartile of exposure for the biomarker (blood) and the τ = 25th, 50th, or 75th 
percentile of the distribution of non-target response magnitude. 
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Figure 3.3DResults from Quantile Regression by Quartile of Exposure for Prepulse Inhibition in Non-target trials; point and 95% 
confidence intervals represent the association between the quartile of exposure for the biomarker (hair) and the τ = 25th, 50th, or 75th 
percentile of the distribution of non-target response magnitude. 
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Appendix 3 
Supplemental Tables 
Table S3.1.1 Sample Sizes Used in Modeling of ASR and PPI 
 
 
Table S3.2.1 Models for Response Magnitude of Intertrial Intervals 
 
 
 
  
Blood Hair
179 177
Target 159 156
Non-Target 145 145
Target 114 109
Non-Target 114 113
Target 132 129
Non-Target 124 124
240 SOA
ITI
Response Magnitudes
Prepulse Inhibition
All 
Responses
120 SOA
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept 1.822 -1.482 -4.270 2.719 0.016 0.488 -6.850
log (Exposure) 0.104 0.099 0.269 0.095 0.215 0.276
Sex of Child: Female 0.240 0.568 0.081 1.002 0.094 0.709 0.003 0.916 0.066
Age of Child at Visit -0.086 0.251 0.677 -0.148 0.193 0.933 0.087
Cohort: 1 0.261 -1.433 -4.068 0.083 0.502 -1.374 -5.273 0.034
Cohort: 2a 0.229 0.556 -0.305 0.292 0.227 -0.269
Cohort: 3 -0.358 1.151 0.814 -0.646 0.028 0.277 1.384
SES Level 0.018 0.044 0.178 -0.011 0.052 0.174 0.020
Maternal Age 0.024 0.035 -0.048 0.009 0.011 -0.079
Maternal Education 0.013 -0.039 -0.102 0.027 -0.064 0.061 -0.148 0.088
Maternal IQ 0.000 0.011 0.024 0.002 0.011 0.037 0.024
Maternal Marital 
Status: Married
-0.719 0.002 -1.527 0.002 -1.895 0.005 -0.481 0.003 -1.524 0.001 -1.558 0.005
Presentation Order: 
B 1st
-0.065 -0.031 1.394 0.073 -0.027 -0.364 1.201 0.074
Presentation Order: 
C 1st
-0.224 -0.226 0.486 -0.168 -0.409 0.507
Intertrial Interval (ITI)
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.3.1 Models for PPI of All Target Responses 
 
 
 
 
Table S3.3.2 Models for PPI of All Non-Target Responses 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.678 0.363 0.132 -1.705 0.002 -2.005 0.065 -1.139
log (Exposure) -0.058 0.063 0.037 0.164 0.058 -0.037 0.014 0.264 0.035
Sex of Child: Female -0.067 0.005 0.121 -0.072 0.079 0.038
Age of Child at Visit 0.059 -0.003 0.047 0.108 0.007 0.172 0.045 0.165
Cohort: 1 -0.312 -0.161 -0.384 -0.504 0.012 -0.870 0.036 -0.828
Cohort: 2a -0.076 -0.008 -0.096 -0.093 -0.068 -0.157
Cohort: 3 0.241 0.013 0.004 0.795 0.427 0.001 0.661 0.090 1.032 0.096
SES Level -0.004 0.011 0.022 -0.007 0.006 0.017
Maternal Age -0.008 -0.010 -0.011 -0.005 -0.006 -0.003
Maternal Education 0.018 0.093 0.015 -0.004 0.004 0.024 -0.036
Maternal IQ -0.006 0.002 -0.007 0.030 -0.006 0.000 -0.005 -0.001
Maternal Marital 
Status: Married
0.034 0.071 -0.079 0.015 -0.045 0.024
Presentation Order: 
B 1st
0.045 0.216 0.085 0.256 0.050 0.174 0.182
Presentation Order: 
C 1st
0.133 0.061 0.234 0.046 0.529 0.026 0.168 0.045 0.297 0.039 0.630 0.027
All Target
τ=0.25 τ=0.50 τ=0.75 τ=0.25
Model
τ=0.50 τ=0.75
HairBlood
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept 0.429 0.465 1.222 -0.248 -0.384 0.222
log (Exposure) 0.032 0.027 -0.032 0.061 0.000 -0.019
Sex of Child: Female 0.021 0.040 0.229 0.012 0.110 0.071
Age of Child at Visit -0.069 -0.087 -0.104 -0.007 -0.018 -0.023
Cohort: 1 0.190 0.358 0.356 -0.150 0.010 -0.032
Cohort: 2a -0.049 0.039 0.031 -0.140 -0.083 0.116
Cohort: 3 0.072 0.119 -0.142 0.164 0.396 0.470
SES Level 0.028 0.014 0.025 -0.001 0.026 0.033 0.018 0.013
Maternal Age -0.009 0.063 -0.003 0.007 -0.006 -0.001 0.000
Maternal Education -0.006 0.013 -0.025 -0.001 0.029 -0.035
Maternal IQ -0.002 -0.004 -0.003 -0.002 -0.003 0.002
Maternal Marital 
Status: Married
0.083 0.073 0.149 0.322 0.046 0.037 0.064 0.324 0.040
Presentation Order: 
B 1st
0.078 0.126 0.004 0.033 0.022 -0.270
Presentation Order: 
C 1st
0.111 0.453 0.001 0.408 0.123 0.312 0.065 0.284
All Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.3.3 Models for PPI of 120 ms Tone Target Responses 
 
 
 
Table S3.3.4 Models for PPI of 120 ms Tone Non-Target Responses 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.997 -1.605 -2.167 -1.119 0.059 -2.913 0.025 -4.253 0.062
log (Exposure) 0.020 -0.002 0.005 -0.013 0.081 -0.054
Sex of Child: Female -0.044 -0.092 0.014 -0.056 0.002 0.059
Age of Child at Visit 0.086 0.056 0.165 0.073 0.259 0.069 0.275 0.004 0.411 0.017
Cohort: 1 -0.460 0.035 -0.710 -1.479 0.057 -0.349 -1.287 0.008 -2.113 0.008
Cohort: 2a -0.071 0.052 -0.030 0.001 -0.104 -0.089
Cohort: 3 0.067 0.272 0.239 0.232 0.056 0.649 0.073 1.168 0.006
SES Level -0.018 -0.010 -0.019 -0.006 -0.004 0.024
Maternal Age -0.011 0.046 -0.016 -0.019 -0.003 -0.021 0.053 -0.024
Maternal Education -0.007 -0.014 0.071 0.093 0.008 0.002 0.063 0.094
Maternal IQ -0.001 -0.002 -0.011 -0.003 0.001 -0.008
Maternal Marital 
Status: Married
-0.031 0.119 0.060 0.063 -0.017 -0.046
Presentation Order: 
B 1st
-0.086 -0.037 -0.098 -0.107 -0.209 0.060 -0.180
Presentation Order: 
C 1st
0.159 0.053 0.230 0.742 0.018 0.049 0.044 0.755 0.002
120 SOA Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.810 0.215 1.606 -0.869 0.290 0.531
log (Exposure) 0.108 0.045 0.081 -0.144 0.020 0.075 -0.057
Sex of Child: Female -0.110 0.076 -0.045 0.015 0.032 -0.099 -0.091
Age of Child at Visit 0.031 -0.034 -0.075 0.041 -0.025 -0.024
Cohort: 1 -0.265 0.133 0.126 -0.282 0.098 -0.071
Cohort: 2a -0.168 0.022 -0.026 -0.237 -0.117 -0.024 -0.102
Cohort: 3 0.519 0.044 0.254 -0.192 0.336 0.055 0.288 0.512
SES Level 0.007 0.009 -0.021 0.010 0.002 -0.020
Maternal Age -0.015 0.023 -0.014 0.058 -0.019 -0.006 -0.010 -0.013
Maternal Education 0.003 -0.011 -0.008 -0.007 -0.010 0.001
Maternal IQ 0.001 -0.001 0.000 -0.001 -0.002 0.002
Maternal Marital 
Status: Married
0.137 0.031 0.251 0.013 0.169 0.032 0.276 0.003 0.326
Presentation Order: 
B 1st
-0.007 -0.013 -0.190 -0.056 -0.088 -0.441
Presentation Order: 
C 1st
0.173 0.056 0.302 0.062 0.415 0.103 0.206 0.245
120 SOA Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.3.5 Models for PPI of 240 ms Tone Target Responses 
 
 
 
Table S3.3.6 Models for PPI of 240 ms Tone Non-Target Responses 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.991 0.053 -0.034 1.084 -2.410 0.000 -2.722 0.065 0.334
log (Exposure) -0.068 0.069 -0.094 0.005 -0.066 -0.157 0.076
Sex of Child: Female 0.018 0.073 0.156 -0.058 0.104 0.316 0.041
Age of Child at Visit 0.062 -0.039 -0.050 0.136 0.003 0.146 -0.018
Cohort: 1 -0.263 -0.095 0.207 -0.648 0.005 -0.826 0.045
Cohort: 2a -0.043 0.001 -0.008 -0.059 -0.070 -0.044
Cohort: 3 0.333 0.029 0.051 0.494 0.496 0.012 0.804 0.056 0.817 0.100
SES Level 0.019 0.076 0.025 0.034 0.015 0.039 0.037
Maternal Age -0.001 -0.003 -0.015 0.005 0.005 0.005
Maternal Education 0.007 0.017 0.019 0.019 0.024 -0.001
Maternal IQ -0.005 0.008 -0.001 -0.006 0.027 -0.002 -0.001 -0.005
Maternal Marital 
Status: Married
0.019 0.128 -0.020 0.041 -0.029 0.002
Presentation Order: 
B 1st
0.086 0.061 0.259 0.069 -0.011 0.100 0.134
Presentation Order: 
C 1st
0.041 0.194 0.368 0.088 0.143 0.426
240 SOA Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.716 -0.670 0.699 -1.120 0.029 -0.775 0.500
log (Exposure) -0.024 -0.049 -0.003 -0.004 -0.013 0.015
Sex of Child: Female 0.076 0.105 0.188 0.089 0.077 0.107 0.170
Age of Child at Visit -0.044 -0.055 -0.101 -0.007 -0.025 -0.029
Cohort: 1 0.150 0.272 0.671 -0.106 0.028 0.241
Cohort: 2a -0.036 0.012 0.306 -0.139 -0.084 0.373
Cohort: 3 0.054 0.182 -0.080 0.050 0.365 0.284
SES Level 0.035 0.028 0.037 0.034 0.007 0.012 0.026 0.010
Maternal Age 0.007 0.011 0.032 0.014 0.004 0.010 0.022
Maternal Education 0.022 0.077 0.050 0.011 -0.034 0.036 0.000 0.048 0.016 -0.018
Maternal IQ -0.001 -0.004 -0.003 -0.002 -0.004 -0.008
Maternal Marital 
Status: Married
0.030 0.063 0.287 0.010 -0.035 0.240
Presentation Order: 
B 1st
0.096 0.144 -0.180 -0.006 0.063 -0.113
Presentation Order: 
C 1st
0.097 0.179 0.167 -0.032 0.214 0.178
Model
240 SOA Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
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Table S3.4.1 Models for Response Magnitude of Intertrial Intervals with Quartiles of Exposure 
 
 
 
Table S3.5.1 Models for PPI of All Target Responses with Quartiles of Exposure 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept 2.019 -1.724 -3.762 3.200 0.012 0.511 -2.791
Exposure Med-Low 0.376 0.030 0.214 0.640 0.476 0.013 0.484 1.079
Exposure Med-High 0.510 0.092 0.685 1.692 0.028 0.371 0.007 0.307 1.128
Exposure High 0.260 0.107 0.124 0.314 0.052 0.563 0.707
Sex of Child: Female 0.133 0.621 0.081 0.686 0.093 0.624 0.061 0.899
Age of Child at Visit -0.090 0.247 0.634 -0.180 0.084 0.137 0.574
Cohort: 1 0.051 -1.405 -4.370 0.034 0.605 -1.252 -3.684
Cohort: 2a 0.165 0.738 -0.354 0.407 0.072 0.233 0.291
Cohort: 3 -0.486 1.278 1.031 -0.739 0.016 0.149 0.617
SES Level 0.020 0.055 0.132 -0.005 0.023 0.186
Maternal Age 0.017 0.024 0.010 0.000 0.019 -0.076
Maternal Education -0.015 -0.043 -0.079 -0.018 -0.034 -0.086
Maternal IQ 0.004 0.014 0.010 0.007 0.008 0.017
Maternal Marital 
Status: Married
-0.748 0.001 -1.471 0.005 -1.922 <0.001 -0.460 0.001 -1.552 0.003 -1.433 0.009
Presentation Order: 
B 1st
-0.197 -0.160 1.023 -0.280 0.088 -0.207 1.066
Presentation Order: 
C 1st
-0.426 -0.437 -0.043 -0.355 0.044 -0.265 0.051
Intertrial Interval (ITI)
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -1.009 0.049 -0.330 0.292 -1.661 0.003 -1.500 -1.363
Exposure Med-Low -0.087 -0.120 -0.233 0.017 0.102 0.177
Exposure Med-High -0.116 -0.064 0.102 -0.059 0.062 0.297
Exposure High -0.123 0.053 -0.058 0.171 -0.067 0.031 0.327
Sex of Child: Female -0.054 0.017 0.101 -0.092 0.065 0.098
Age of Child at Visit 0.074 0.064 0.049 0.044 0.114 0.002 0.148 0.132
Cohort: 1 -0.328 0.099 -0.403 -0.451 -0.511 0.007 -0.781 0.077 -0.802
Cohort: 2a -0.018 -0.038 -0.090 -0.078 -0.080 -0.213
Cohort: 3 0.349 0.003 0.053 0.547 0.407 0.005 0.347 0.963
SES Level -0.001 0.004 -0.044 -0.006 0.001 0.043
Maternal Age -0.006 -0.008 -0.008 -0.004 -0.008 -0.002
Maternal Education 0.016 0.007 0.014 0.006 0.021 -0.040
Maternal IQ -0.004 0.035 -0.004 -0.004 -0.001 -0.006 0.090 0.000
Maternal Marital 
Status: Married
0.026 0.070 -0.016 0.043 -0.024 0.038
Presentation Order: 
B 1st
0.025 0.200 0.211 0.051 0.168 0.127
Presentation Order: 
C 1st
0.136 0.074 0.285 0.025 0.482 0.082 0.137 0.332 0.019 0.521 0.051
All Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.5.2 Models for PPI of All Non-Target Responses with Quartiles of Exposure 
 
 
 
Table S3.5.3 Models for PPI of 120 ms Tone Target Responses with Quartiles of Exposure 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept 0.588 0.165 0.295 -0.755 -1.016 -0.081
Exposure Med-Low -0.055 -0.033 -0.076 -0.083 -0.123 0.177
Exposure Med-High 0.044 -0.028 -0.206 -0.156 -0.209 -0.253
Exposure High 0.120 0.088 0.014 -0.056 -0.066 -0.086 0.029
Sex of Child: Female -0.027 0.123 0.211 0.054 0.082 0.053
Age of Child at Visit -0.087 0.072 -0.064 -0.033 0.011 0.019 -0.005
Cohort: 1 0.270 0.253 0.077 -0.225 -0.002 0.010
Cohort: 2a -0.012 -0.018 -0.052 -0.129 0.094 -0.048 -0.068
Cohort: 3 0.095 0.186 0.225 0.163 0.628 0.030 0.532
SES Level 0.022 0.052 0.032 0.089 -0.002 0.026 0.015 0.018 0.041
Maternal Age -0.010 0.028 -0.001 0.006 -0.005 0.001 0.001
Maternal Education -0.006 0.013 -0.037 0.010 0.031 -0.029
Maternal IQ -0.001 -0.004 0.001 0.000 -0.002 -0.001
Maternal Marital 
Status: Married
0.091 0.073 0.129 0.288 0.069 0.085 0.067 0.112 0.298
Presentation Order: 
B 1st
0.069 0.093 -0.051 0.024 0.010 -0.064
Presentation Order: 
C 1st
0.102 0.472 0.002 0.468 0.074 0.047 0.345 0.040 0.417
All Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.628 -0.955 -1.689 -1.647 0.042 -2.977 0.020 -4.652 0.072
Exposure Med-Low -0.061 -0.009 -0.226 0.076 0.155 -0.049
Exposure Med-High -0.050 0.074 0.081 -0.219 0.061 0.105 -0.062
Exposure High 0.024 -0.110 -0.339 0.021 0.189 -0.198
Sex of Child: Female -0.044 -0.153 -0.050 -0.049 -0.039 0.054
Age of Child at Visit 0.052 0.111 0.197 0.123 0.049 0.272 0.008 0.455 0.034
Cohort: 1 -0.287 -0.415 -1.133 -0.557 0.054 -1.302 0.011 -2.319 0.014
Cohort: 2a -0.084 0.093 0.189 -0.054 -0.087 -0.055
Cohort: 3 0.062 0.129 -0.051 0.378 0.052 0.724 0.031 1.247 0.050
SES Level -0.013 0.002 -0.008 -0.024 -0.010 0.023
Maternal Age -0.011 0.042 -0.016 -0.011 -0.009 -0.020 0.080 -0.021
Maternal Education -0.007 0.002 0.036 0.001 0.000 0.062
Maternal IQ -0.001 -0.005 -0.005 0.001 0.001 -0.009
Maternal Marital 
Status: Married
-0.022 0.124 0.056 0.018 0.007 -0.054
Presentation Order: 
B 1st
-0.035 0.006 -0.291 -0.169 0.081 -0.178 -0.206
Presentation Order: 
C 1st
0.163 0.040 0.308 0.094 0.475 0.068 0.117 0.713 0.031
120 SOA Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.5.4 Models for PPI of 120 ms Tone Non-Target Responses with Quartiles of Exposure 
 
 
 
 
Table S3.5.5 Models for PPI of 240 ms Tone Target Responses with Quartiles of Exposure 
 
 
 
  
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.721 0.409 1.831 -1.076 0.232 0.600
Exposure Med-Low -0.033 0.035 -0.162 -0.062 -0.141 0.402
Exposure Med-High 0.090 0.086 -0.313 -0.004 -0.068 -0.284
Exposure High 0.152 0.088 0.180 -0.341 -0.010 0.053 -0.236
Sex of Child: Female -0.031 -0.083 0.027 0.018 -0.119 -0.057
Age of Child at Visit 0.002 -0.049 -0.085 0.047 -0.036 -0.028
Cohort: 1 -0.131 0.182 0.298 -0.310 0.161 -0.072
Cohort: 2a -0.161 0.044 -0.007 -0.138 -0.162 0.052 0.002 -0.194
Cohort: 3 0.365 0.210 -0.212 0.352 0.070 0.220 0.586
SES Level 0.011 0.004 -0.024 0.022 -0.005 -0.006
Maternal Age -0.006 -0.014 0.025 -0.018 -0.004 -0.008 -0.004
Maternal Education -0.007 -0.010 -0.015 -0.008 -0.010 -0.002
Maternal IQ 0.002 -0.001 0.002 -0.001 0.000 0.001
Maternal Marital 
Status: Married
0.084 0.253 0.004 0.074 0.008 0.276 0.002 0.168
Presentation Order: 
B 1st
0.007 0.009 -0.163 -0.009 -0.097 -0.295
Presentation Order: 
C 1st
0.119 0.295 0.049 0.452 0.165 0.235 0.088 0.080
120 SOA Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -1.081 0.007 -1.565 0.648 -1.803 0.002 -1.902 -0.383
Exposure Med-Low -0.130 -0.274 0.051 -0.406 0.035 -0.243 0.022 0.010 0.053
Exposure Med-High -0.139 0.099 -0.223 -0.136 -0.187 0.057 -0.163 -0.030
Exposure High -0.221 0.009 -0.263 -0.008 -0.254 0.001 -0.332 0.061 0.053
Sex of Child: Female 0.027 0.045 0.154 0.068 0.087 0.214
Age of Child at Visit 0.076 0.008 0.085 0.022 0.101 0.014 0.132 0.034
Cohort: 1 -0.335 0.021 -0.639 -0.227 -0.488 0.022 -0.790 -0.140
Cohort: 2a -0.033 -0.060 -0.191 0.016 -0.130 -0.090
Cohort: 3 0.390 0.019 0.340 0.444 0.558 0.002 0.831 0.036 0.951 0.062
SES Level 0.020 0.031 0.037 0.014 0.028 0.009 0.034 0.025
Maternal Age 0.001 -0.004 -0.029 0.004 0.007 0.004 -0.005
Maternal Education 0.012 0.003 0.013 0.009 0.016 0.014
Maternal IQ -0.006 0.000 0.004 -0.002 -0.003 -0.002 -0.004
Maternal Marital 
Status: Married
0.023 0.092 -0.101 0.056 -0.033 0.058
Presentation Order: 
B 1st
0.052 -0.012 0.323 0.006 -0.069 0.063 0.180
Presentation Order: 
C 1st
0.047 0.131 0.358 -0.034 0.033 0.476 0.055
240 SOA Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
Model
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Table S3.5.6 Models for PPI of 240 ms Tone Non-Target Responses with Quartiles of Exposure 
 
 
 
Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value Beta P-value
Intercept -0.463 -0.259 0.189 -0.474 -0.515 0.223
Exposure Med-Low -0.098 -0.021 0.144 -0.128 -0.036 -0.202
Exposure Med-High -0.024 -0.028 0.009 -0.179 0.093 -0.076 -0.291
Exposure High -0.008 -0.062 -0.010 -0.086 -0.009 0.022
Sex of Child: Female 0.016 0.080 0.070 0.071 0.080 0.169
Age of Child at Visit -0.058 -0.085 -0.077 -0.050 -0.024 -0.026
Cohort: 1 0.198 0.360 0.603 0.128 0.052 0.221
Cohort: 2a 0.017 0.025 0.295 0.068 -0.039 -0.018 0.393
Cohort: 3 -0.001 0.115 -0.031 -0.004 0.354 0.061 0.469
SES Level 0.018 0.041 0.020 0.008 0.019 0.050 0.021 -0.002
Maternal Age 0.011 0.042 0.010 0.036 0.034 0.011 0.071 0.008 0.027
Maternal Education 0.022 0.086 0.047 0.010 -0.027 0.029 0.048 0.048 0.032 -0.021
Maternal IQ -0.002 -0.004 -0.002 -0.002 -0.006 -0.005
Maternal Marital 
Status: Married
0.083 0.077 0.281 0.072 -0.012 0.138
Presentation Order: 
B 1st
0.054 0.141 0.057 -0.183 -0.005 0.022 -0.106
Presentation Order: 
C 1st
-3.0E-05 0.170 0.153 -0.048 0.156 0.073
Model
240 SOA Non-Target
Blood Hair
τ=0.25 τ=0.50 τ=0.75 τ=0.25 τ=0.50 τ=0.75
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Conclusion 
Objectives and significance 
 Our long term goal for this research was to better understand the relationship between 
mercury and attention deficits, via the central hypothesis that MeHg might contribute to ADHD 
through the disruption of dopaminergic pathways. 
 This work aimed to answer several questions that were unanswered by the existing 
literature. Within the first aim, looking at prenatal and postnatal Hg exposure and ADHD 
screening scores, our objective was to add to the understanding of which windows of exposure 
might be of most concern for ADHD. In particular, prenatal versus postnatal exposure and 
several time points during gestation, were the focus. Additionally, we sought to examine how 
MeHg and Pb, another common neurotoxic metal, could potentially interact. Previous work in 
this area has found inconsistent results for postnatal Hg exposure (MeHg or IHg) (Bellinger et al. 
2007; Debes et al. 2006; DeRouen et al. 2006). Studies of prenatal exposure primarily used 
biomarkers of exposure related to late pregnancy, such as cord blood (Grandjean et al. 1999; 
Oken et al. 2005; Sagiv et al. 2012; van Wijngaarden et al. 2013). Here, we also include 
measures from earlier in pregnancy, potentially exposing vulnerabilities earlier in gestation. 
Further, examining possible interactions between more than one neurotoxic metal reflects real 
world exposures, where an individual is unlikely to be exposed to only one potentially harmful 
substance. 
 Second, we examined gene-environment interactions between dopamine (DA) related 
SNPs and MeHg. All of the SNPs we examined have been previously related to ADHD or 
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correspond to a gene which has been related to ADHD (Gatt et al. 2015; Li et al. 2014). Changes 
to DA synthesis, signaling, and processing have been implicated in ADHD etiology (Swanson et 
al. 2007; Thapar et al. 2013). This is interesting in relation to MeHg, as a number of animal 
studies have found MeHg induced changes to DA signaling, most notably changes to the release 
of DA into the synapse (Asherson and Gurling 2011; Faro et al. 2000; Faro et al. 1997; Tiernan 
et al. 2013). A relationship between MeHg and these SNPs could support the idea that MeHg 
could impact ADHD symptoms. 
 Finally, we examined the potential relationships between concurrent MeHg exposure and 
acoustic startle reflex (ASR) and prepulse inhibition (PPI). There are limitations to studying 
ADHD in epidemiology (Faraone et al. 2014). Specifically, screening instrument scores are 
generally used rather than clinically diagnosed disorders. While this allows for study of sub-
clinical symptoms, it also assumes that all factors are relevant across the continuum. Further, 
depending on the screening instrument, there is a possibility for reporter based differences 
between studies (e.g. teacher versus parent responses) (Lavigne et al. 2012). PPI potentially 
allows for a way to look at attention related processes from a physiological standpoint 
(Swerdlow et al. 2003). Further, the relationship between PPI and DA signaling makes it a 
compelling choice for studies related to MeHg.  
Major results 
Aim 1: Explore the relationship between Hg exposure in multiple windows of exposure and 
screening instrument scores 
 In general we found no significant relationships were found between CPT-II and CRS-R 
scores and prenatal (Trimesters 1, 2, 3 and delivery) and postnatal (ages 6-12 years) mercury 
exposures. While we did find that concurrent exposure to Hg, as measured in blood, hair, and 
urine, generally corresponded to higher CRS-R and CPT-II scores, this relationship was not 
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significant, except for one marginally significant association between urinary Hg and omission 
errors (p=0.076). Similarly, prenatal Hg exposure typically corresponded to higher CRS-R and 
CPT-II scores, although these relationships were again not statistically significant.  
 We found no statistically significant interactions between concurrent MeHg and Pb 
exposure. Existing studies generally find that Pb is associated with ADHD, but MeHg is not (Ha 
et al. 2009; Kim et al. 2013; Nicolescu et al. 2010). Previous studies in our group found non-
linear associations with Pb exposure and attention (Huang et al. 2015), so additional analyses 
with an altered methodology may further clarify this relationship. Prenatal exposure to both 
metals presented a somewhat more complicated picture. Exposures to both metals in the first 
trimester showed a synergistic interaction that was significant or marginally significant in many 
cases. However, in the second trimester, interactions were observed in the opposite direction. No 
statistically significant interactions were observed between concurrent Pb and prenatal MeHg 
exposure. 
 While our results were still unclear in many places, there does seem to be evidence that 
prenatal exposures are more likely to be relevant to ADHD etiology. Further, we observed the 
most compelling results when examining interactions between first trimester Pb and MeHg. 
Aim 2: Examine potential disruptions in dopaminergic pathways as a mechanism for MeHg 
effects on attention processes, via study of genetic polymorphisms 
 In our study cohort, we found associations between increased CRS-R ADHD index and 
DSM-IV total symptom scores and the genotypes of rs1800497 (Taq1A DRD2) and rs27072 
(DAT1/SL6A3) containing “T” alleles. These crude associations then remained statistically 
significant after adjustment for demographic covariates. One other association was seen between 
the AG genotype of rs40184 (DAT1/SL6A3) and lower CRS-R scores, but this was only 
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marginally statistically significant for ADHD index and was not significant after demographic 
covariate adjustment.  
Only two interactions between SNPs and MeHg were statistically significant and both 
involved hair Hg exposure, but not blood Hg exposure. For rs1800955 (DRD4), increasing Hg 
was associated with increasing ADHD symptoms for the TT genotype, but a decrease in those 
scores for all other genotypes. A similar differential association was observed for rs4680 
(COMT), where increasing hair Hg exposure was associated with decreasing ADHD index 
scores for the GG genotype, but increasing scores about the GA and AA genotypes. This was 
only statistically significant for the GA genotype, however.  
While further work, especially with a larger sample size or other SNPs related to these 
genes and pathway, will continue to clarify these potential relationships, these results suggest 
that an interaction between MeHg exposure and dopamine related SNPs might exist. 
Aim 3: Explore the relationship between concurrent MeHg exposure and ASR and PPI 
 We found that ASR responses without a prepulse (intertrial intervals, ITIs) were non-
linearly associated with MeHg exposure. The greatest magnitude of association was seen in the 
middle two quartiles of exposure, and all three of the upper quartiles of exposure corresponded to 
higher magnitudes of response. That is, individuals with higher MeHg levels than the reference 
group tended to startle more in response to a stimulus. Similarly, among both target and non-
target ASR responses, higher MeHg generally corresponded to higher response magnitudes. 
These results all suggest that individuals with higher MeHg are generally having greater startle 
responses to a startling stimulus.  
 There was no clear relationship between MeHg and PPI. Although for target responses, in 
the lower tail of the distribution, higher MeHg corresponded to more inhibition, while in the 
upper tail, higher MeHg corresponded to less inhibition. An opposite pattern was seen in the 
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non-target responses. However, none of these were statistically significant. Because relationships 
were observed between MeHg and ASR, it is possible that that relationship is making any 
association between PPI and MeHg harder to detect. 
 Although our results are not conclusive, they represent one of the first studies of MeHg 
and ASR and PPI in human participants, rather than in animal models. Additional work with a 
larger sample size could potentially make any relationships more clear. Further, similarly to our 
work with CRS-R and CPT-II, ASR and PPI is an outcome which could be used to study 
interactions between MeHg and Pb. Animal studies have also focused on prenatal exposure, so 
further study of this outcome with exposures from pregnancy could be informative. 
Public Policy Concerns and Potential Interventions 
There are three core functions of public health: assessment, policy development, and 
assurance (Schneider 2014). Assessment includes monitoring the health status and identifying 
health problems in a given population. This would also incorporate investigating these problems, 
their risk factors, and other observed health hazards. Policy development includes the creation of 
laws meant to educate the public on health issues and initiate community-based efforts to solve 
health problems. Assurance consists of enforcement of existing regulations, efforts to connect 
individuals to clinical care and health services, and evaluation of population-based health service 
effectiveness (Schneider 2014).  
These assertions provide a framework for how researchers might consider public health 
policies relevant to ADHD. The previous sections of this paper covered the assessment function 
of public health and the ongoing research into potential environmental risk factors. The 
following details several areas where research may assist in the development of health and 
environmental policy, using MeHg as the focus. While many of the results in this work were 
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inconclusive, they represent an attempt to better understand the health effects of MeHg. Refining 
that knowledge will eventually impact policymaking decisions by furthering the knowledge base 
available to policymakers. Moreover, exposures to toxic substances like MeHg can be limited or 
removed with effective policies and education, which could help to reduce the burden of and 
excess cost due to health effects of this pollutant. 
Health Behavior and Education  
 Two of the major cohort studies examining the cognitive and behavioral effects of MeHg 
consistently find contrasting results. The studies in the Faroe Islands find deficits, while those in 
the Seychelles do not. A major difference in these two cohorts, which may partially explain these 
differing results, is source of exposure. In the Faroe Islands, exposure is primarily via 
consumption of pilot whales, while in the Seychelles exposure is via consumption of ocean fish 
(Davidson et al. 2010; Grandjean et al. 2012; Grandjean et al. 1997; Myers et al. 2003). Fish 
contain a number of compounds, such as ω-3 fatty acids (Mahaffey 2004; Ponce et al. 2000) that 
may have beneficial effects during neurodevelopment (Karr et al. 2011). Additionally, fish 
consumption is nutritionally beneficial for other conditions (Ginsberg and Toal 2009). Our study 
does not neatly align with the exposures seen in the Faroe Islands or the Seychelles. In our 
population, exposure is most frequently through consumption of canned tuna and it is not as 
large a staple of the diet as in either of those populations (Basu et al. 2014). Thus, the question is 
how to best balance the potential protective benefits of fish, as possibly seen in the Seychelles, 
with the deficits observed in the Faroe Islands. 
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 In 2004, the FDA and EPA released a joint statement attempting to communicate 
guidelines for fish consumption to women of child bearing age (U.S. EPA and U.S. CDC 2004). 
These include: 
1. Not eating species of fish known to have very high levels of MeHg. These include shark 
and swordfish. 
2. Eating up to 12 oz. of low MeHg fish up to twice per week. Information is also provided 
about what constitutes a low MeHg species of fish. 
3. Seeking information about local fish advisories which may affect the above guidelines. 
This is a good start to help limit pre-natal exposure, while maximizing the nutritional benefits of 
fish consumption. However, there are still flaws. A recent study by Oken et al. found that 
participants had concerns over the ecological and economic impacts of their consumption habits. 
There is also a need for the guidelines to be clear and comprehensive, while not overwhelming 
the audience with technical information (Oken et al. 2012). 
Environmental Policy 
 As mentioned in previous sections, a major source of Hg in the environment is coal-fired 
utilities (Clarkson and Magos 2006) , though never research suggests that this may now be 
derived from artisanal and small-scale gold mining operations. A major way to reduce exposure 
without reducing fish consumption, is reducing anthropogenic Hg emissions. As of 2010, it 
appeared that Europe and North America were, overall, reducing their Hg emissions. However, 
emissions from developing nations are still rising (Rallo et al. 2012), creating concerns as 
developing nations often have disparate health risks compared to other nations 
(Chongsuvivatwong et al. 2011; Doherty and Clayton 2011; Hanna and Kangolle 2010). In 2013, 
the United Nations Environment Programme (UNEP) agreed to the text of the Minamata 
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Convention on Mercury, which has the objective of protecting health and the environment from 
mercury pollution originating from anthropogenic emissions. It provides goals related to 
reducing emissions, dealing with existing contamination and mercury- containing waste, as well 
as measures to support the efforts of developing nations to address those goals (UNEP 2013). 
There is continued need for Hg specific policy to reduce emissions and potential exposure.  
In Conclusion  
 The high prevalence and associated costs of ADHD make it a pressing public health 
concern. There is consistent evidence that a diagnosis of ADHD is related to reduced quality of 
life, poor academic performance, and difficulties in later employment (Birnbaum et al. 2005; 
DeShazo Barry et al. 2002; Escobar et al. 2005; Secnik et al. 2005). A thorough understanding of 
the etiology of ADHD could help us identify possible cases early, refine treatment, and, in the 
case of environmental risk factors, reduce incidence rates. 
 The chemical exposures of most interest for ADHD risk are those that have been 
previously observed to cause dysfunction in catecholamine signaling or lesions in areas of the 
brain suspected to be responsible for functional deficits. There is existing evidence that MeHg 
can disrupt normal DA signaling (Faro et al. 1997; Tiernan et al. 2013; Beyrouty et al. 2006; 
Chakrabarti et al. 1998). At high levels, it can cause lesions in some of the same brain regions 
which are affected in cases (Bertossi et al. 2004; Ceccatelli et al. 2010; Cherkasova and 
Hechtman 2013; Eto 2000), suggesting there is biological plausibility for it to add to ADHD risk.  
Additionally, risk is likely to be associated with a particular window of development. In 
the case of MeHg, exposure current evidence points towards pre-natal exposure as the most 
susceptible period (Oken et al. 2005; Grandjean et al. 2012; Grandjean et al. 1997), although the 
exact window is not yet known. Further research to determine this vulnerable period could allow 
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existing interventions, such as the EPA and FDA fish consumption guidelines, to be more 
effectively targeted.  
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